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Abstract
Objectives:
The aim of this thesis was to evaluate the value of modern high-resolution transvaginal 
ultrasound for differential diagnosis of adnexal tumours. This was done by performing a 
series of studies: (1) comparison of risk of malignancy index (RMI) and ovarian crescent 
sign (CCS) for the diagnosis of ovarian malignancy; (2) assessment of the value of pattern 
recognition for the diagnosis of borderline ovarian tumours (BOT); (3) comparison of 
diagnostic accuracy using real-time and static images (4) assessment of the reproducibility 
of ultrasound pattern recognition for the diagnosis of BOT; (5) assessment of the effect of 
degree of operator’s confidence on diagnostic accuracy; (6) examination of the effect of the 
quality of gynaecological ultrasound diagnosis on the management of patients with 
suspected ovarian cancer; and (7) determining the value of preoperative ultrasound 
examination for selection of women for laparoscopic surgery.
Interpretation of findings:
(1) The OCS proved to be a simpler and better method in diagnosing ovarian cancer when 
compared to the RMI. (2) Ultrasound diagnosis of BOT is highly specific but typical 
features are absent in one third of cases. (3) The diagnosis of an adnexal mass is more 
accurate when made on the basis of real-time ultrasound examination than on static 
ultrasound images. (4) Accuracy of ultrasound diagnosis of BOT is less in comparison to 
benign and invasive malignant lesions. (5) Accuracy of ultrasound pattern recognition in 
differentiating ovarian tumours depends on the degree of certainty with which the diagnosis 
is made. (6) Improved quality of ultrasound examination has a measurable positive effect 
on the management of women with suspected ovarian malignancy. (7) Detailed
preoperative ultrasound examination of benign adnexal lesions is helpful for assessing 
feasibility of their removal by laparoscopic surgery.
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PART ONE:
Background
20
Chapter 1: Introduction
The reported prevalence of ovarian tumours has significantly increased in the past two 
decades (Borgfeldt and Andolf, 1999; Nelson et al., 1986; Yazbek et al., 2007). This 
increase is mainly attributed to the routine use of ultrasound for the assessment of women 
with a wide range of gynaecological complaints. In many cases women with clinical 
suspicion of adnexal mass are urgently referred by their general practitioners to a rapid 
access unit and they usually receive a scan as a part of the investigations. In many women 
the diagnosis of ovarian cyst generates considerable anxiety because of uncertainty about 
its nature. The presence of an ovarian cyst is traditionally considered to be an indication for 
operative intervention due to fear of ovarian cancer and acute complications of ovarian 
cysts such as torsion and cyst rupture. However, these risks are difficult to quantify and it is 
possible that many asymptomatic women with cysts are being over-treated. Surgery itself is 
not without risks and many asymptomatic women with benign cyst may develop 
complications following an operation to remove the ovarian cyst (Chapron et al., 1998; 
Minelli, 1996).
The management of patients diagnosed with ovarian tumours is mainly determined 
by their nature. The best survival rates for women with ovarian cancer are achieved when 
treatment is organised and carried out by gynaecological oncologists working in cancer 
centres (Junor et al., 1999). However, women with asymptomatic benign tumours can be 
managed expectantly (Yazbek et al., 2007; Platek et al., 1995, Lee et al., 2004) or by 
minimally invasive surgery if symptomatic (Hilger et al., 2006; Mais et al., 1995). These 
operations can be safely performed by general gynaecologists in their local hospitals.
21
There is an added pressure on the ultrasonographers to provide a diagnostic opinion 
about the nature of the adnexal mass being benign or malignant. Furthermore, there is still 
no consensus on the most effective diagnostic criteria to discriminate between benign and 
malignant ovarian tumours on ultrasound scan (Granberg et al., 1990; Sassone et al., 1991; 
Lerner et al., 1994; Jacobs et al., 1990; Tailor et al., 1997; Timmerman et al., 1999a; 
Valentin et al., 2001; Aslam et al., 2000). Ultrasound methods used to establish a diagnosis 
in the case of an adnexal lesion will be discussed in further detail in the relevant chapters. 
Most ultrasonographers in the United Kingdom use the pattern recognition method in order 
to establish a diagnosis of an ovarian tumour. However, the differentiation between benign 
and malignant adnexal tumours is often difficult and it mainly depends on the expertise of 
the ultrasonographers (Valentin, 1999; Timmerman et al., 1999b). Timmerman et al. 
(1999b) aimed at differentiating benign and malignant ovarian tumours using subjective 
pattern recognition in a study of 300 patients, taking into account the influence of 
observer’s experience on overall test performance. The best reported accuracy (calculated 
as the sum of true positives and true negatives divided by the total number of studied cases) 
was achieved by the most experienced operator and this was 275/300 (91.7 %, 95% Cl 88 -
94.3). The study was performed on stored still ultrasound images and did not classify 
borderline ovarian tumours separately from invasive malignant tumours.
Valentin (1999) assessed the value of ultrasound pattern recognition method in 173 cases 
scheduled for surgery because of pelvic masses. She reported a sensitivity of 88% (95% Cl, 
69 -  96), specificity 96% (95% Cl, 92 -  98), positive likelihood ratio 22 and negative 
likelihood ratio 0.13. Again this study classified borderline ovarian tumours as invasive 
malignant.
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Tumours with complex morphological appearance on ultrasound such as borderline 
ovarian tumours (BOT) are difficult to characterise and they are easily confused with 
invasive ovarian malignancy (Valentin et al., 2006). The inability to establish accurately the 
nature of the ovarian tumour would eventually lead the gynaecologist to perform additional 
tests such as checking serum CA-125 as this could be used to establish a risk of malignancy 
index (RMI) (Jacobs et al., 1990) based on which results, the patient could be offered 
management locally or could be referred to a gynaecological cancer centre for management 
(RCOG Greentop guidelines, 2003).
Jacobs et al. (1990) assessed the risk of malignancy index on 143 patients 
preoperatively. A cut-off level of 200 provided a sensitivity of 85.4% (95% Cl, 70.8 -
94.4), specificity 96.9 (95% Cl, 91.3 -  99.4), positive likelihood ratio 42.1 and negative 
likelihood ratio 0.15. The problem is that the study included a small proportion of ovarian 
malignancies (n=42), which were mainly stage III and of serous histology. This could have 
contributed to the high CA-125 level, which is only elevated in 50% of stage I ovarian 
cancer.
Some centres, have facilities to refer those patients with inconclusive scan result to 
a tertiary gynaecological ultrasound centre, where the scans are carried out by ‘experts’ in 
gynaecological ultrasound scan (EFSUMB Newsletter, 2005). Experienced 
ultrasonographers using relevant clinical information and their subjective assessment of 
ultrasonographic images can differentiate malignant from benign masses in most cases 
(Timmerman et al., 1999b). However, it is unclear whether the gynaecologist and the 
patient would be completely reassured and opt for conservative management if a diagnosis 
of benign adnexal tumour is made by experts in gynaecological ultrasonography. 
Furthermore, the reproducibility of ultrasound pattern recognition, when used by different
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experts in gynaecological ultrasonography, for the differentiation between benign, 
borderline and malignant invasive ovarian tumours is not known. We also do not know 
whether expert ultrasound operators use similar criteria to differentiate between the three 
different types of adnexal tumours and how confident these operators are in reaching their 
final diagnoses. In addition, an important issue in gynaecological ultrasonography yet to be 
investigated and that is whether expert ultrasound operators could review still ultrasound 
images, when their opinion is required and they are not personally available to scan the 
patient, and achieve a high diagnostic accuracy (in our thesis diagnostic accuracy is 
expressed through sensitivity and specificity, positive and negative predictive values, or 
positive and negative diagnostic likelihood ratios) comparable to when they are performing 
the real-time ultrasonography.
Despite the fact that the diagnostic accuracy of expert ultrasound operators in 
differentiating between benign and malignant tumours is high (Valentin, 1999; Timmerman 
et al., 1999b), these experts are not available in all hospitals and the day to day ultrasound 
examinations aie carried out by ultrasonographers or by general gynaecologists. Thus, it 
was important to describe “easy” ultrasound markers, which may help less experienced 
ultrasonographers in the differentiation between benign and malignant adnexal tumours. 
The RMI, which has been widely adopted in the UK to facilitate triage of women with 
ovarian tumours for referral to tertiary gynaecological oncology units (Jacobs et al., 1990; 
RCOG Greentop guidelines, 2003). Although the RMI is relatively a simple test to use in 
clinical practice, it has significant false negative and false positive rates (Aslam et al., 
2000). In addition, the results are not immediately available and the test is relatively costly, 
as it involves the use of serum biochemistry. Our research group have recently described a 
new morphological ultrasound feature, the ‘ovarian crescent sign’ (CCS), which depends
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on the fact that healthy ovarian tissue can be seen adjacent to the cyst within the ipsilateral 
ovary (Hillaby et al., 2004). The initial report, which included 100 women, reported a 
sensitivity of 91% (95% Cl, 76 -  97), specificity 84% (95% Cl, 73 -  91), positive 
likelihood ratio 5.54 and negative likelihood ratio 0.11 in the diagnosis of ovarian 
malignancy (this included borderline ovai'ian tumours). This study was not applied on the 
general population but only included women who were scheduled to have surgery to 
remove their ovarian tumours. A relatively low proportion of benign ovarian tumours 
(n=67) was included as a result. This study showed that this morphological ultrasound sign 
has a potential of becoming a simple and effective way of excluding an invasive ovarian 
malignancy, without the need for a detailed morphological assessment of the tumour or the 
use of serum biochemistry. We carried out further work on the OCS and prospectively 
compared its value to that of RMI for the diagnosis of ovarian cancer in a large group of 
women with an ultrasound diagnosis of ovarian tumour.
BOTs remain the most difficult adnexal tumours to be correctly classified both pre- 
operatively and on histological examination (Valentin et al., 2006). Since 1971, the 
International Federation of Gynecology and Obstetrics (FIGO) (1971) has classified BOTs 
as an entity separate from benign and invasive ovarian tumours (Serov et al., 1973). 
However, until recently, BOTs have been treated in the same way as invasive malignant 
tumours. BOTs are more prevalent in women of childbearing age (Gotlieb et al., 2005, 
Gotlieb et al., 1998; Boran et al., 2005) and their prognosis is generally good (Ahmed and 
Lawton, 2005; Silverberg et al., 2004). They often follow a relatively benign course 
(Ahmed and Lawton, 2005; Silverberg et al., 2004) and therefore fertility sparing 
conservative surgery is often contemplated in women with BOT who wish to preserve their 
reproductive potential (Maneo et al., 2004). Therefore, accurate diagnosis is essential for
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planning appropriate patient management (Osmers, 1996). The diagnostic accuracy of 
ultrasound pattern recognition for the differential diagnosis between benign, borderline and 
invasive ovarian tumours has not been tested as yet. We collected data on a selected mix of 
women who were referred to our gynaecological ultrasound assessment unit with adnexal 
tumours, which nature was “difficult” to characterise. We prospectively assessed the value 
of pattern recognition for the differential diagnosis of adnexal tumours and in particular its 
accuracy in establishing the specific diagnosis of histological subtypes of BOTs.
In our hospitals, a patient with an adnexal mass is often first scanned by a junior or 
senior sonographer. Subsequently, the images are discussed with a supervising ultrasound 
operator, who will often rescan the patient, because he or she believes that this will help in 
gaining the right information to make a correct diagnosis. However, to the best of our 
knowledge, it has never been confirmed in a scientific study that real-time scanning is 
superior to evaluating saved static images of an adnexal mass. If examining static 
ultrasound images had a comparable accuracy to real-time ultrasonography, this could have 
a positive effect on the management of patients in small hospitals where expertise could be 
lacking and a second opinion might be sought by sending the images to an expert 
ultrasound operator in a tertiaiy hospital. We examined a large data set containing 
representative images of different types of adnexal tumours in order to determine if the 
prediction of the character of an adnexal mass using subjective evaluation of gray-scale and 
Doppler ultrasound findings based on the evaluation of static images is as accurate as that 
based on a real-time ultrasound examination.
Previous studies have shown that the ultrasound pattern recognition method is 
superior to other ultrasonographic methods for differentiating between benign and 
malignant adnexal tumours (Valentin, 1999), especially if the examination was carried out
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by an experienced ultrasound operator (Timmerman et al., 1999b). However, the 
reproducibility of expert ultrasound operators at identifying borderline ovarian tumours as a 
separate entity from benign and malignant invasive ovarian tumours has not been properly 
tested before. We carried out a study to assess reproducibility of ultrasound pattern 
recognition method for the diagnosis of borderline ovarian tumours by asking experienced 
ultrasound operators to systematically examine a large data set containing representative 
images of different types of adnexal tumours.
Ultrasound pattern recognition technique is operator-dependent and its accuracy 
improves with the increase in the operator’s experience. However, it is unclear whether 
expert ultrasound operators have a similar degree of confidence in making their diagnoses 
and whether the diagnostic accuracy decreases with the decrease in the level of confidence. 
We used the same dataset from the above study to assess the degree of confidence with 
which expert ultrasound operators differentiate benign, borderline and malignant invasive 
ovarian tumours and to measure the diagnostic accuracy and interobserver agreement when 
the ultrasound operators make a certain, probable or uncertain diagnoses.
In recent years we have witnessed significant improvements in the ability of 
ultrasound examination to discriminate between different types of adnexal tumours. It is 
not clear, however, whether this improved diagnostic accuracy has a measurable impact on 
the management of women with ovarian tumours. We carried out a prospective randomised 
study to check whether the improved specificity of ultrasound diagnosis would lead to a 
significant decrease in the number of major surgical procedures in women who were 
referred to our regional gynaecological cancer centre with suspected ovarian cancer. This 
study also investigated whether, and for the first time, the efforts to improve the quality of 
ultrasound diagnosis aie worthwhile. The study assessed the role of highly skilled
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ultrasound operators in the management protocols of women diagnosed with adnexal 
tumours as this may have important benefits: shorter and more effective diagnostic 
assessment, reduced number of major surgical procedures and their associated morbidity, 
better use of subspecialty oncology services and reduced cost of treatment.
In the past, several studies have assessed the value of ultrasound and Doppler in 
correctly identifying the risk of malignancy of adnexal tumours and selecting those with 
low risk of malignancy for laparoscopic surgery (Berlanda et al., 2002; Guerriero et al., 
2005). However, the value of ultrasound for the preoperative selection of women with 
benign adnexal masses for removal by either laparoscopic surgery or by laparotomy has not 
been examined. We collected prospective data on women who had non-invasive adnexal 
tumours diagnosed on ultrasound scan and required surgery. These women underwent a 
pre-operative scan by a highly skilled ultrasound operator in order to develop and assess a 
set of ultrasound criteria that were designed to select women for laparoscopic removal of 
ovarian cyst with a minimum risk of converting the operation to a laparotomy. Although 
there is no doubt that the success of laparoscopic surgery is mainly dependent on the skill 
and expertise of the operating surgeon. In expert hands most operations can be completed 
successfully using a laparoscopic approach. Most consultant gynaecologists in the UK and 
worldwide perform intermediate-level laparoscopic surgery (RCOG in collaboration with 
BSGE, 2005). The results of this study may aid them when selecting women with benign 
cysts for minimally invasive surgery.
In summary, this work investigated whether the improved diagnostic accuracy of 
gynaecological ultrasonography has a measurable impact on the management of women 
with ovarian tumours. It also aimed at aiding less experienced ultrasound operators in 
correctly differentiating between different types of adnexal tumours.
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Chapter 2: Ultrasound gray scale morphology (pattern recognition) 
2.1. Introduction
Ovarian morphology differs and depends on the woman’s age and the menopausal 
status. It is very difficult to measure the ovaries of a female child (Orsini et al., 1984; 
Sample et al., 1977). On the other hand, the premenopausal ovarian morphology is a 
continually varying landscape, which is controlled by the hypothalamic-pituitary axis. Thus 
the ovarian morphology would differ depending on the day of the menstrual cycle. 
Whereas, the inability to visualise one or both ovaries in postmenopausal women is not 
unusual due to the relative inactivity of these ovaries.
The introduction of transvaginal ultrasound scanning (TVS) into practice provided 
ultrasound operators with better resolution in order to assess the morphology of the normal 
and the abnormal ovary. TVS has a high patient acceptability (Van Nagell Jr et al., 1991). 
Transabdominal ultrasound scanning (TAS) has limited resolution and requires the patient 
to have a full bladder in order to provide an acoustic window. Nonetheless, TAS and TVS 
complement each other in order to ensure complete examination of large ovarian tumours, 
extending beyond the range of the transvaginal transducer.
There was a lack of standardised description of findings in gynaecological 
sonography (Timmerman et al., 2000). A review of the literature had revealed considerable 
variation in the diagnostic accuracy of test procedures as a result of this lack of 
standardisation (Timmerman, 1997). Consequently, a new initiative was started by the 
International Ovarian Tumor Analysis (IOTA) group, where a steering committee had made 
recommendations about terms and procedures for morphologic end-points by B-mode 
imaging (Timmerman et al., 2000).
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2.2 Lesion
An adnexal lesion is the part of an ovary or an adnexal mass that is judged from the 
assessment of ultrasound images to be inconsistent with normal physiologic function. This 
situation can arise from the presence of a persistent unilocular cyst, surrounded by healthy 
ovarian tissue. In this case the whole ovary containing the cyst is the ‘ovary’, whilst the 
unilocular cyst is the ‘lesion’. The size of both structures is measured independently, and 
the cyst is described as being unilocular (see below). In cases where the lesion is separate 
from the ovaries (e.g. hydrosalpinx), the size of both ovaries and the lesion are measured 
separately. When no normal ovarian stroma is visible; the lesion and the ovary are 
undistinguishable, and consequently the size of the lesion and the ovary will be the same 
(Timmerman et al., 2000).
2.3 Locularity
A loculated cyst is one that is divided into compartment by septa. A septum is defined as a 
thin strand of tissue running across the cyst cavity from one internal surface to the 
contralateral side. An incomplete septum is defined as a thin strand of tissue running across 
the cyst cavity from one internal surface to the contralateral side, but which is not complete 
in some scanning planes. When the septum is incomplete the cyst is described as unilocular.
The number of compartment in cystic ovarian tumours is related to the potential 
likelihood of the lesion being malignant. A previous study by Osmers et al. (1996) found 
that in the absence of solid components, the clinical significance of a tumour increases in 
the presence of more than three compartments within the cyst. A study by Meire et al. 
(1978) found that multilocular cysts are more likely to be malignant when compared to 
unilocular cysts.
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The septum thickness has been analysed in previous studies. Malignant tumours are 
more likely to have thick and irregular septa compared to thin septa in benign lesions. A 
thick septum has been arbitrarily defined as one greater than 3 mm. Meire et al. (1978) 
found the majority of ovarian cysts with thick septa were malignant.
2.4. Papillary projections
These are solid projections arising from the cyst wall into the cyst cavity with a height 
greater than or equal to 3 mm. These solid tissues are thought to represent localised 
overgrowths of epithelium. Although they are seen occasionally in benign ovarian tumours, 
they appear to be characteristic features of both borderline ovarian tumours and stage I 
epithelial ovarian cancer (Valentin et al., 2006a). It is also believed that the greater the 
number of papillary projections present, the greater the likelihood of malignancy (Granberg 
et al., 1990; Bailey et al., 1998).
It is occasionally difficult to report solid papillary projections in the presence of 
incomplete septum. It is recommended (Timmerman et al., 2000) that excrescences 
associated with the ‘cogwheel’ sign and the ‘beads-on-a-string’ sign (usually observed in 
hydrosalpinges) (Timor-Tritsch et al., 1998) should be classified as papillary projections if 
their height is greater or equal to 3 mm. It is also important not to classify the hyper- 
reflective area in the centre of a dermoid cyst (Cohen and Sabbagha, 1993) as a solid 
papillary projection (Timmerman et al., 2000). In this thesis a projection with a thin base 
(<2 mm in width) especially an isolated one was recorded as an incomplete septum.
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2.5 Cyst wall
The internal cyst wall is described as being smooth or irregular. In the presence of at least 
one solid papillary projection, then the wall is described as irregular. The external wall of 
the cyst is not taken into account. The risk of malignancy is greater with the increase in the 
internal wall irregularity.
2.6 Cyst content
The dominant feature of the tumour content is described as anechoic when the content 
appears black like in the case of functional cysts. The content may alternatively be 
described as low-level echogenic as seen in mucinous tumours, ‘ground glass’ appearance 
when the homogenously dispersed echogenic cystic contents is noted like in the case of 
endometriotic cysts, haemoiThagic appearance (star-shaped, cobweb-like, or jelly-like), or 
mixed echogenicity like in the case of teratomas. Solid tumours tend to have high 
echogenicity, however the dominant feature of any cystic contents is only described if it 
can be assessed.
2.7 Solid lesion
Solid tumours exhibit high echogenicity suggesting the presence of tissue like in the case of 
ovarian fibromas. Occasionally, cystic tumours containing thick fluid could be mistaken for 
solid tumours like in the case a blood clot filling an ovarian cyst. Pushing the transducer 
gently towards the structure and looking for internal movement may distinguish between 
blood clots and solid tissue. However in cases of uncertainty, it is recommended to classify 
the lesion as solid.
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2.8 Acoustic shadows
This is defined as the loss of acoustic echo behind a sound-absorbing structure. Acoustic 
shadowing is noted in the presence of small calcified particles within the tumour like in the 
case of dermoid cysts or ovarian fibromas.
2.9 Ascites
This is the presence of free fluid outside the pouch of Douglas, within the peritoneal cavity. 
It is usually documented as present or absent. Ascites is typically present in cases of 
ovarian malignancies. Osmers et al. (1996) reported the presence of free fluid in 11.1% of 
borderline ovarian tumours, but free fluid was also present in 13% of cases with functional 
cysts. In a more recent study, Valentin et al. (2006b) reported the presence of ascites in 9% 
of borderline ovarian tumours. This was less, statistically, than the frequency of ascites in 
the case of Stage I epithelial ovarian cancer (31%) and Stage II-IV epithelial ovarian cancer 
(61%). This group also observed the presence of ascites in cases of rare ovarian 
malignancies (56%) and in cases of metastatic ovarian tumours (43%).
2.10 Size
An adnexal tumour is measured in three perpendicular planes and its mean diameter is 
calculated according to the formula (Di + D% + D3)/3. The tumour volume is calculated 
using the formula (7t/6 x Di x D 2  x D 3 ) .
Several studies have demonstrated that the risk of malignancy increases with the 
size of the lesion (Granberg et al., 1990; Andolf et al., 1986). Granberg et al. (1990) 
reported a positive predictive value for malignancy of 5.9% for cysts less than 5 cm in 
mean diameter, 21.3% from 5 to 10 cm, and 43.6% for cysts greater than 10 cm. Osmers et
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al. (1998) reported an incidence of malignancy of 13.9% in cysts less than 4 cm in mean 
diameter compared to an incidence of malignancy of more than 50% in cysts greater than 7 
cm in mean diameter.
In another study Osmers et al. (1996) found that 36.9% of all premenopausal 
ovarian tumours to be between 3 and 4 cm in diameter. Of these 68.2% turned out to be 
functional in nature. They also found that 27.4% of tumours greater than 9 cm in mean 
diameter were malignant.
Rulin and Preston (1987) found, in a study population of 150 postmenopausal 
women with adnexal pathology, that only one of 47 malignant masses to be less than 5 cm 
in diameter. In addition, only one of 32 masses less than 5 cm in diameter was found to be 
malignant. The likelihood of malignancy in postmenopausal women with adnexal masses 
less than 5 cm in diameter was 3% (Rulin and Preston, 1987)
2.11 Qualitative classification of adnexal lesions
Timmerman et al. (2000) suggested classifying all lesions into one of six categories:
• Uniloculai' cyst: A cyst without septa or solid parts or papillary projections.
• Unilocular solid cyst: a unilocular cyst with a measurable solid component or at 
least one papillary projection. Hydro- or pyosalpinges may be included in this 
category, if the height of the ‘beads-on-a-string’ is greater than or equal to 3 mm.
• Multilocular cyst: a cyst with at least one septum but with no measurable solid 
components or papillary projections.
• Multilocular solid cyst: a multilocular cyst with a measurable solid component or at 
least one papillary projection.
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• Solid tumour: a tumour where the solid components comprise 80% or more of the 
tumour, when assessed in a two dimensional section
• Not classifiable: owing to poor visualisation
2.12 ‘Simple’ cysts
These are thin, smooth walled unilocular cysts with anechoic fluid content, with no visible 
septum or solid components. The minimum diameter of simple cysts used in all the studies 
forming this thesis was 3 cm.
The risk of malignancy within simple cysts less than 10 cm in diameter is minimal 
(Auslender et al, 1996; Levine, 1994; Bailey C et al., 1988). However, when a cyst 
diameter approaches and extends beyond the range of the transvaginal probe (usually up to 
8-10 cm) a complete survey of the internal wall is not possible, and “simple cyst” 
classification should be used with caution in these large ovarian cysts. In these cases, 
transvaginal ultrasound and transabdominal ultrasound should be subsequently used in 
order to ensure complete examination of the lesion. These simple cysts may represent 
physiological (functional) cysts, serous cystadenomas, or peritoneal inclusion cyst.
Osmers et al. (1996) estimated that around 60% of all premenopausal ovarian 
tumours are simple cysts. Two-thirds of these are functional cysts that would resolve 
spontaneously. This group found that 0.8% of ovarian malignancies presented as simple 
cyst (Osmers et al., 1996). The risk of malignancy would obviously increase with the 
diameter of the simple cyst.
The prevalence of simple cysts in postmenopausal women is reported to be between 
3% and 17% (Auslender et al., 1996; Levine, 1994). The most common histology of simple 
cysts in this group of women is benign cystadenoma. The risk of malignancy is small when
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the cyst is less than 5 cm in diameter (Roman, 1998). Ekerhovd et al. (2001) compared 
preoperative sonographic morphology with gross and histological findings in 927 pre- and 
337 postmenopausal women with unilocular cysts. They found three borderline and three 
malignant tumours at surgery in supposedly simple cysts, all of which were over 7.5 cm in 
greatest diameter. All had visible papillations at surgery. In addition, there was one 
paradoxically benign truly simple ovarian cyst of 3.9 cm associated with stage III cancer 
and ascites. The authors calculated the false-positive rate as being seven of 660 simple 
cysts or 1.06%, including the benign cyst, in all women. There were no cancers in this 
series of simple cysts, which were less than or equal to two centimetres. Of the 377 total 
unilocular (both simple and complex) postmenopausal cysts, almost a third were benign 
tumours, 28% were histologically simple cysts, 6% were functional cysts, 6% were 
hydrosalpinges, 8% were endometriomas and 7% were paraovarian cysts. There were five 
tumours of low malignant potential and 12 cancers.
Valentin and Akrawi (2002) methodically observed 134 asymptomatic women with 
160 benign appearing adnexal cysts found incidentally and followed over 8 years. The 
findings of this study reinforced the concept that simple cysts do not require surgery.
However, some borderline ovarian tumours (BOT) may exhibit a unilocular 
smooth-walled appearance. 9% of the BOTs described by Exacoustos et al. (2005) and 4% 
of those described by Fruscella et al. (2005) were unilocular smooth-walled cysts. This 
again could be due to the fact that this type of ovarian tumour is characterized by its large 
size at presentation, which makes the complete assessment of the entire tumour a difficult 
task.
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2.13 Complex adnexal cysts
These are multilocular cysts, which may or may not contain echogenic fluid or solid 
papillary projections. It has been shown that the more complex the tumour appearance, the 
greater is the likelihood of it being malignant (Granberg et al., 1990). However, the term 
complex cyst could represent any adnexal tumour ranging from a functional corpus luteum 
cyst to an invasive ovarian malignancy. Therefore a large degree of overlap between benign 
and malignant pathology exists in this group of adnexal tumours. Thus, it is recommended 
to use the standardised terms in describing the appearances of different adnexal tumours as 
detailed in section 2.11.
Subjective evaluation of the gray-scale ultrasound image, i.e. pattern recognition, 
for discrimination between benign and malignant tumours can almost certainly be learnt by 
anyone performing gynaecological ultrasound examinations on a regular basis, but 
diagnostic accuracy increases with increasing experience (Timmerman et al., 1999b). An 
experienced ultrasound examiner can very confidently discriminate between benign and 
malignant pelvic tumours in the adnexal region using pattern recognition, the reported 
sensitivity of pattern recognition varying between 96 and 98%, specificity between 89 and 
90%, LR+ between 8.72 and 9.8 and LR- between 0.02 and 0.05 (Timmerman et al., 
1999b),
Pattern recognition has been shown to be superior to all other ultrasound methods 
(these will discussed separately in further chapters) (Valentin, 1999; Jain, 1994; Buy et al., 
1996; Levine et al., 1994; Salem et al., 1994; Stein et al., 1999; Aslam et al., 2000a; 
Valentin et al., 2001).
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Chapter 3: Other methods used in the ultrasound assessment of adnexal pathology
3.1 Introduction
Assessment of an adnexal mass can be made using B-mode imaging alone. Colour 
Doppler studies have been also introduced in order to help in the differentiation between 
benign and malignant adnexal tumours. It was hoped that the introduction of Doppler 
ultrasound would allow detection of abnormal angiogenesis within the pelvis and this 
would subsequently lead to better detection of malignant changes within a mass.
Morphological scoring systems and statistical models, such as those involving 
multivariate logistic regression analysis and more recently artificial neural networks, have 
been developed, to facilitate the differentiation of benign from malignant, and in the case of 
mathematical models, to assign an individual “risk” of malignancy. They aim to try and 
mimic the processes of evaluation that occur within the mind of an experienced 
ultrasonographer, in assigning a risk of malignancy when presented with a number of 
parameters concerning a given patient or lesion (Tailor et al, 1997; Timmerman et al., 
1999a). Considerable overlap exists between the individual ultrasonographic findings that 
are used to define the malignant and benign features of a mass. Initial studies set out to 
establish that the presence or absence of certain morphological characteristics was 
predictive of ovarian malignancy. Increasing complexity, in the form of locularity of the 
cyst, or irregularities of the cyst wall, corresponded with an increasing probability of the 
lesion being malignant.
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3.2 Colour Doppler
Colour Doppler ultrasound of adnexal lesions helps to identify vascularised tissue and can 
assist in differentiating solid tumour tissue from non-vascularised structures. It is also used 
in conjunction with pulsed Doppler US to identify vessels for waveform analysis. Areas of 
blood flow can be seen on Doppler ultrasound as areas of colour.
The Doppler information obtained is colour frequency-coded i.e. colour is assigned 
based on the direction of blood flow and the variance of detected frequency shifts. Red 
indicates blood flow towards the probe, and the blue indicates blood flow away from the 
transducer. The brightness of the colour is proportional to the velocity of flow within the 
vessel.
The gain and pulse repetition frequency are initially adjusted for maximum 
sensitivity of low blood flow. The lowest velocity signals are filtered out gradually by 
increasing the pulse repetition frequency and flow analysis is concentrated on the highest 
velocity signals. A pulsed Doppler range gate is placed over the area of interest to provide 
flow velocity waveforms that can be analysed. The indices measured are the pulsatility 
index (PI), resistance index (RI), peak systolic velocity (PSV) and time-averaged maximum 
velocity (TAMXV). RI and PI value represent a measure of impedance to blood flow distal 
to the point of sampling (Thompson et al., 1988). A low value indicates decreased 
impedance to blood flow, whereas a high value is indicative of increased impedance to 
blood flow.
Most studies have relied on waveform analysis to distinguish benign from 
malignant ovarian masses (Kurjak and Predanic, 1992; Franchi et al., 1995; Kurjak et al., 
1992; Brown et al., 1998). Benign lesions tend to initiate new tumour blood vessel 
formation peripherally from pre-existing host vessels, whereas malignant tumours tend to
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initiate new tumour blood vessel formation centrally (Kurjak et al., 1993; Dock et al., 1991 ; 
Folkman et al., 1989). Waveform analysis is based on the fact that malignant tumour 
vessels are morphologically abnormal: they lack smooth muscle in their walls and 
demonstrate an irregular course and arteriovenous shunt formation (Kurjak et al., 1993; 
Dock et al., 1991; Folkman et al., 1989). In addition, malignant tumour vessels generally 
have low impedance, which causes high diastolic flow and low systolic-diastolic variation. 
Some differentiation between benign and malignant masses is achieved by quantifying 
these differences.
A compai'ison of different studies shows that no standard has been established 
concerning which Doppler index to use or what cut-off value is most appropriate. However, 
RI less than 0.4-0.8 (84-90) and PI less than 1.0 are generally considered to be suspicious 
for malignancy (Hamper et al., 1993; Brown et 1., 1998; Jain, 1994; Levine et al., 1994; 
Salem et al., 1994). Doppler ultrasound has yielded variable results in distinguishing benign 
from malignant masses, with a sensitivity of 50%-100% and a specificity of 46%-100% 
(Hata et al., 1992; Kurjak et al., 1992; Reles et al., 1997; Timor-Tritsch et al., 1993). 
Differing results are partly due to varying threshold values and corresponding tradeoffs 
between sensitivity and specificity.
In cases in which septations, papillae, and solid areas of tumour are absent, it is 
difficult to detect signal for waveform analysis. In addition, certain Doppler indexes can be 
misleading in premenopausal women and usually have a lower specificity because of 
physiologic alterations in the ovary due to the menstrual cycle which cause lower blood 
vessel resistance, thereby mimicking malignancy. Finally, acute inflammatory adnexal 
disease and endometriosis are common conditions associated with an increased number of 
capillaries and dilatation of blood vessels, which cause a low PI (Pellerito et al., 1995). In a
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study by Reles et al. (1997), the sensitivity of colour Doppler ultrasound was 80%, and the 
specificity only 67% (LR+ of 2.42 and LR- of 0.30) in premenopausal patients, whereas in 
postmenopausal patients, the sensitivity and specificity were 93% and 83%, respectively 
with LR+ of 5.47 and LR- of 0.08 .
Valentin et al. (1994) compared the ability of colour Doppler and that of gray-scale 
ultrasound morphology to distinguish between benign and malignant adnexal tumours. 
They found that PI, peak systolic volume (PSV) and TAMXV values overlapped in almost 
all benign and malignant masses, except for multilocular cysts with solid parts. In this 
group of cysts the PI was significantly lower, and the blood flow velocities significantly 
higher, in malignant tumours. The ultrasound morphology was a better discriminator 
between benign and malignant tumours compared to Doppler variables. They concluded 
that Doppler has a limited role in the assessment of adnexal pathology.
In summary, variations exist in the reported results of Doppler ultrasound. At 
present, there are no reliable criteria regarding absolute cut-off values for the different 
Doppler indices in the discrimination of benign and malignant adnexal tumours. Adding 
Doppler ultrasound examination to subjective evaluation of the gray-scale ultrasound image 
does not seem to yield much improvement in diagnostic precision but it may increase the 
confidence with which a correct diagnosis of benignity or malignancy is made (Valentin, 
2004).
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3.3 Morphological Scoring Systems
Because the diagnostic performance of ultrasound pattern recognition method is operator 
dependent (Valentin 1999; Timmerman et al., 1999b) and in order to overcome these 
limitations, scoring systems were designed with an aim to define strict criteria when 
describing ultrasound findings, which were easily reproducible.
Morphological scoring systems were introduced in order to improve the diagnostic 
accuracy of ultrasound in the differentiation between benign and malignant adnexal masses. 
Granberg et al. in 1989 demonstrated a correlation between the ultrasonographic 
appearance and the microscopic characteristics of a cyst. Within the population studied, 296 
cysts were characterised as simple and unilocular. Of these, only one was malignant, and 
this cyst was between 5-10 cm in diameter, with a macroscopically visible papillary 
process in a woman aged 60 yeai's. Of the cysts with papillations 93% were malignant, and 
papillations were the most predictive morphological feature of malignancy, when compared 
to the woman’s age or cyst size. There was no correlation between the size of a simple cyst 
and malignancy, however, increasing cyst size in complex cysts will correlate with an 
increased risk of malignancy. It must also be remembered that a cyst size of greater than 10 
cm in diameter may be difficult to characterize as a full assessment of the internal cyst wall 
will not always be possible due to the limited scanning field of the transvaginal probe. An 
extension of initial morphological classifications was the development of scoring systems 
to assign a risk of malignancy to a particular mass.
Sassone et al. (1991) developed one of the most popular scoring systems to allow an 
objective description of extrauterine pelvic disease, based on morphological characteristics. 
They were able to differentiate benign from malignant tumours with a specificity of 83%, 
sensitivity of 100%, LR+ of 5.88 and LR- of 0. The positive and negative predictive powers
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were 37 and 100%, respectively. The variables studied were inner wall structure, wall 
thickness, septal thickness, and the echogenicity of cyst contents. Tumour size did not 
improve the sensitivity, and so it was excluded. Benign cystic teratomas were the main 
cause of false positive test results.
Lerner et al. (1994) modified the morphological scoring system devised by Sassone 
et al. (1991) by producing a weighted scoring system including the presence or absence of 
acoustic shadowing, resulting in better differentiation between benign and malignant 
masses. The sensitivity and specificity achieved were 96.8% and 77% respectively (LR+ of 
4.21 and LR- of 0.04), with a positive predictive value of 29.4%. They concluded that 
further amendments to the scoring system were necessary in order to reduce the high false 
positive rates. They postulated whether the addition of Doppler flow studies would improve 
the diagnostic performance (Lerner et al., 1994).
Bourne et al. in 1993 prospectively tested the use of a morphology score as a second 
stage test within an ovarian cancer screening program. Its use, while significantly reducing 
the false positive rate, also reduced the sensitivity to 83% from 100%.
3.4 Multiparameter Models
These models were introduced in an attempt to improve sensitivity and specificity in the 
ultrasound diagnosis of adnexal tumours. These models combine demographic, biochemical 
and ultrasound data to calculate a probability of malignancy.
43
3.4.1 Risk of Malignancy Index
Described by Jacobs et al. in 1990, this was one of the first models, which combined 
ultrasound, demographic and biochemical data. This risk of malignancy index has been 
widely adopted in the UK to facilitate triage of women with ovarian tumours for referral to 
tertiary gynaecological oncology units (Jacobs et al., 1990; RCOG Greentop guidelines, 
2003).
Jacobs et al. (1990) included one hundred and forty-three women who were 
scheduled to have surgery for an adnexal mass in their study. Demographic data were 
recorded for each patient and all women had a serum CA-125 level checked pre- 
operatively. 139 women underwent a pre-operative transabdominal scan. Postmenopausal 
status was defined as greater than one year of amenorrhoea or age over 50 in the case of 
prior hysterectomy.
The study included 101 benign cases and 42 malignant cases. Stepwise logistic 
regression analysis of the data revealed that menopausal status, ultrasound score and serum 
CA-125 levels were the most significant variables for determining the risk of malignancy.
Using logistic regiession analysis Jacobs et al. (1990) devised the following risk of 
malignancy index (RMI):
RMI = U (ultrasound score) x M (menopausal status) x serum CA-125 (kU/L).
Each of the following gray-scale morphological features was given one point when present: 
bilateral lesions, multilocular lesions, solid areas, intra-abdominal métastasés and ascites. If 
the sum of points was 1, an ultrasound score U = 1 was given, while a sum of >2 was given 
a score U = 3. Premenopausal women were given a score M=1 and postmenopausal women 
were given a score M=3.
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By analysing their results, Jacobs et al. (1990) found that using a RMI cut-off level 
of 200 will achieve the greatest diagnostic accuracy with a sensitivity of 85.4% (95% Cl,
70.8 -  94.4), specificity 96.9 (95% Cl, 91.3 -  99.4), LR+ of 42.1 and LR- of 0.15.
Davies et al. (1993) tested the RMI proposed by Jacobs et al. (1990) using the same 
cut-off value of 200, they reached a sensitivity of 87%, specificity of 89%, LR+ of 7.9 and 
LR- of 0.15 in diagnosing ovarian malignancy.
Tingulstad et al. (1996) evaluated the RMI devised by Jacobs et al. (1990) and 
proposed a second RMI (RMI 2). The RMI 2 was calculated using the following formula:
RMI 2= U x M  X serum CAl 25 (kU/L).
If the sum of points was 0 or 1, an ultrasound score U = 1 was given, while a sum of >2 
was given a score U = 4. Premenopausal women were given a score M=1 and 
postmenopausal women were given a score M=4.
RMI 2 had better sensitivity compared to RMI 1 (80% vs. 71%) but slightly worse 
specificity (92% vs. 96%).
The problem is that CA-125 level is a main component of the RMI. However, this 
tumour marker may be elevated in several benign conditions, which mainly affect 
premenopausal women such as menstruation, endometriosis or recent ovulation. As a result, 
the RMI is likely to have lower specificity in premenopausal women despite the fact that 
the menopausal status score is lower (M =l) in this group of women.
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3.4.2 Logistic Regression Models
These are mathematical models based on multivariate logistic regression analysis, with the 
aim of assigning an individual risk of malignancy. These aie based on a statistically derived 
weighting system of certain ultrasonographic and demographic characteristics, rather than 
the arbitrary definitions of more simple morphology scores. This allows the relationship of 
each individual factor to be related to each other, as well as the histological diagnosis. In 
order to use mathematical models within routine clinical practice, a large initial data set is 
required.
Tailor et al. (1997) used a multivariate logistic regression model to assign a 
probability of malignancy to sixty-seven women undergoing surgery for adnexal masses. 
All women underwent a transvaginal B-mode and colour Doppler imaging. Ten variables 
were recorded for each patient. Only three of these variables (age of patient, papillary 
projection score and the time averaged maximum velocity (TAMXV)) were considered 
significant and were retained in the final equation. The papillary projection score was 
assigned values of either 1 or 0 indicating their presence or absence respectively in 
transvaginal ultrasound assessment. The dataset included 52 women with benign, three with 
borderline and 12 with invasive ovarian tumours
The probability of malignancy was calculated using the following formula:
1/(1 + e")
Where z = (0.1273 x Age) + (0.2794 x TAMXV) + (4.4136 x papillary projection score) -  
14.2046.
At a cut-off value of 25%, they achieved the best sensitivity and sensitivity of 
93.3% and 90.4% respectively. They concluded that prediction of malignancy using their
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logistic regression model was significantly better than any of the individual Doppler 
indices, patient’s age, tumour volume or largest diameter.
Timmerman et al. (2005) described a logistic regression model based on the 
assessment of 1066 women with adnexal masses (800 benign and 266 malignant). All 
patients underwent transvaginal ultrasonography with colour Doppler imaging.
The most useful variables for the logistic regression analysis were: personal history 
of ovarian cancer, hormonal therapy, age, maximum diameter of the lesion, pain, ascites, 
blood flow within a solid papillary projection, presence of an entirely solid tumour, 
maximal diameter of solid component, irregular internal cyst walls, acoustic shadows and a 
colour score of intratumoural blood flow. The model containing all the 12 variables gave an 
area under the receiver operating characteristic curve of 0.95 for the development data set 
(n=754 patients). The corresponding value for the test data set (n=312 patients) was 0.94, 
and a probability cut-off value of .10 gave a sensitivity of 93%, specificity of 76%, LR+ of 
3.88, LR- of 0.09, PPV of 55% and NPV of 97%.
3.4.3 Artificial Neural Network Models
Artificial neural networks (ANN) are able to investigate non-linear relationships 
between variables, as opposed to logistic regression models, which are based on linear 
classification. ANN are essentially computer-based decision making tools, which are 
modelled on the structure and learning behaviour of human biological nervous systems 
(Shepherd and Koch, 1990; Haykin, 1994; Newey, 1997).
Knowledge is acquired by the network through a learning process (i.e. training) and, 
second, interneuron connection strengths (known as synaptic weights) are used to store the 
knowledge. These neurons exchange information in the form of numerical values with each
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other via synaptic interconnections. The neurons take a weight sum of their inputs, subtract 
a certain inhibition bias and then feed this numerical value through the network to produce 
an output. These outputs are then fed into the next neuron layer. Finally, at the output level 
of the ANN the outcome represents a probability of an adnexal mass being malignant.
A neuron has the same mathematical form as a logistic regression model and 
therefore an artificial neural network is a generalisation of the logistic regression technique. 
A unique feature of an ANN is its ability to generalise. Generalisation refers to the neural 
network producing reasonable outputs for inputs not encountered during training. Neurons 
within an ANN are structured depending upon the learning algorithm used to train the 
network. This learning algorithm refers to the procedure used to perform the learning 
process.
ANN fall into two distinct categories: supervised and unsupervised. Unsupervised 
networks are capable of partitioning an input feature set (e.g. morphological variables) into 
distinct subsets with no prior knowledge of subset classes (Newey, 1997). On the other 
hand, supervised networks require an external teacher to decide for the network, which sets 
of features belong to the same classes. The adjustment of the network weights (for example, 
through the back-propagation algorithm) and thus the network’s behaviour is based on an 
external supply of examples of correct performance. In most network models the initial 
weights are set at random. During training, examples are presented to the network and the 
synaptic weights have been fine-tuned such that a maximum number of training data were 
correctly classified. These weight values are then fixed and the network can be used to 
classify new cases (Gurney, 1997).
Networks may be structured in a variety of different ways (Haykin 1994). Amongst 
the most commonly used structures for classification are multilayer feedforward networks.
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These consist of three layers: an input layer, a hidden layer and output layer. The hidden 
layer allows the network to extract higher-order statistics (non-linear regression analysis). 
Single-layer feedforward networks consist of an input layer and an output layer. There is no 
hidden layer. In its simplest form this is equivalent to linear logistic regression analysis.
The design of a neural network and the selection of the optimal number of source 
nodes in the input layer and the optimal number of hidden neurons are difficult and results 
from trial and error. A network that is too complex for the size of the training set is at risk 
of becoming overtrained and therefore will have a poor generalisation capacity. However, if 
the network is not complex enough, it will not have a good learning capacity and the test 
results will be equally suboptimal (Gurney, 1997).
Timmerman et al. (1999a) investigated ANN models from simple clinical and 
ultrasound-derived criteria to predict whether or not an adnexal mass will have histological 
evidence of malignancy. They collected prospective data from 173 consecutive patients 
who were scheduled to undergo surgery for adnexal tumours. The prevalence of 
malignancy was 28.3% and the best ANN gave a sensitivity of 95.9%, specificity of 93.5%, 
LR+ of 14,75 and LR- of 0.04.
Tailor et al. (1999) tested ANN models on 67 women with adnexal masses, of 
which 22.4% were malignant. With an optimum cut-off value of 0.45, they reached a 
sensitivity of 100% , specificity of 98.1%, LR+ of 52.6 and LR- of 0.
Aslam and Co-workers (2000a) prospectively tested the accuracy of the RMI 1 
(Jacobs et al., 1990), RMI 2 (Tingulstad et al., 1996) and Tailor’s regression model (Tailor 
et al., 1997) in the diagnosis of adnexal malignancy. They included 61 patients in their 
study. Of these, 38 women had benign tumours and 23 had ovarian cancer. Tailor’s 
regression model (Tailor et al., 1997) achieved a sensitivity of 43% (95% Cl, 23 -  64),
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specificity of 92% (95% Cl, 84 -  100), LR+ of 5.38 and LR- of 0.62. This compared with a 
sensitivity of 74% (95% Cl, 56 -  92) and 74% (95% Cl, 56 - 92), specificity of 92% (95% 
Cl, 84 -  100) and 89% (95% Cl, 80 -  99), LR+ of 9.25 and 6.72 and LR of 0.28 and 0.29 
for RMI 1 and RMI 2 respectively. This study showed that all three models when applied 
prospectively, they performed less accurately than originally described. The authors (Aslam 
et al., 2000a) went to speculate that it is likely that the accuracy of these tests would be 
even less in a population of women in whom there was a substantial clinical uncertainty.
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Chapter 4: Serum CA-125
CA-125 antigen is a high molecular weight glycoprotein, which is expressed by a large 
proportion of epithelial ovarian cancers. It is detected by the OC125 monoclonal antibody, 
which was first described by Bast et al, in 1981. Serum CA-125 is the most extensively 
studied ovarian cancer-associated marker. The incorporation of serum CA-125 in the risk 
of malignancy index (RMI) (Jacobs et al., 1990) and the recommended use of the RMI 
nationwide as a triaging test for adnexal malignancy (RCOG Greentop guidelines, 2003) 
has given this tumour marker a very important role and made it widely investigated.
The sensitivity and specificity of CA-125 is known to be poor. It is only raised in 
approximately 50% of stage 1 epithelial ovarian cancers and in 75-90% of patients with 
advanced disease. False positive results have been noted in many medical disorders, both 
malignant (Ozguroglu et al., 1999; Gaspar et al., 2003) and benign (Levine et al., 1997; 
Meden and Fattahi-Meibodi, 1998; Krishnan et al., 2002; Buamah, 2000).
Examples of benign conditions with raised CA-125 include: endometriosis, ovarian 
hyperstimulation syndrome, Meig’s and pseudo-Meig’s syndrome, multi visceral 
tuberculosis, tuberculous peritonitis, liver cirrhosis, fulminant hepatic failure, uraemia and 
renal failure, nephrotic syndrome and pancreatitis. Malignant conditions with raised CA- 
125 include ovarian cancer, advanced fallopian tube cancer, advanced uterine cancer, breast 
cancer with peritoneal métastasés, gastric cancer with peritoneal métastasés, lymphoma 
with peritoneal involvement, pancreatic carcinoma, advanced rectal/bladder cancer, and 
advanced hepatocellular carcinoma (Ahmed and Lawton, 2005).These false positive results 
are more frequently encountered in premenopausal women. Serum CA-125 level is elevated 
in 1% of healthy female subjects (Maggino et al., 1994).
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Requests for CA-125 testing are increasing, but there are suggestions that a large 
proportion of this increase is a result of its use by specialties other than gynaecology or 
oncology, thus leading to concerns that CA-125 is being used by clinicians who are not 
fully aware of its limitations and its role in ovarian cancer. This may result in missed 
diagnoses or unnecessary investigation of patients (Moss et al., 2005).
The normal cut-off value for CA-125 is 35 units/ml. These levels are altered in 
pregnant women (Jacobs et al., 1988) and therefore non-pregnant reference ranges cannot 
be used for the investigation of cysts detected in pregnancy.
Aslam et al. (2000b) carried out a study on 291 pregnant women, who attended their 
hospital for the routine first trimester nuchal translucency scan. They attempted to establish 
a reference range for maternal serum CA-125 levels at 11-14 weeks of gestation. They 
excluded women who had an ovarian cyst greater than 2 cm in mean diameter and those in 
whom either ovary was not visualised. They measured the serum CA-125 of 188 women 
who had a median CA-125 level of 23.4 U/ml (range 2.2-166.3, 95% Cl 5.3-70.2). Their 
data demonstrated that in the investigation of ovarian cysts in pregnancy, the non­
pregnancy cut-off values cannot be used. They concluded that if the discriminatory power 
of serum CA-125 in pregnancy is similar to that in nonpregnant women, a more appropriate 
cut-off value in pregnancy may be 112 U/ml, which corresponds to the 99^  ^ centile in their 
study (Aslam et al., 2000b)
A multimodality approach (i.e., clinical examination, imaging, and serum assays) is 
necessary to detect malignant masses at an early stage. The combination of normal findings 
at serum CA-125 assay, endovaginal US, and clinical examination of the pelvis virtually 
excludes the possibility of ovarian cancer (Schutter et al., 1994).
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Although elevated serum CA-125 levels (>35U/mL) have been found at 
radioimmunoassay in more than 80% of ovarian cancer patients, only 50% of patients with 
stage I disease have elevated serum CA-125 levels (Zanaboni et al., 1987; Zurawski et al., 
1988; Maggino et al., 1994). Serial measurements of the serum CA-125 level are routine in 
the clinical follow-up of ovarian cancer patients (Zanaboni et al., 1987).
Increasing serum CA-125 levels in patients with early-stage disease is predictive of 
recurrence regardless of imaging findings. In 87% of patients, doubling or halving of the 
serum CA-125 level correlates with tumour progression or regression, respectively (Bast et 
al., 1983). A combination of serum CA-125 assays and imaging studies may aid in patient 
treatment. Negative serum CA-125 assays and negative imaging findings do not exclude 
recurrent tumour; occult tumour will be detected in up to 50% of affected patients at 
second-look laparotomy (Folk et al., 1995).
Timmerman et al. (2007) investigated the value of serum CA-125 measurements 
alone or as part of a multimodal strategy to distinguish between malignant and benign 
ovarian tumours before surgery based on a large prospective multicentre study 
(International Ovarian Tumor Analysis). 809 Patients with at least one persistent ovarian 
mass preoperatively underwent transvaginal ultrasonography using gray scale imaging to 
assess tumour morphology and colour Doppler imaging to obtain indices of blood flow. Of 
these, 567 (70%) patients had benign tumours and 242 (30%) had malignant tumours. A 
logistic regression model including CA-125 (M2) resulted in an area under the receiver 
operating characteristic curve (AUC) of 0.934 and did not outperform a published (M l) 
without serum CA-125 information (AUC, 0.936). Specifically designed new models 
including CA-125 for premenopausal women (M3) and for postmenopausal women (M4) 
did not perform significantly better than the model without CA-125. In postmenopausal
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patients, serum CA-125 alone (AUC, 0.920) and the risk of malignancy index (AUC, 0.924) 
performed very well. Results were very similar when the models were prospectively tested 
on a group of 345 new patients with adnexal masses of whom 126 had malignant tumours 
(37%). The authors concluded that adding information on CA-125 to clinical information 
and ultrasound information does not improve discrimination of mathematical models 
between benign and malignant adnexal masses (Timmerman et al., 2007).
In summary, CA-125 has a high false positive rate and poor sensitivity and 
specificity. The substantial inappropriate usage of CA-125 may lead to results that are 
useless to the clinician, have cost implications, and add to patient anxiety and clinical 
uncertainty. CA-125 should be used in conjunction with imaging modalities. The patient’s 
age, menstrual history and other diseases should be taken into consideration when 
interpreting the CA-125 results.
54
Chapter 5: Ovarian Tumours
5.1 Introduction
The prevalence of ovarian tumours is on the increase and this could be simply due to the 
liberal use of transvaginal ultrasound. Clinicians are faced with adnexal tumours that have 
been diagnosed incidentally. These tumours would not have been detected otherwise before 
the ultrasound era. The natural history of incidentally detected pelvic tumours with benign 
ultrasound morphology is not known. Therefore, the optimal management of such tumours 
is also unknown. It is usually left up to the treating clinician to advise on the best 
management, although no clear guidelines exist.
Certain adnexal tumours such as functional cysts and hydrosalpinges are best 
treated expectantly (Valentin, 2004), especially if the patient is asymptomatic. Other 
tumours like peritoneal pseudocysts may be treated by cyst aspiration (Jain, 2000) and 
some adnexal tumours require definitive surgery like in the case of borderline or invasive 
ovarian tumours. It is of prime importance to establish a preoperative diagnosis regarding 
the nature of an adnexal tumour, because if the tumour is benign then the best treatment 
would be by removal via laparoscopic surgery (Yuen et al., 1997), whereas malignant 
masses require to be operated on by laparotomy by a gynaecological oncologist.
This chapter will discuss different types of benign, borderline and malignant 
adnexal pathology. Ultrasound appearances and management of each tumour will also be 
discussed. I will also go through the demographics of ovarian cancer and try to shed some 
light on the natural history of ovarian cancer.
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5.2 Demographics of Ovarian Cancer
Ovarian cancer is the most common gynaecological cancer in UK women (ISD Scotland 
online, 2007; Office for national statistics, 2007; Welsh cancer intelligence and surveillance 
unit, 2007; Northern Ireland cancer registry, 2007). In 2004 there were 6,615 cases of 
ovarian cancer diagnosed in the UK. The lifetime risk of developing ovarian cancer is 
approximately 1 in 48 (2.1%) for women in England and Wales. This risk increases to 2.5% 
in women with one affected first degree relative and between 30-40% in women with two 
affected first-degree relatives. Ovarian cancer is predominantly a disease of older, post­
menopausal women with almost 85% of cases being diagnosed in women over 50 years of 
age (5568 out of 6615 cases). There is a steep increase in incidence after the usual age of 
the menopause. The highest incidence rates are for women aged 65 and over as shown in 
figure 1. The incidence of ovarian cancer in British women has increased over the last 25- 
30 years from around 15 per 100,000 women in 1975 to around 17 per 100,000 women in 
2004, an increase of more than 16% whilst the mortality rate has remained fairly stable 
(ISD Scotland online 2007; Welsh cancer intelligence and surveillance unit, 2007; Northern 
Ireland cancer registry, 2007).
Worldwide there are more than 190,000 new cases of ovarian cancer each year, 
accounting for around 4% of all cancers diagnosed in women (lARC, 2004). Incidence 
rates vary considerably, with the highest rates in the USA and Northern Europe and the 
lowest rates in Africa and Asia (lARC, 2004). Around 43,000 cases occur each year in 
Europe and 22,000 in the USA. Within the EU the lowest rates are in the Southern 
European countries of Greece, Portugal and Cyprus, while the highest are in the Northern 
and Eastern European countries of Lithuania, Denmark, Czech Republic and Estonia 
(lARC, 2004).
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Evidence from population migrant studies is conflicting. In a study of immigrants to 
Israel, those who migrated from a country with a higher incidence of ovarian cancer 
retained a similar level of risk as their country of origin, but within one generation the risks 
were no longer significantly different (Parkin and Iscovich, 1997). However, research in 
other migrant populations has not shown a similar pattern (Hamminki and Li, 2002a; 
Hamminki and Li, 2002b; Hamminki et al., 2002; Harding, 1998)
The most important prognostic factor in ovarian cancer remains the stage of the 
disease at presentation. Unfortunately, around 75% of affected women present with 
advanced stage (FIGO III, IV) disease.
Ovarian cancer has been described as a ‘silent killer’ owing to the fact that most 
women with this disease remain asymptomatic in the early stages. Granberg and Wikland 
(1988) found in a retrospective study that the most common presenting complaint in 
women with FIGO Stage I and II was abdominal discomfort (64%). 10% of women were 
completely asymptomatic, and 8% presented with postmenopausal bleeding.
A recent retrospective study by Lataifeh et al. (2005), which included 100 women 
with early stage ovarian cancer and 100 women with advanced stage ovarian cancer, 
showed that 90% of women with early stages ovarian cancer and 100% of women with 
advanced ovarian cancer had at least one symptom. 51% of women with early disease 
reported abdominal pain and 32% reported abdominal distension. However, 62% of women 
with advanced disease reported abdominal swelling and 44% reported abdominal pain. 
Seventy percent of the early stage and 69% of the advanced stage cohorts reported 
symptoms of less than 3 months duration. Tumours less than 5 cm diameter were three 
times more likely to have advanced disease (p=0.02). The authors concluded that advanced 
disease is not invariably due to delayed diagnosis (Lataifeh et al., 2005)
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Women with early stage ovarian cancer are more likely to report an abdominal mass 
or urinary symptoms but less likely to report gastrointestinal problems or general malaise 
compaied to advanced stage cancer. General malaise and other non-specific symptoms are 
least common in borderline disease. Older women, and those with higher parity or a family 
history of breast or ovarian cancer, are more likely to be diagnosed at an advanced stage of 
disease (Webb et al., 2004).
Most malignant ovarian tumours are epithelial ovarian cystadenocarcinomas. 
Tumours of low malignant potential comprise approximately 20% of malignant ovarian 
tumours, fewer than 5% of malignant germ cell tumours, and approximately 2% of 
granulosa cell tumours.
Different risk factors have been associated with ovarian cancer. Examples of risk 
factors include exposure to an increased number of ovulatory cycles like with early 
menarche, late menopause, nulliparity and recurrent fertility treatment. The use of the oral 
contraceptive pill appears to have a protective effect against ovarian cancer (Edmondson 
and Monaghan, 2001). Genetic predisposition like the one seen in women with BRCAl and 
BRCA2 gene mutations (Malander et al., 2004), and family history of ovarian, breast or 
colorectal cancer are also risk factors for ovarian cancer.
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5.3 Natural History of Ovarian Cancer
The natural history of ovarian carcinoma remains unknown. A study by Horiuchi et al. 
(2003) suggested that approximately half of ovarian carcinomas develop from pre­
existing, benign appearing cysts and they called this pathway adenoma-carcinoma 
sequence, whereas the remaining half seem to develop from a normal appearing ovary 
and they called this pathway de novo carcinogenesis. This study suffers from being a 
retrospective study containing a selected mix of only forty-nine women.
Another proposed theoretical model by Shih and Kurman (2004) suggested that 
surface epithelial tumours are divided into two broad categories designated type I and 
type II tumours, which correspond to two main pathways of tumourigenesis. Type I 
tumours tend to be low-grade neoplasms that arise in a stepwise manner from borderline 
ovarian tumours. This group includes mucinous carcinomas, endometrioid carcinomas, 
malignant Brenner tumours, and clear cell carcinomas. Type I tumours are associated 
with distinct molecular changes such as BRAF and KRAS mutations for serous 
tumours, KRAS mutations for mucinous tumours, and (3-catenin and PTEN mutations 
and microsatellite instability for endometrioid tumours.
Type II tumours are high-grade neoplasms, which arise from normal ovaries (de 
novo development). This group of tumours includes high-grade serous carcinoma, 
malignant mixed mesodermal tumours (carcinosarcoma), and undifferentiated 
carcinoma. There are very limited data on the molecular alterations associated with type 
II tumours except frequent p53 mutations in high-grade serous carcinomas and 
malignant mixed mesodermal tumours.
Shih and Kurman (2004) suggested that their model for carcinogenesis 
reconciles the relationship of borderline ovarian tumours to invasive carcinoma and 
provides a morphological and molecular framework for studies aimed at elucidating the 
pathogenesis of ovarian cancer.
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This study is theoretical and there is no clinical proof as yet to support these 
theories of tumourigenesis.
5.4 Benign Ovarian Tumours
Benign ovarian tumours have increased in prevalence in the last few years due to the 
increased use of ultrasound scanning in our everyday clinical practice (Valentin, 2004). 
Many adnexal masses that would almost certainly have remained undetected before the 
ultrasound era are now found incidentally at transvaginal ultrasound examination of 
women without symptoms of an adnexal tumour.
In modern clinical practice it is not acceptable to operate on all asymptomatic 
women with an incidental ultrasound diagnosis of a benign looking cyst. Some of these 
cysts may be functional in nature and would resolve spontaneously, while others may 
need to be operated on.
Laparoscopic treatment of ovarian cysts has been established as the optimal 
route for surgical management of benign adnexal tumours (Mahdavi et al., 2004). This 
minimally invasive approach offers many advantages over laparotomy, including 
decreased postoperative pain, faster recovery and reduction in postoperative intra­
abdominal adhesions (Lin et al., 1995; Howard, 1995; Mais et al., 1995). As a result, 
many operations can be performed as day-surgery procedures, with patients being 
discharged home few hours after their operation.
Certain ovarian cysts may manifest typical appearance on ultrasound and 
therefore could be diagnosed with confidence (Patten, 1992; Guerriero et al., 1995; Kim 
et al., 1995, Kupfer et al., 1992; Caspi et al., 1996). Other tumours may have features 
similar to malignant tumours and these could be misdiagnosed and over-treated as a 
result.
Detailed below, are the different benign ovarian tumours that can occur.
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5.4.1 Follicular cysts
These cysts arise from the ovarian follicles and may occur at any age before the 
menopause and could reach large sizes. Their lining cells (granulosa and theca cells) 
may secrete excessive quantities of oestrogens.
On ultrasound, these cysts appear as thin-walled cysts with anechoic fluid 
content and they are surrounded by healthy ovarian tissue. Occasionally, haemorrhage 
into the cyst may result in a web-like appearance.
The vast majority of these cysts are asymptomatic and tend to resolve 
spontaneously. However, in order to be able to reach a diagnosis of follicular cyst, a 
follow up ultrasound is usually recommended and this should be performed usually in 
the first week of the woman’s menstrual cycle.
5.4.2 Corpus Luteum cysts
The corpus luteum is a direct result of ovulation from a follicle. The morphology of the 
corpus luteum vary throughout the luteal phase, and will he predominantly cystic or 
solid in nature.
On ultrasound, the corpus luteum tends to have a haemorrhagic cystic 
appearance containing spider-web-like material (Grant, 1992; Patel et al., 1999). Odd 
looking blood clots may also be seen (Carter et al., 1992). These clots may be confused 
with papillary projections or solid components even by the best trained eye and this may 
lead to them being misdiagnosed as malignant lesions. Doppler ultrasound examination 
may help to discriminate between a clot and a solid component, which tend to have 
detectable Doppler signals. The blood clot will move like jelly when the ovary is pushed 
using the vaginal probe.
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Again, expectant management is the option of choice in the case of corpus 
luteum cysts and a follow up with ultrasound after 6-12  weeks may he offered, if in 
doubt about the diagnosis.
5.4.3 Theca-Lutein cysts
These cysts tend to occur when a coi*pus luteum becomes cystic and persist in a 
functional state for longer than normal. Alternatively these cysts occur when the 
granulosa and theca cells of a follicular cyst become luteinised.
On ultrasound, these cysts have a unilocular smooth-walled appearance with 
anechoic content.
The majority of these cysts resolve spontaneously and expectant management is 
recommended.
5.4.4 Serous inclusion cysts
These cysts form as a result o f cortical invagination of the surface germinal epithelium. 
They are typically less than 3 cm in diameter. On ultrasound, they appear as unilocular, 
smooth-walled cysts with anechoic content. Expectant management is also 
recommended here.
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5.4.5 Endometriomas
The ovarian endometrioma represents an advanced stage of endometriosis. Although 
many reports describe them as having typical ultrasound features, they are a common 
source of false positive diagnosis of malignancy. They are typically seen on ultrasound 
examination as well circumscribed thick walled cysts that contain homogeneous low 
level internal echoes. This so-called ‘ground glass’ appearance is due to altered blood. 
The fluid is often hypoechoic so in some cases it may be necessary to increase the gain 
setting to detect the low-level echogenicity (Tailor et al., 1999). Internal septations have 
been described in 10-30% of all endometriotic cysts seen, which may cause diagnostic 
difficulties (Athey and Diment, 1989; Kupfer et al., 1992; Volpi et al., 1995). Patel and 
co-workers (1999) noted ‘solid masses’ protruding from the endometriotic cyst wall into 
the cyst lumen. Such protrusions ( ‘wall nodularity’) are seen in 20% of endometriomas 
(Patel et al., 1999). They reported that ‘hyperechoic wall foci’ were much more 
common in endometriomas than in other types of adnexal pathology (35% versus 6%), a 
finding that has not been reported by others.
In addition, ovarian endometriomas may undergo decidualisation in pregnancy, 
which sometimes creates confusing morphological and Doppler features (Fruscella et 
al., 2004).
While operative laparoscopy is the gold standard procedure to treat 
endometrioma, there was no proven role for the medical management of these cysts. 
The use of cyclical oral contraceptive pill postoperatively does not seem to affect the 
long-term recurrence of endometriosis after surgical removal (Chapron et al., 2002).
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5.4.6 Epithelial tumours
These tumours arise from the ovarian surface epithelium and the majority of benign 
epithelial tumours could be either serous or mucinous.
Benign serous ovarian cystadenomas aie the commonest in benign epithelial 
tumours and they are usually seen in women over the age of 40 (Girling and Soutter, 
1997). 10% of serous cystadenomas are bilateral. The characteristic ultrasound features 
of serous cystadenomas are unilocular or biloculai* cysts with homogeneous 
echogenicity (often anechoic) with a thin régulai' wall and occasionally with a thin 
regular septum and no papillary projections (Buy et al., 1991). Although, Russell in 
1979 found that papillary projections were identified in 4.5% of benign serous 
cystadenomas (Russell, 1979). The prevalence of papillary projection in this type of 
benign ovarian tumour is likely to be higher as demonstrated later in the results of this 
thesis. Valentin et al. (2001) showed no statistically significant difference in the 
prevalence of papillary projections between henign and malignant ovarian tumours. 
Papillary projections were present in up to 26% of benign tumours compared to 28% of 
malignant ovarian tumours (p=0.88).The presence of inegulai' thickenings along the 
septa of a multilocular thin-walled cyst may be representative of a serous 
cystadenofibroma.
Mucinous cystadenomas account for approximately 15-20% of all ovarian 
tumours. 10% of these are bilateral and tend to be larger in size compared to serous 
cystadenomas. Mucinous cystadenomas could be unilocular in 35% of the cases; 
however the majority of these cysts are multilocular. On ultrasound, these tumours 
appear as multilocular cysts containing fluid of different echogenicities, with regular 
wall and septa (Buy et al., 1991). They may also exhibit a unilocular smooth-walled 
cyst appearance with echogenic fluid content. Papillary projections may occasionally be 
noted in the cysts.
65
Other less common types of benign epithelial ovarian tumours include Brenner 
(transitional cell) tumours, mixed epithelial and endometrioid. Brenner tumours tend to 
be solid, well circumscribed, hypoechoic tumours with calcification and acoustic 
shadowing on ultrasound examination.
Buy et al. (1991) diagnosed serous cystadenomas with a sensitivity of 70%, 
specificity of 98%, LR+ of 35 and a LR- of 0.31, and mucinous cystadenomas with a 
sensitivity of 50%, specificity of 96%, LR+ of 12.5 and a LR- of 0.52 using the 
ultrasound features described above. Fleisher and co-workers (1978) found the 
sensitivity of gray-scale imaging for diagnosing serous cystadenoma to be 75%, the 
specificity to be 75%, LR+ to be 3 and LR- to be 0.33. The sensitivity, specificity, LR+ 
and LR- of gray-scale imaging for diagnosing mucinous cystadenomas were reported by 
Fleischer and co-workers to be 95%, 99%, 31.67 and 0.05 respectively (Fleisher et al., 
1987).
These tumours could be managed expectantly, if the patient is asymptomatic, 
with regular- follow up scans. However, the gold standard management is by 
laparoscopic surgical excision of the cysts.
5.4.7 Germ cell tumours
Mature cystic teratomas (Dermoid cysts) are the most common type of germ cell 
tumours. They develop from totipotential cells and consist of well differentiated 
ectodermal and mesodermal elements. Approximately 10-12% of all ovarian neoplasms 
are benign cystic teratomas, which are bilateral in 10-15% of patients.
Most dermoid cysts are easily recognised at gray-scale imaging owing to their 
fat and hair content (Caspi et al., 1996; Cohen and Sabbagha, 1993). Having said that, 
aiound 18% of dermoid cysts may manifest a predominantly cystic echo pattern 
indistinguishable from that of other cystic masses (Cohen and Sabbagha, 1993). The
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most characteristic ultrasound features of a dermoid cyst are the presence of (1) a ‘white 
ball’ (corresponding to hair and sebum) in the corner of a cyst, or filling up the whole 
tumour; (2) long, echogenic (white) lines and prominent echogenic dots in cyst fluid 
(corresponding to hair floating freely in non-fatty fluid); and (3) shadowing (Caspi et 
al., 1996; Cohen and Sabbagha, 1993; Bronshtein et al., 1991). The latter often makes it 
difficult or impossible to measure the size of dermoid cysts correctly. Some dermoid 
cysts are impossible to detect, even when they are clearly palpable, because their 
echogenicity is similar to that of surrounding howel (Valentin, 2004).
Dermoid cysts are managed by laparoscopic ovarian cystectomy. The majority 
are less than 10 cm, and 15% are bilateral. If ruptured intra-operatively, copious 
irrigation is warranted because the content can cause a chemical peritonitis (Huus et al., 
1996; Coccia el ah, 1996; Remorgida et ah, 1998). Therefore some authors advocate 
open surgery for large dermoid cysts >10  cm in mean diameter as they are difficult to 
remove form the abdominal cavity without rupture (Mettler et ah, 2001).
5.4.8 Sex cord-stromal tumours
The stromal cells retain the potential for differentiation into any of the cells or tissues 
arising from the mesenchyme of the gonad. These tumours, which are also known as 
gonadal sti'omal tumours, mesenchymomas, may secrete any or all of the ovarian 
steroids. Thecal cell tumours consist of:
- Fibromas: consist mainly of fibroblast-like cells producing collagen. These are 
large, firm and mobile tumours, which are bilateral in 10% of cases. Ascites may 
be present in 15% of cases. They could be part of a complex known as M eig’s 
syndrome, which is a triad of a benign solid ovarian tumour, ascites and pleural 
effusion (usually right sided) (Meigs and Cass, 1937). Both ascites and pleural 
effusion tend to resolve after removal of the tumour (Nemeth and Patel, 2003).
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- Thecomas: predominantly contain lipid-rich theca like cells 
Fibromas and fibrothecomas aie solid, round or oval tumours with a smooth outline and 
a régulai* ‘stripy’ echogenicity and usually have an echo pattern indistinguishable from 
that of pedunculated uterine fibroids. Different types of solid benign ovarian tumours, 
such as fibroma, thecoma, fibrothecoma and Brenner tumour may have similar 
appearance and echogenicity on gray-scale ultrasound (Athey and Malone, 1987). 
Guerriero and co-workers (1995) reported confusion of ovarian endometrioma and 
fibroma at gray-scale sonography.
The management of these tumours depend on their size. Furthermore, the 
presence of a solid tumour may raise suspicion of malignancy and additional 
investigations such as serum tumour markers may be used. The choice between 
laparoscopy and laparotomy will depend on the operating surgeon and the facilities 
available to remove the solid lesion via a small abdominal incision.
5.4.9 Other Benign Adnexal tumours
Lesions adjacent to the ovary occasionally present in a similai* fashion to ovarian 
tumours. These are not infrequently seen especially in young women and in those who 
have undergone previous pelvic surgery.
5.4.9.1 hydro-pyo-haemato-salpinx
These appear as fluid-filled tubular cystic structures, which sometimes are easily 
distinguishable from other types of adnexal masses at gray-scale ultrasound 
examination. Characteristic ultrasound features of tubal disease include: fluid-filled 
sausage-shaped cystic structure, presence of ‘incomplete septa’, i.e. septa that are not 
seen to reach the opposite wall of the cystic structure, and on a transverse section of 
these lesion, mucosal folds are seen to protrude into the lumen, resulting in a ‘cog­
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wheel’ appearance if the tube is swollen and in a ‘heads-on-a-string’ appearance 
(Timor-Tritsch and Lerner, 1998).
Management of tubal disease is usually conservative with analgesia and 
antibiotics, like in the case of a pyosalpinx. Surgery may be carried out on infertility 
patients and this will he in the form of bilateral salpingectomy in order to improve the 
success of in vitro fertilisation (IVF) treatment.
5.4.9.2 Tubo-ovarian abscess
The ultrasound appearance of a tubo-ovarian abscess may var y from a unilocular cystic 
structure to a complex multicystic lesion containing thick walls and thick septa, filled 
with homogeneously echogenic material (‘ground-glass’ appearance) (Valentin, 2004). 
These abscesses may be confused with endometriomas or ovarian malignancies (Hata et 
al., 1989; Varras et al., 2003). Differentiating a tubo-ovarian abscess from a pelvic 
abscess of other origin such as peri-appendiceal or diverticular abscess is not an easy 
task (Valentin, 2004). Thus, a full clinical history and results of blood tests are 
important in order to establish the correct diagnosis.
Tubo-ovarian abscesses are usually treated conservatively with broad spectrum 
antibiotics and occasionally by ultrasound guided transvaginal drainage.
5.4.9.3 Paraovarian cysts
These cysts may aiise from embryonic ducts and may be mésothélial, mesonephric and 
paiamesonephric in origin (Genadry et al., 1977). They are usually situated between the 
tube and the ovary (Grant, 1992). These cysts occur most commonly in premenopausal 
women and account for approximately 10% of all adnexal lesions (Athey and Cooper, 
1985).
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Paraovarian cysts may appear as cysts, which are clearly separate from a normal 
ovary on ultrasound examination; on other occasions it is difficult to distinguish an 
ovarian cyst from a paraovarian cyst. They usually appear as unilocular anechoic cysts 
but may have echogenic fluid content occasionally. Papillary projections and septa may 
be present (Korbin et al., 1998). Malignancy, especially in the form of a borderline 
tumour rather than an invasive malignancy may develop in a paraovarian cyst (Stein et 
al., 1990).
These cysts can be managed expectantly with regular follow up scanning. 
However, transvaginal drainage or surgical removal may be indicated if the patient 
becomes symptomatic or the cyst changes in appearance.
5.4.9 4 Peritoneal pseudocysts
Peritoneal pseudocysts are fluid collections among adhesions occurring after an 
inflammatory process in the peritoneal cavity or after an operation. On ultrasound 
examination, peritoneal pseudocysts appear as cystic lesions following the contours of 
the pelvis with a deformed ovaiy suspended among adhesions centrally or peripherally 
in the cyst. Occasionally, pseudocysts may also be oval or round with anechoic or 
echogenic fluid content. Thin septa may be noted within the cysts and these septa 
appear to move in response to pressure from the endovaginal probe (flapping sail sign) 
(Savelli et al., 2004). Papillary projections may sometimes be noted within pseudocysts 
(Jain, 2000; Hoffer et al., 1988; Kim et al., 1997).
5.5 Borderline Ovarian Tumours (BOTs)
BOTs account for 10-15% of all ovarian tumours. They commonly affect white women 
in the fourth decade of life, hut they are seen in women of all ages (Silverberg et al.,
2004). They are usually localised to the ovary at the time of the initial presentation
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(Harlow et al., 1987). The reported annual incidence of serous and mucinous BOTs is
24.7 per one million women, the incidence increasing with increasing age but at a 
slower pace than for invasive malignant ovarian tumours.
Serous and mucinous BOTs constitute around 96% of BOTs. The remaining 
types are clear cell, endometrioid, Brenner (transitional cell) or mixed histology. Serous 
BOTs are subdivided into typical serous BOTs and micropapillary/cribriform serous 
BOTs (Seidman and Kurman, 1996). The majority of serous BOTs are of typical 
subtype (Gilks et al., 2003). This type of BOTs is bilateral in 35-40% of the cases and is 
similar in gross histological appearance to benign serous ovarian tumours. However, 
papillary excrescences are more common and likely to have surface component (70% of 
lesions) (Russell et al., 2002a). Micropapillary serous BOTs have higher frequency of 
bilaterality (Ahmed and Lawton, 2005).
Mucinous BOTs are subdivided into gastrointestinal (GI) type, which is the most 
common type, and endocervical (Mullerian or seromucinous) type. GI type mucinous 
EOT is usually unilateral, whilst endocervical type mucinous BOT is bilateral. On 
macroscopic histological examination, GI type mucinous BOTs are laige tumours 
reaching an average of 15-20 cm in mean diameter. The external surface of the tumour 
and its cyst walls aie generally smooth. These tumours have tendency to a finer 
honeycombing of the cut surface in higher-grade proliferating tumours but this may be 
only focal (Russell et al., 2002b). These tumours are tensely filled with mucin. 
Endocervical mucinous BOTs are characterised by the presence of prominent intracystic 
and exophytic papillary structures resembling serous BOTs (Hart, 2005).
Several recent studies have examined the gray-scale sonographic and colour 
Doppler features of borderline ovarian tumours (Exacoustos et al., 2005; Pascual et al., 
2002; Wu et al., 1994). There were also attempts to describe the typical sonographic
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features of different histopathological subtypes of BOTs (Fruscella et al., 2005; 
Exacoustos et al., 2005; Gotlieb et al., 2000).
Fruscella et al. (2005) and Exacoustos et al. (2005) retrospectively reviewed the 
ultrasound appearance of BOTs. They reached a conclusion that serous BOTs and 
endocervical type mucinous BOTs have a common ultrasonic appearance of a 
unilocular cyst with papillary projections arising from the inner wall. They also found 
that GI type mucinous BOTs have the appearance of a multilocular (containing more 
than 10 locules on most occasions) cyst with mucinous fluid or a cyst. These 
appearances coincided with the gross histopathological description of these tumours.
However, the diagnostic accuracy of pattern recognition for the differential 
diagnosis between benign, borderline and invasive ovarian tumours has not been tested 
as yet.
Most BOTs have a good prognosis. Important prognostic factors are the 
histological subtype and tumour stage. Accurate surgical pathological staging is 
important (Ahmed and Lawton, 2005). The 5-yeai' survival is neaiiy 100% for serous 
BOTs in stage I (Zanetta et al., 2001). In cases of extraovarian disease, 5-year survival 
is more than 85% if the implants aie non-invasive and aiound 60% if  the implants are 
invasive (exhibiting irregular infiltration of the surrounding or underlying normal tissue, 
and usually resembling low- grade serous carcinoma histologically). However, lesions 
demonstrating these features are quite rare in most series (Silverberg et al., 2004). 
Micropapillary type serous BOTs are more likely to be diagnosed at an advanced stage, 
and their prognosis is worse than that of typical serous BOTs (Ahmed and Lawton,
2005). Almost all mucinous BOTs have an excellent prognosis with a 5-year survival 
rate approaching 100% after surgical treatment (Silverberg et al., 2004). In the past, 
pseudomyxoma peritonei, which is associated with a high mortality rate, used to be 
classified as mucinous BOT. However, pseudomyxoma peritonei is now believed to be
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of gastrointestinal (often appendix) - not ovarian - origin and is therefore no longer 
classified as mucinous BOT (Ronnett et aL, 2004).
Management is surgical and is divided into conservative (unilateral 
oophorectomy) or radical (total hysterectomy, bilateral salpingo-oophorectomy and 
omental biopsy), depending on the patient’s age and reproductive potential.
5.6 Malignant ovarian tumours
The appeai'ance and behaviour o f invasive ovarian malignancies depend on the 
histological type of these tumours.
5.6.1 Epithelial ovarian cancers
Epithelial ovarian cancers (cystadenocarcinoma) represent 85% of all primary 
malignant neoplasms. These tumours affect women aged 50-70 years. This type of 
ovarian cancer is associated with raised serum CA-125 in over 85% of the cases. 
Bilateral tumours are noted in 50% of serous cystadenocarcinomas and in 25% of 
mucinous cystadenocarcinomas.
On ultrasound examination, serous cystadenocarcinomas may be either 
unilocular or multilocular and are associated with varying proportions of a solid 
component (Troiano and McCarthy, 1994; Yamashika et al., 1995). The presence of 
papillary projection is typical in early stage cystadenocarcinomas, which makes them 
difficult to differentiate from serous borderline ovarian tumours (Valentin et al., 2006a). 
In multilocular tumours, the septa are often thick and nodulai*. These cysts are large and 
in around half of the cases they are greater than 15 cm in diameter. Doppler examination 
shows increased vascularity to the tumour and 50% of cases has ascites present.
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Mucinous cystadenocarcinomas are larger than their serous counterpart. They 
appear as multilocular cysts containing echogenic fluid material and extensive papillary 
projections on ultrasound examination. These tumours also show high vascularity on 
Doppler examination. Mucinous (gelatinous) ascites may be found and this is difficult 
to drain by paracentesis, thus patients may have to undergo laparotomy for the drainage 
puipose.
Endometrioid ovarian cancers represent 10-25% of all epithelial ovarian cancers. 
Endometrial adenocarcinomas coexist with up to 30% of endometrioid ovarian cancer 
(Cotran et al., 1994). 30-50% of cases are bilateral and they appear as cystic masses 
containing extensive papillary projections on ultrasound examination. These tumours 
are also characterised by increased vascularity on Doppler examination.
5.6.2 Sex-cord stromal ovarian cancers
Six percent of ovarian cancers are sex-cord stromal cancers. These tumours arise from 
the stromal cells and thus secrete any or all of the ovaiian steroids. Granulosa cell 
tumours are the commonest subtype. Five percent of these tumours happen before 
puberty and the remainder over the reproductive and postmenopausal years.
The appearance of these tumours varies considerably on ultrasound examination. 
Large tumours have a complex appearance and could be mistaken for epithelial cancers, 
whereas smaller tumours may appear as solid hypoechoic masses similar to ovarian 
fibromas. These tumours have high vascularity on Doppler examination.
Because of their hormonal secreting characteristics, these tumours may present 
with postmenopausal bleeding owing to endometrial hyperplasia or endometrial 
carcinoma in view of the oestrogen secreted by this type of ovarian tumours.
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Granulosa cell tumours present in early stages, they have a low malignant 
potential, and subsequently a lower mortality rate and better prognosis compared to 
epithelial ovarian cancers.
Other less common subtypes of sex-cord ovarian cancers include Sertoli-Leydig 
cell tumours, which may secrete virilising hormones and often appear as solid masses 
on ultrasound examination.
5.6.3 Germ cell ovarian cancers
Three percent of ovarian cancers fall into this category. These cancers tend to occur 
more frequently in younger women between 20-30 years of age. Histological subtypes 
include; choriocarcinomas, yolk sac tumours and dysgerminomas. The dysgerminomas 
are the commonest subtype.
On ultrasound examination, these tumours appear as solid and hyperechoic
masses.
Germ cell tumours can produce pregnancy associated plasma proteins such as 
human chorionic gonadotrophin or alpha-fetoprotein, which may be useful as tumour 
markers in the diagnosis of this type of ovarian cancer and its subsequent follow-up 
after treatment.
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5.6.4 Metastatic ovarian tumours
The ovary is a common site of métastasés from malignant tumours, 5-20%  of ovarian 
masses being métastasés from primary tumours in other organs (Young and Scully, 
1991). Most (50-90%) métastasés in the ovaries originate from the gastrointestinal tract 
or the breast (Antila et al., 2006).
Metastatic tumours are described as often (about 60% of cases) being bilateral 
lesions that appear as diffusely solid tumours, multiple solid nodules, partly cystic 
masses or, rather uncommonly, entirely cystic lesions. Even when the primary tumour is 
solid, métastasés in the ovaries may be cystic or semicystic. Extensive areas of 
haemorrhage and/or necrosis aie common. Krukenberg tumours (metastasis from a 
gastric cancer to the ovary) are typically solid masses with a bosselated outer surface.
Testa et al. (2007) retrospectively reviewed the ultrasound appearance of 67 
metastatic tumours in the ovaiy. They found that ovarian métastasés derived from 
stomach cancer, breast cancer, lymphomas and uterine cancer are solid in almost all 
cases, whereas those derived from the colon, rectum and biliary tract manifest more 
heterogeneous morphological patterns, most being cystic with many cyst locules and 
irregular borders. Papillary projections seem to be relatively rare (12%) in metastatic 
tumours in the ovaries.
5.7 Management of Ovarian Cancer
Management of ovaiian cancer is usually guided by the histological grade and the stage 
of the tumour. The best survival rates for women with ovarian cancer are achieved when 
treatment is organised and carried out by gynaecological oncologists working in cancer 
centres (Junor et al., 1999). These cancer centres have been recently introduced across 
the UK. Ideally all patients with suspected or proven ovarian cancers should be referred 
to these tertiary centres for management (Kehoe et al., 1994).
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The treatment of choice for stage I ovarian cancer is surgical staging with 
laparotomy. Although simple oophorectomy at the time of surgical staging may be 
considered in yonger women with stage I disease who wish to preserve their 
reproductive potential. Cytoreductive surgery is advocated for patients with more 
advanced stages of the disease, followed by chemotherapy.
The International Federation of Gynecology and Obstetrics (FIGO) has 
produced strict criteria for the accurate staging of ovarian cancers (Table 1) (Shepherd, 
1988^
The 5-year survival rates vary and depend on the stage and the histological type 
of the tumour. Stage la epithelial cancers have a 5-year survival rate of 70%, whilst with 
stage IV disease the survival rate falls to below 5%. The survival rates for gonadal- 
stromal and germ cell tumours are better stage for stage than those for epithelial 
cancers.
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Table 1 International Federation of Gynecology and Obstetrics (FIGO) staging 
of primary ovarian carcinoma.
FIGO Tumour characteristics
Stage___________________________________________________________________
I Growth limited to the ovaries
la  Growth limited to one ovary, no ascites present containing malignant
cells, no tumour on the external surface, capsule intact 
Ib Growth seen in both ovaries, no ascites present containing malignant
cells, no tumour on the external surfaces, capsules intact 
Ic Tumour either stage la or Ib but tumour found on surface of one or both
ovaries, capsule ruptured, ascites present containing malignant cells, or 
peritoneal washings positive
II Growth involving one or both ovaries with pelvic extension
Ila Extension or métastasés to the uterus or fallopian tubes
Ilb Extension to other pelvic tissues
lie Tumour either stage Ila or lib but tumour found on surface of one or both
ovaries, capsule(s) ruptured, ascites present containing malignant cells, or 
peritoneal washings positive 
III* Tumour involving one or both ovaries with histologically confirmed
peritoneal implants outside the pelvis or positive retroperitoneal or 
inguinal nodes; tumour limited to the true pelvis but with 
histologically conRrmed malignant extension to small bowel or 
omentum
Ilia Tumour grossly limited to the true pelvis with negative nodes but with
histologically confirmed microscopic seeding of abdominal peritoneal 
surfaces or extension to small bowel or mesentery 
Illb Tumour involving one or both ovaries with histologically confirmed
implants, metastasis to abdominal peritoneal surfaces (lesions <2 cm), 
negative nodes
IIIc Extrapelvic peritoneal metastasis (lesions >2 cm) or positive
retroperitoneal or inguinal nodes 
I Vf Growth involving one or both ovaries with distant métastasés,
____________positive cytologic findings if pleural effusion is present_____________
Source: Shepherd 1988 
* Includes superficial liver métastasés, 
f  Includes parenchymal liver métastasés.
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PART TWO:
Aims, Methods and Results
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Chapter 6: Aims
6.1 Aims of the thesis
•  Compare the value of the ovarian crescent sign and that of the risk of
malignancy index for the diagnosis of ovarian cancer in women with an
ultrasound diagnosis of ovarian tumour.
•  Assess the value of pattern recognition for the differential diagnosis of adnexal
tumours and in particular its accuracy in establishing the specific diagnosis of
histological subtypes of borderline ovarian tumours.
• Determine if the prediction of the character of an adnexal mass using subjective 
evaluation of gray-scale and Doppler ultrasound findings (i.e. pattern 
recognition) based on the evaluation of static images is as accurate as that based 
on a real-time ultrasound examination.
• Evaluate the reproducibility of ultrasound ‘pattern recognition’ for the diagnosis 
of borderline ovarian tumours.
• Examine the degree of confidence with which expert ultrasound operators 
differentiate between benign, borderline and invasive malignant ovarian tumours 
and assess the effect of their diagnostic confidence on diagnostic accuracy and 
interobserver agreement.
•  Examine whether the improved accuracy of expert (level III) ultrasonography 
has a measurable effect on the management of patients with adnexal masses 
when compared with routine (level II) ultrasonography.
•  Develop and assess a set of ultrasound criteria that were designed to select 
women for laparoscopic removal of ovarian cyst with a minimum risk of 
converting the operation to a laparotomy.
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Chapter 7: Materials, Methods and Results
7.1 Setting
The Early Pregnancy and Gynaecology Assessment Unit, King’s College Hospital, 
London.
7.2 Gynaecology population
The work contained at this thesis was carried out at the Early Pregnancy and 
Gynaecology Assessment Unit, King’s College Hospital between April 2005 and 
October 2007.
The hospital is a teaching hospital located in South East London and is one of 
the main two teaching hospitals for Guy's, King's and St Thomas' Schools of Medicine 
and Dentistry. It serves the health needs of Lambeth, Southwark and Lewisham Health 
Authority. The local population of approximately 750,000 people is one of the most 
deprived in England with high levels of premature death, mental illness and infectious 
diseases including HIV.
King’s College Hospital became a NHS Foundation Trust in December 2006. It 
is one of London’s largest and busiest teaching hospitals, with a unique profile of strong 
local services and a focused set of tertiary specialties. It has 900 beds and employs 4000 
staff with an annual budget of approximately £185 million. The women’s health 
directorate makes up one of the largest departments and offers specialist services 
including gynaecological ultrasound scanning, gynaecological oncology, 
urogynaecology, fetal medicine, colposcopy, menopause, assisted conception and 
family planning. In 2006, a total of 17000 women were referred to the Early Pregnancy 
and Gynaecology Assessment Unit, half of whom were seen for variety of 
gynaecological disorders. A significant portion of these women were referred from
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other hospitals in the UK with adnexal lesions or difficult eaiiy pregnancy 
complications.
All the women in the randomised controlled trial were recruited from the Rapid 
Access Unit of the Regional Gynaecological Cancer Centre, Guy’s and ST Thomas’ 
NHS Foundation Trust. A proportion of women included in the remaining studies 
refeiTed from the Regional Gynaecological Cancer Centre or the Obstetrics and 
Gynaecology department at Guy’s and ST Thomas’ NHS Foundation Trust. This 
hospital is the other large teaching hospital for Guy's, King's and St Thomas' Schools of 
Medicine and Dentistry, This trust, which was given a Foundation status in 2004 
employs around 9,000 staff and provides three-quarter million patient contacts in acute 
and specialist hospital services every year. The Gynaecological Cancer Centre is one of 
the main tertiary gynaecology cancer centers in the South East.
7.3 Preoperative assessments
Preoperative assessment took place either at King’s College Hospital or at Guy’s and St 
Thomas NHS Foundation Trust. Women with known adnexal pathology were recruited 
for the different studies where an informed consent was obtained from all patients.
Women were examined preoperatively using transvaginal gray-scale and colour 
Doppler ultrasound in the dorsal lithotomy position. Age and menopausal status were 
recorded in all women. Postmenopausal status was defined as more than one year of 
amenorrhoea or age more than 50 years in women who had had a hysterectomy.
7.4 Randomisation
Randomisation of patients into the randomised controlled study took place at the 
Regional Gynaecological Cancer Centre, Guy’s and ST Thomas’ NHS Foundation 
Trust. An information leaflet about the study was given to all eligible patients before
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assessment. The patients were reviewed by a member of the gynaecological oncology 
team who took a detailed clinical history, did a physical examination, and arranged 
additional tests when needed. If the diagnosis of an adnexal mass was confirmed, 
ultrasonography was requested. Written informed consent was obtained from all 
patients who agreed to take part in the study.
Consecutively numbered, opaque sealed envelopes were prepared at King’s 
College Hospital NHS Foundation Trust using a computer-generated randomisation 
sequence. The envelopes were then taken to the gynaecological rapid access clinic at 
Guy's and St Thomas’ NHS Foundation Trust and securely kept in the nurses' office. 
The envelopes were distributed by the nursing staff to the clinicians who were 
responsible for randomisation. The patients were randomised into either having a level 
II or a level III ultrasonography and each envelope contained the name of the 
department to which the patient was allocated.
7.5 Ultrasonography
Ultrasound examinations were performed using an Aloka SSD-5000 or an Aloka SSD- 
2000 machine (Aloka Co, Tokyo, Japan) or a Siemens Antares^^ machine (Siemens 
Medical Solutions, UK). Trans vaginal scan was performed except in cases were it was 
contraindicated, such as virgins or those unable to consent. Transabdominal sonography 
was used to examine a large mass that could not be seen in its entirety using a 
transvaginal probe or where transvaginal ultrasonography was not possible.
Transvaginal ultrasound examination was performed using a 5 MHZ transducer 
with B-mode and Doppler facilities, incorporating a filed view of 90°. The following 
morphological ultrasound information was recorded in each case: volume of cyst (s), 
presence of septations and solid areas within the cyst, métastasés and ascites. An 
attempt was made at identifying healthy ovarian tissue adjacent to the tumour (the
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ovarian crescent sign). This was defined as visible hypoechogenic tissue with or without 
ovarian follicles enclosed within the ovaiian capsule and located adjacent to the cyst 
wall. This tissue would not be separated from the cyst when applying a moderate 
amount of pressure. Measurements of the diameter of each cyst were taken in three 
perpendicular planes. The tumour or solid part mean diameter was calculated according 
to the formula (Di + D2 + Dsj/S and the tumour volume was calculated according to the 
formula (tc/6  x  Di x  D2 x  D3). Transabdominal scans were performed in women with 
large pelvis masses extending out of the range of the vaginal probe to ensure a complete 
examination or in cases where the patient was a virgin.
The nature of the ovarian cyst was assessed by use of the pattern recognition 
method. Features considered suspicious of an ovarian cancer included: presence of 
ascites and peritoneal tumour deposits within the pelvis; extensive papillarities (defined 
as the presence of multiple papillary (>2) projections >3mm in height covering large 
sections of the inner cyst wall) arising from the inner cyst wall (Valentin, 2004; 
Timmerman et al., 2000; Jokubkiene et al., 2007; ); and irregular solid components 
within the cyst with evidence of necrosis (i.e. ill-defined anechoic areas within a 
predominantly solid lesion). Métastasés were defined as the presence of irregular solid 
tumour deposits within the pelvis or the presence of omental cake. Operators were asked 
to classify tumours as either benign or malignant. When such estimates could not he 
made, the ultrasonography findings were classified as non-diagnostic and only a 
morphological description of the tumour was provided to the clinicians.
Level III ultrasonogr aphy was done by gynaecologists who had a special interest 
in gynaecological ultrasonography; had more than 10 years’ experience in 
gynaecological ultrasonography; worked in a tertiary referral unit; had been 
continuously involved in research in the field of gynaecological ultrasonography; and 
were recognised preceptors for the training of gynaecological ultrasonography by the
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UK Royal College of Obstetricians and Gynaecologists. Thus, they satisfied the criteria 
for level III operators as specified by the European Federation of Societies for 
Ultrasonography in Medicine and Biology (EFSUMB Newsletter, 2005).
Level II ultrasonography was done by ultrasonographers who were trained in 
gynaecological ultrasonography and all routinely and independently assessed patients 
with adnexal tumours, who were referred for a second opinion from other units.
7.6 Colour Doppler Imaging
Following transvaginal B-mode assessment, the entire tumour was surveyed by Colour 
Doppler imaging. In the colour, spectral and power modes, the Doppler ultrasound had 
a frequency of 5 MHz. All colour Doppler examinations began with the same settings of 
the ultrasound system: the highest sensitivity for detection of colour Doppler signals 
was used allowing detection of blood flow velocities >3 cm/s, and the colour gain was 
set just below the background noise level to increase, as far as possible, the Doppler 
sensitivity for low-velocity flow detection.
A subjective semiquantitative assessment of the amount of blood flow within the 
examined tumour was made (colour score): a score of 1 was given when no colour 
could be found in the lesion, a score of 2 was given when only minimal colour could be 
detected, a score of 3 was given when a moderate amount of colour was present, and a 
score of 4 was given when the tumour appeared highly vascular, showing a large area of 
colour signals (Timmerman et al., 2000).
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7.7 Serum CA 125 measurements
A blood sample was taken from a proportion of women (only those in whom the RMI 
needed to be measured or in the randomised trial) for measurement of CA-125 levels 
using Immuno-1 analyser (Bayer Diagnostics, Tarrytown, NY, USA). The detection 
limit of the assay was 1 U/mL, the coefficients of intra-assay and inter-assay variance at 
the levels of 32.5 U/mL and 279 U/mL were 2%, 1.1% and 4.5%, 1.1% respectively.
7.8 Histopathology and staging
A histopathologist examined specimens that were obtained at the time of surgery. 
Specimens were mounted onto blocks and one section per centimetre was taken for 
examination. Tumours were classified according to the World Health Organisation 
(WHO) guidelines (Serov et al., 1973). Ovarian malignancies were staged according to 
the classification of the International Federation of Gynaecology and Obstetrics (FIGO) 
(Shepherd, 1989).
7.9 Statistical Analysis
Database files were set up using Microsoft Excel (Redmond, Washington, USA) for 
windows to facilitate data entry and retrieval. Statistical analyses were carried out using 
Medcalc® version 9.2.0.2 and version 9.2.0.3 (Medcalc Software, Mariakerke, Belgium) 
or SPSS version 11 (SPSS Inc., Chicago, Illinois, USA) or the SAS system 9.1.3 (SAS 
Institute Inc., Cary, NC, USA). Continuous variables were expressed as mean and SD or 
median and interquartile range. Dichotomous variables were described using 
proportions. When suitable, relative effect sizes were quoted with difference between 
medians or relative risk (RR) with 95% confidence intervals. The statistical significance 
of differences in continuous variables was determined using Mann-Whitney U-test,
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McNemar’s test, Kruskall-Wallis test or Student t-test depending on data distribution. 
Proportions were compared using Yates’-corrected Chi-square test or Fisher’s exact 
test. Two-tailed p<0.05 was considered statistically significant. The diagnostic accuracy 
of the tests was assessed using sensitivity, specificity, positive and negative predictive 
value (PPV, NPV) and positive (LR+) and negative (LR-) likelihood ratio measures. 
The likelihood ratio of a positive test (sensitivity/[ 1 -specificity]) and the likelihood ratio 
of a negative test ( [ 1 -sensitivity]/specificity) were also calculated in order to eliminate 
the effect of the prevalence of ovarian malignancy on the interpretation of the value of 
the diagnostic test (Chien and Khan, 2001). LR+ >10 or LR- <0.1 indicate a very useful 
test, 5-10 and 0.1-0.2 indicate a moderately useful test, 2-5 and 0.2-0.5 indicate a 
somewhat useful test, and 1-2 and 0.5-1 indicate a test of little usefulness (Chien and 
Khan, 2001; Jaeschke R et al., 1994). Diagnostic performance of the tests was also 
assessed by examining the areas under receiver-operating characteristics (ROC) curves.
Percentage agreement was calculated and the agreement beyond chance was 
estimated using weighted Cohen’s kappa. Kappa values of 0.81-1.0 were assumed to 
indicate very good agreement, kappa values of 0.61-0.80 good agreement, kappa values 
of 0.41-0.60 moderate agreement. Kappa values of 0.21-0.40 fair agreement and Kappa 
values < 0.20 poor agreement (Brennan and Silman, 1992).
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7.10 Ethics Committee approval
The research was approved by the ethics committee and the research and development 
committee at King’s College Hospital and at Guy’s and St Thomas’ NHS Foundation 
Trust and it was entered in the registry of randomised trials. All patients gave informed 
consent to paiticipate in the study. A proportion of patients were recruited through the 
on-going-familial ovarian cancer screening programme, which has received prior ethical 
approval. Another proportion of patients included formed a part of the multicentre 
International Ovarian Tumor Analysis (IOTA) group collaboration, which was 
approved by the King’s College Hospital Ethics Committee.
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Chapter 8 
Study 1
A comparative study of the risk of malignancy index and the ovarian crescent sign 
for the diagnosis of invasive ovarian cancer
8.1 Background
In recent year's, ultrasound has been increasingly used for the assessment of women 
presenting with a wide range of gynaecological complaints. During a pelvic scan, an 
attempt is routinely made to identify the ovaries and to examine their morphological 
appearance. This has led to a substantial increase in the number of asymptomatic 
women diagnosed with ovarian abnormalities (Borgfeldt and Andolf, 1999). Although, 
the quality of ultrasound equipment has significantly improved in recent years, there is 
still no consensus on the most effective diagnostic criteria to discriminate between 
benign and malignant ovarian tumours on ultrasound scan (Granberg et al., 1990; 
Sassone et al., 1991; Lerner et al., 1994; Jacobs et al., 1990; Tailor et al., 1997; 
Timmerman et al., 1999a; Valentin et al., 2001; Aslam et al., 2000a). As a result women 
are often referred for additional investigations, such as tumour markers and magnetic 
resonance imaging (MRI), in order to clarify the nature of ovarian lesions. Many 
women are also offered surgery because of concerns about the possibility of 
malignancy, which is costly and carries the risk of complications.
The risk of malignancy index (RMI) - a scoring system based on a combination
of demographic and ultrasound data with measurement of serum CA-125 - has been
widely adopted in the UK to facilitate ti'iage of women with ovarian tumours for referral
to tertiary gynaecological oncology units (Jacobs et al., 1990; RCOG greentop
guidelines, 2003). Although the RMI is relatively a simple test to use in clinical
practice, its false negative and false positive rates are significant (Aslam et al., 2000a).
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In addition, the results are not immediately available and the test is relatively costly, as 
it involves the use of serum biochemistry.
Recent studies have shown that a detailed sonographic examination of an 
ovarian tumour by an expert in gynaecological ultrasonography may be superior to all 
previously described diagnostic models for noninvasive diagnosis of ovarian cancer 
(Timmerman et al., 1999b). However, in routine clinical practice most scans are 
performed by sonographers, many of whom have no particular expertise in the 
characterisation of ovarian tumours.
We have recently described a new morphological ultrasound feature, the 
‘ovaiian crescent sign’ (OCS), which depends on the fact that healthy ovarian tissue can 
be seen adjacent to the cyst within the ipsilateral ovary (Hillaby et al., 2004). The initial 
report showed that this morphological ultrasound sign has a potential of becoming a 
simple and effective way of excluding an invasive ovarian malignancy, without the need 
for a detailed morphological assessment of the tumour or the use of serum biochemistry.
In this study, we prospectively compared the value of the OCS and that of RMI 
for the diagnosis of ovarian cancer in a large group of women with an ultrasound 
diagnosis of ovarian tumour.
8.2 Methods
This prospective observational study was cairied out at the Gynaecological Assessment
Unit at King’s College Hospital, which is a tertiary referral gynaecological ultrasound
centre. All women referred to the unit underwent a pelvic ultrasound scan, which
involved a detailed examination of the uterus and the adnexa. All examinations were
performed by gynaecologists with special interest in gynaecological ultrasound using an
Aloka SSD-5000 machine (Aloka Co, Tokyo, Japan). Transvaginal and / or
transabdominal scans were performed as described in section 7.5. All women with a
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diagnosis of an ovarian tumour were invited to join the study. Simple cysts, defined as 
anechoic unilocular lesions with regular walls and no internal septations or solid parts 
(Timmerman et al., 2000), were all excluded from the study.
Demographic data and menopausal status were recorded as described in section
7.3. The following morphological ultrasound information was recorded in each case: 
site and volume of cyst, presence of septations and solid areas within the cyst, 
métastasés and ascites. Healthy ovarian tissue adjacent to the tumour -  the OCS- was 
defined as visible hypoechogenic tissue with or without ovarian follicles enclosed 
within the ovarian capsule and located adjacent to the cyst wall. This tissue would not 
be separated from the cyst when applying a moderate amount of pressure (Figure 2) 
(Hillaby et al., 2004).
A blood sample was taken from each patient to assess the serum CA125 levels 
with the Immuno-1 analyser (Bayer Diagnostics, Tarrytown, NY, USA). The RMI was 
calculated as originally described by Jacobs et al. (1990) (please refer to RMI 
calculation in chapter 3, paragraph 3.4.1)
In women with ovarian tumours, indications for surgery were suspected ovarian 
malignancy, clinical symptoms attributable to the adnexal cyst or patient’s request to 
have the ovaiian tumour removed. Women who did not have an indication for surgical 
treatment were managed expectantly and were invited to attend for a follow-up 
ultrasound scan 6-8 weeks later. The cyst was classified as benign on follow up visit if 
the woman remained asymptomatic and there was no increase in the size of the cyst and 
these women attended for another follow-up scan 3 months later. All women in whom 
the cyst increased in size were offered surgery. However, cysts that resolved 
spontaneously were classified as being functional in nature. In women who underwent 
surgery the ultrasound findings were compared to the histology, which was classified 
according to the World Health Organisation (WHO) guidelines (Serov et al., 1973).
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Ovarian malignancies were staged according to the classification of the International 
Federation of Gynaecology and Obstetrics (FIGO) (Shepherd, 1989).
The study was approved by the King’s Research Ethics Committee and all 
patients gave their informed consent.
8.3 Statistical Analysis
All statistical analyses were carried out using SPSS version 11 (SPSS Inc., Chicago, 
Illinois, USA). The statistical significance of differences in continuous variables was 
determined using Mann-Whitney, Ki’uskall-Wallis or Student’s t-tests depending on the 
distribution of the data. Proportions were compaied using Yates corrected test. Two- 
tailed P < 0.05 was considered statistically significant.
The diagnostic accuracy of the tests was assessed using sensitivity, specificity, 
positive predictive value (PPV), negative predictive value (NPV) and positive and 
negative likelihood ratio (LR+/LR-) measures. Diagnostic performance of the tests was 
also assessed by examining the areas under receiver-operating characteristics (ROC) 
curves.
A minimum of 90 patients was necessary to detect a 22% difference between the 
previously reported sensitivities, in diagnosing invasive ovarian malignancy, of 74% for 
RMI (Aslam et al., 2000a) and 96% for ovarian crescent sign (Hillaby et al., 2004), with 
85% power.
8.4 Results
One hundred and six consecutive women with ovaiian masses were included in the 
study. The indications for the ultrasound scan were: pain in 38 (35.9%) women, 
suspected ovarian tumour on a previous routine scan 37 (34.9%) women, menstrual 
disorders in 17 (16%) women, clinical suspicion of abdominal mass in seven (6 .6%)
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women, ovarian cancer screening in four (3.8%) women and postmenopausal bleeding 
in three (2.8%) women. 55 (51.9%) women were managed expectantly and 51 (48.1%) 
women had surgery. Thirty-one (60.8%) of the women operated on had minimally 
invasive surgery, while 20 (39.2%) had a laparotomy. The indications for surgery in all 
51 women operated on were: symptoms attributable to the adnexal lesion in 25 (49.0%) 
women, suspected malignancy in 14 (27.5%) women and patient’s choice in 12 (23.5%) 
women. The final diagnoses are listed in Table 2. There were significant differences in 
types of tumours in women who were managed expectantly in comparison to those who 
underwent surgery (%2 = 89.86; p < 0.001)
None of the women had invasive tumour on one side and non-invasive one on 
the other. FIGO staging and histological types of invasive cancers are listed in Table 3.
A RMI > 200 was found in 8/9 (88.9 %) women with invasive ovarian cancer 
and in 8/92 (8.7%) of those with benign lesions. RMI was < 200 in one case of invasive 
cancer, which was a stage II clear cell carcinoma. None of the five women with 
borderline tumours had RMI above that threshold. The ovarian crescent sign was absent 
in all nine cases of invasive ovarian cancer, 3/5 (60%) of borderline tumours and 4/92 
(4.3%) of benign cysts.
False positive results with the RMI typically occurred in women with 
endometriotic cysts, whilst the OCS was more likely to provide a false positive result in 
women with benign cystadenomas (Table 4).
A RMI > 200 diagnosed invasive ovarian malignancy with a sensitivity of 89% 
(95% Cl, 0.57 -  0.98), specificity of 92% (95% Cl, 0.85 -  0.96), PPV of 50%, NPV of 
99%, LR+ of 10.78 (95% Cl, 5.34 -  21.77) and LR- of 0.12 (95% Cl, 0.02 -  0.77). 
Absence of the OCS gave a sensitivity o f 100% (95% Cl, 0.70 -  1.0), specificity of 93% 
(95% Cl, 0.86 -  0.96), PPV of 56%, NPV of 100%, LR+ of 13.86 (95% Cl, 6.79 -
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28.29) and LR- of 0, which was significantly better than the RMI (p<0.01). The area 
under the ROC curve for the OCS was 0.928 (SE 0.052, asymptotic 95% Cl 0.826 -  
1.030) vs. 0.822 (SE 0.081, asymptotic 95% Cl 0.62 -  0.981) for RMI > 200 (Figure 3).
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Table 2. Types of ovarian lesions and management strategies applied in each group.
Final diagnosis Laparoscopy Laparotomy Expectant Total
N(%)* N (%)* N (% f N
Dermoid 16 (45.7) 3 (8.6) 16 (45.7) 35
Cystadenoma 5 (62.5) 3 (37.5) - 8
Endometrioma 3 (13.6) 1 (4.6) 18(81.8) 22
Cystadenofibroma 2 (100) - - 2
Fibroma 1(50) 1(50) - 2
Functional cyst 2 (8.7) - 21 (91.3) 23
Borderline 2(40) 3(60) - 5
Epithelial cancer - 8 ( 100) - 8
Non-epithelial cancer - 1 ( 100) - 1
Total 31 20 55 106
* Final diagnosis based on histological report, t  Final diagnosis based on ultrasound 
appearance.
95
Table 3. Histology and International Federation of Gynaecology and Obstetrics stage of 
invasive ovarian cancer.
Stage I (%) Stage II (%) Stage III (%) Stage IV (%)
Epithelial 1 (12.5) 3 (37.5) 3 (37.5) 1 (12.5)
Non-epithelial 0 1 (100) 0 0
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Table 4. False-positive cases in the diagnosis of invasive ovaiian cancer by the risk of 
malignancy index (RMI) and ovarian crescent sign (OCS).
Diagnosis RMI > 200 (n) Negative OCS (n)
Functional ovarian cyst 1 0
Dermoid 0 1
Cystadenoma 0 3
Endometrioma 7 0
Borderline tumour 0 3
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Figure 2 A complex ovarian cyst with healthy ovarian tissue (arrows) clearly visible 
adjacent to the wall of the cyst (the ovarian crescent sign).
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Figure 3 Receiver-operating characteristics curve comparing the diagnostic 
performance of the risk of malignancy index (RMI) and the ovarian crescent sign (OCS) 
for the diagnosis of invasive ovarian cancer. Solid line, RMI >200; Dashed line, OCS.
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Chapter 9
Study 2 
The accuracy of ultrasound subjective “pattern recognition” for the diagnosis of 
borderline ovarian tumours
9.1 Background
An accurate pre-operative differential diagnosis of ovarian tumours is of major clinical 
significance due to the implications for further management and survival. In the past, 
ovarian tumours used to be classified only as benign or malignant. Since 1971, the 
International Federation of Gynecology and Obstetrics (FIGO) (1971) has classified 
borderline ovarian tumours as an entity separate from benign and invasive ovarian 
tumours (Serov et al., 1973). However, until recently, borderline ovarian tumours 
(BOT) have been treated in the same way as invasive malignant tumours. BOTs are 
more prevalent in women of childbearing age (Gotlieb et al., 2005, Gotlieb et al., 1998; 
Boran et al., 2005) and their prognosis is generally good (Ahmed and Lawton, 2005; 
Silverberg et ah, 2004). They often follow a relatively benign course (Ahmed and 
Lawton, 2005; Silverberg et ah, 2004) and therefore fertility sparing conservative 
surgery is often contemplated in women with BOT who wish to preserve their 
reproductive potential (Maneo et ah, 2004). BOTs aie divided into two major 
histological groups: serous (two subtypes: typical serous and micropapillary) and 
mucinous (two subtypes: gastrointestinal and endocervical) (Ahmed and Lawton, 2005).
In the past decade, ultrasound examination has been accepted as the optimal 
diagnostic modality for the non-invasive assessment of ovarian tumours. However, the 
differentiation between various types of ovarian tumours on ultrasonography is 
sometimes difficult. Although, several ultrasound-based diagnostic algorithms have 
been proposed to facilitate differentiation between benign and malignant tumours
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(Granberg et al., 1990; Sassone et al., 1991; Lerner et al., 1994; Jacobs et al., 1990; 
Tailor et al., 1997; Timmerman et al., 1999a; Aslam et al., 2000a), the “pattern 
recognition” method remains the best way of assessing the nature of ovarian tumours 
(Valentin et al., 2001). However, the accuracy of pattern recognition is dependent on the 
operator’s skill and experience (Timmerman et al., 1999b). Several recent studies 
examined the gray-scale sonographic and colour Doppler features of borderline ovarian 
tumours (Exacoustos et al., 2005; Pascual et al., 2002; Wu et al., 1994). There were also 
attempts to describe the typical sonographic features of different histopathological 
subtypes of BOTs (Fruscella et al., 2005; Exacoustos et al., 2005; Gotlieb et al., 2000). 
However, the diagnostic accuracy of pattern recognition for the differential diagnosis 
between benign, borderline and invasive ovarian tumours has not been tested as yet.
The aim of this study was to prospectively assess the value of pattern 
recognition for the differential diagnosis of adnexal tumours and in particular its 
accuracy in establishing the specific diagnosis of histological subtypes of BOTs.
9.2 Methods
This was a prospective observational study of women who were referred to our regional 
gynaecological cancer centre with the diagnosis of an adnexal mass. They were all 
assessed clinically and had a level II (EFSUMB Newsletter, 2005) gynaecological 
ultrasound scan. Women with conclusive features of ovarian cancer or benign tumours 
were managed according to the centre’s protocols. Those women, in whom the nature of 
the lesion was uncertain during the level II gynaecological ultrasound scan, were 
referred for a level III (EFSUMB Newsletter, 2005) ultrasound scan at our centre, which 
is a tertiary referral gynaecological ultrasound unit. All women referred to the unit 
underwent a pelvic ultrasound scan, which involved a detailed examination of the uterus 
and the adnexa. All examinations were performed by gynaecologists with special
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interest in gynaecological ultrasound using an Aloka SSD-5000 machine (Aloka Co, 
Tokyo, Japan), Trans vaginal and /  or transabdominal scans were performed as described 
in section 7.5.
Demographic data and menopausal status were recorded as described in section
7.3. The following morphological ultrasound information was recorded in each case: 
site and volume of cyst, presence of septations and solid areas within the cyst, 
métastasés and ascites. The tumour pattern recognition method was used prospectively 
to differentiate between vaiious types of ovarian tumours.
Morphological features suggestive of a BOT were: unilocular cyst with a 
positive ovarian crescent sign and extensive papillaiities arising from the inner wall, or 
a cyst with a well-defined multilocular nodule. Solid papillary projections were defined 
as any solid projections into the cyst cavity arising from the cyst wall with a height 
greater than or equal to 3 mm. A multiloculai" nodule (“honeycomb nodule”) was 
defined as a predominantly solid nodule with cystic areas arising from the inner cyst 
wall. The presence of multiple papillary projections and positive ovarian crescent sign 
were suggestive of a serous type (Figure 4) or an endocervical type BOT (Figure 5), 
while the presence of a “Honeycomb nodule” and thick echogenic fluid content was 
indicative of a gastrointestinal (GI) type BOT (Figure 6).
The presence of healthy ovarian tissue adjacent to the tumour “the ovarian 
crescent sign” (Hillaby et al. 2004) was used to exclude invasive ovarian cancer. The 
ovarian crescent sign was defined in section 8 .2 .
Women who were diagnosed with benign ovarian tumours underwent 
conservative surgery. Women of childbearing age with a suspected BOT, who wished to 
preserve their fertility, undeiwent fertility sparing surgery such as cystectomy, 
oophorectomy or adnexectomy. Other women with BOTs who completed their families 
and those with suspected invasive ovarian cancer underwent a laparotomy, total
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abdominal hysterectomy, bilateral salpingo-oophorectomy and omentectomy at the 
gynaecological cancer centre. The ultrasound findings were compared to the histology, 
which was classified according to the World Health Organisation (WHO) guidelines 
(Serov et al., 1973). Ovarian malignancies were staged according to the classification of 
the International Federation of Gynaecology and Obstetrics (FIGO (International 
Federation of Gynaecology and Obstetrics, 1971; Shepherd, 1989).
The study was approved by the King’s Research Ethics Committee and all 
patients gave informed consent.
9.3 Statistical Analysis
All statistical analyses were carried out using SPSS version 14 (SPSS Inc., Chicago, 
Illinois, USA). The statistical significance of differences in continuous variables was 
determined using Mann-Whitney or Student t-tests depending on data distribution. 
Proportions were compared using Yates corrected test. Two-tailed p value of <0.05 
was considered statistically significant. The diagnostic accuracy of the tests was 
assessed using sensitivity, specificity and likelihood ratio (LR) measures.
9.4 Results
A total of 224 women with an adnexal mass of uncertain nature were referred for an 
expert scan, 166 (74.1%) of whom underwent surgery. The remaining 58 (25.9%) had 
functional ovaiian cysts, hydrosalpinges, peritoneal inclusion cysts or uterine fibroids 
diagnosed on ultrasound scan, and these did not require surgical intervention. Women 
with suspected functional ovarian cyst had at least one follow up ultrasound scan to 
confirm spontaneous resolution of the cyst.
Histopathological results were available in all 166 women who underwent 
surgery and they were all included in the final data analyses. There were 99 (59.6%,
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95% CI 52 -  67) benign tumours, 35 (21,1%, 95% CI 15 -  27) borderline and 32 
(19.3%, 95% Cl 13 -  25) invasive ovarian cancers. The patients’ mean age was 42 years 
(range, 14 - 88) and 45/166 (27%, 95% Cl 20 -  34) women were postmenopausal. 
Patients’ demographic data and clinical symptoms at presentation are listed in Table 5. 
When compaiing women’s demographic data and clinical symptoms, there were 
statistically significant differences between benign and invasive ovarian tumours and 
also between borderline and invasive ovarian tumours (except for the menopausal 
status), but not between benign and borderline ovarian tumours.
FIGO staging and histological types of BOT and invasive cancers are listed in 
Table 6 ; 25/35 (71.4%, 95% Cl 56 -  86) BOT underwent surgical staging. All the 
staged GI type BOTs and the majority of the staged serous /  endocervical type BOTs 
were FIGO stage I. Only 2/16 (12.5%, 95% C I O - 29) serous / endocervical type BOTs 
were FIGO stage III.
Morphological ultrasonic characteristics and final histology of all ovarian 
tumours in the study population aie summarised in Table 7. Papillary projections were 
present in approximately half of all borderline and invasive ovarian tumours, and in one 
fifth of ovarian cystadenomas (%^  = 35.0, p < 0.001). Solid papillary projections were 
much more frequent in serous / endocervical type BOTs (80%, 95% Cl 63 - 98) than in 
cases of GI type BOTs (7%, 95% Cl 0 -  20) (%^  = 18.5, p < 0.001). There were also 
significant differences in the presence of the ovarian crescent sign between benign, 
borderline and invasive ovarian tumours (%^= 75.6, p < 0.001). In the subtypes of BOTs, 
the ovarian crescent sign was present in 75% (95% Cl, 56 -  94) serous / endocervical 
type BOTs and in 20% (95% Cl, 0 -  40) GI type BOTs (%^  =10.38, p < 0.01). Thick 
fluid was present in all GI type BOT. However, this was not a specific finding as it was 
also found in most endometriomas as well as in some serous / endocervical type BOT 
and occasionally in epithelial ovarian cancers. The honeycomb nodule was a highly
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specific feature of GI type BOTs. However, its sensitivity was low as it was absent in 
nearly half of cases.
The false-negative and the false-positive cases encountered in this study are 
summarised with their respective gray scale moiphological appearances in Table 8. The 
women’s age and the tumour volume were not significantly different in cases of true- 
positive, false-positive or false-negative diagnoses in women with different subtypes of 
BOTs (Table 9). The median volume of the false-negative unilocular cysts was 1226 
(range 412 -  5661) mL.
The area under the receiver-operating characteristics curve, sensitivity, 
specificity, and positive and negative likelihood ratios of pattern recognition combining 
different moiphological features for the diagnosis of henign, borderline or malignant 
tumours are shown in Table 10. The sensitivity was better in cases of serous / 
endocervical type (75%, 95% Cl 56 -  94) compared to GI type (60%, 95% Cl 35 -  85) 
BOTs.
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Table 5. Demographic data and clinical symptoms at presentation of 166 women with 
an adnexal mass.
Type of adnexal mass p value (n)
Benign
n=99
Borderline
n=35
Invasive
N=32
Benign vs. 
Borderline
Benign vs. 
Invasive
Borderline 
vs. Invasive
Age (years, mean 
(range))
39
(14-83)
39
(21-65)
52
(17-88)
0.84 0.0007 0.003
Postmenopausal 
(n (%) [95% Cl])
19(19)
[11-27]
7(20)
[7-33]
19 (59) 
[42-76]
0.89 <0.0001 0.002
Pain (n (%) 
[95% Cl])
41 (41) 
[31-51]
9(26)
[12-41]
5(1Q
[3-29]
0.15 0.015 0.48
Abdominal 
distension 
(n (%) [95% Cl])
8(8)
[3-13]
5(14)
[3-26]
18(56)
[39-73]
0.46 <0.0001 0.0008
Incidental finding 
on USS or clinical 
examination (n 
(%) [95% Cl])
50 (51) 
[41-61]
21 (60) 
[44-76]
9(28)
[12-44]
0.44 0.045 0.018
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Table 6 . Histology and International Federation of Gynaecology and Obstetrics stages 
of borderline and invasive ovarian cancers.
Stage I 
n(%)
Stage II Stage III
n(%)
Stage IV
N ( % )
Serous /  endocervical 
BOT* (n= 16)
14 (87.5) 0 (0) 2 (12.5) 0 (0)
G IBOT* (n=9) 9 (100) 0 (0) 0 (0) 0 (0)
Epithelial invasive 
(n=24)
9 (37.5) 6(25) 6(25) 3 (12.5)
Non-epithelial invasive 
(n=8)
3 (37.5) 1 (12.5) 3 (37.5) 1 (12.5)
*25/35 (71%) borderline tumours had formal surgical staging. BOT, borderline ovarian 
tumour; GI, gastrointestinal.
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Table 8 . Ultrasound morphological appearance of false positive and false negative
cases.
Histology Ultrasound diagnosis Ultrasound morphology
n = 7 Cystadenoma Serous / endocervical 
BOT
Unilocular solid cyst with 
numerous PP
n = 1 Cystadenoma GI BOT Unilocular cyst with a 
Honeycomb nodule
n = 3 Serous / endocervical 
BOT
Cystadenoma Unilocular cyst
n = 1 Serous / endocervical 
BOT
Cystadenoma Unilocular cyst with a PP
n = 1 Serous / endocervical 
BOT
Cystadenoma Multilocular cyst
n = 3 G IBO T Cystadenoma Multilocular cyst
n = 1 G IBO T Endometrioma Unilocular cyst containing 
fluid with ‘ground glass’ 
appearance
n = 1 G IB O T Dermoid Multilocular solid cyst
n = 1 G IB O T Invasive cancer Multilocular solid cyst
BOT, borderline ovarian tumour; GI, gastrointestinal; PP, papillary projection.
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Figure 4 Ultrasound image showing a serous borderline ovarian tumour with extensive 
papillary projections arising from the cyst wall. Note the presence of healthy ovarian 
tissue, the ‘ovarian crescent sign’ (arrow).
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Figure 5 Ultrasound image showing a mucinous endocervical-type borderline ovarian 
tumour (BOT). Note the resemblance to a serous BOT, but more organized papillary 
projections. The ovarian crescent sign is also a common feature (arrow).
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Figure 6 Ultrasound image showing a mucinous gastrointestinal-type borderline 
ovarian tumour. A ‘honeycomb nodule’ is seen suspended within the cyst cavity 
(arrow).
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Chapter 10
Study 3 
Real-time ultrasound versus evaluation of static images in the preoperative 
assessment of adnexal masses
10.1 Background
Trying to make an accurate prediction of the benign or malignant nature of an adnexal 
mass during a preoperative ultrasound examination remains an important task because 
the preoperative diagnosis influences the treatment strategy and, as a consequence, the 
prognosis of the patient (Buchweitz et ah, 2005; Medeiros et ah, 2005; Carley et ah, 
2002; Vergote et ah, 2001; Hacker et ah, 1983). As mentioned in previous chapters, 
several reports have shown that subjective evaluation of ultrasound findings (pattern 
recognition) by an expert sonologist is one of the best methods for discriminating 
between benign and malignant adnexal masses before surgery (Valentin, 1999; 
Timmerman et ah, 1999b; Timmerman, 2004; Valentin, 2004)). If the evaluation is 
performed by a less experienced sonologist, the diagnostic performance is reduced 
(Timmerman et ah, 1999b). In training hospitals, a patient with an adnexal mass is often 
first scanned by a junior or senior ultrasound operator. Subsequently, the images are 
discussed with a supervising ultrasound operator, who will often rescan the patient, 
because he or she believes that this will help in gaining the right information to make a 
correct diagnosis. However, to the best of our knowledge, it has never been confirmed 
in a scientific study that real-time scanning is superior to evaluating saved static images 
of an adnexal mass.
The aim of this study is to determine if the prediction of the nature of an adnexal 
mass using pattern recognition, i.e. subjective evaluation of gray-scale and Doppler
115
ultrasound findings, is as accurate when based on static images as it is when based on a 
real-time ultrasound examination.
10.2 Methods
For this prospective observational study, a dataset of non-consecutive patients with an 
adnexal mass was created in the Eaiiy Pregnancy and Gynaecology unit of King’s 
College Hospital, London, UK. Patients were included if they had complex or difficult- 
to-classify masses when using pattern recognition. A large number of patients were 
referred to this tertiary referral centre after they had undergone an ultrasound 
examination in their referring hospital. In this way we collected a dataset of 171 
selected patients with adnexal masses. The study was a part of the multicentre IOTA 
(International Ovarian Tumor Analysis) group collaboration, which was approved by 
the King’s College Hospital Ethics Committee,
All patients included in this study were preoperatively scanned by one of the 
expert sonologists at the tertiary referral centre, the “real-time” sonologist (DJ). The 
ultrasound examination was performed transvaginally and transabdominally using the 
gray-scale and colour/power Doppler modes of an Aloka SSD-5000 ultrasound machine 
(Aloka Co., Tokyo, Japan), and the images were saved electronically. The anonymised 
electronic images of all 171 adnexal masses were later independently evaluated by three 
expert sonologists, the “image experts” (DT, ACT, LV). Patients were excluded if one 
of the “image experts” found the quality of the images insufficient to make a reliable 
diagnosis. The image experts received relevant clinical information and information on 
the colour score if the colour content of the tumour scan was not clearly demonstrated in 
the static ultrasound images. The colour score is described in section 7.6. Both the real­
time sonologist and the image experts classified each mass as benign or malignant using 
pattern recognition. Borderline ovarian tumours were regarded as malignant. They also
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stated with which degree of confidence they made their diagnosis (certainly benign or 
malignant, probably benign or malignant, uncertain). All four ultrasound experts 
involved in this study had more than 10 years of experience in gynaecologic ultrasound 
at the start of the study, and they are all senior clinicians in tertiary referral centres.
The primary outcome was the histopathological classification of the adnexal 
mass following the WHO guidelines (Serov et al., 1973). In case of malignancy, 
patients were staged according to the FIGO criteria (Shepherds, 1989).
10.3 Statistical Analysis
All statistical analyses were carried out using SAS version 9.1.3 for Windows (SAS 
Institute Inc., Cary, NC, USA). The accuracy, sensitivity and specificity were calculated 
for the real-time sonologist and for each of the image experts. The performance of the 
real-time expert was compared with the performance of each image expert and also with 
the “consensus opinion” of the three image experts. The consensus opinion was defined 
as the diagnosis predicted by at least two of the three image experts. McNemar’s test 
was used to determine the statistical significance of a difference in nominal variables 
between matched samples.
10.4 Results
Five of the 171 masses were excluded because of poor image quality, leaving 166 
adnexal masses for evaluation. Seventy masses (42%) were malignant of which 34 
(49%) were borderline tumours. Ninety-six masses (58%) were benign. Table 11 shows 
the histopathological diagnoses.
Table 12 shows the performance of the real-time sonologist, that of each image 
expert and that of the consensus opinion of the image experts. The accuracy and 
specificity of the real-time sonologist were superior to those of two of the image experts
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and also to the consensus opin ion  o f  the three im age experts, although the latter w as
only  significant w ith respect to specificity .
The consensus opinion had nine more false positive cases in comparison with 
the real time sonologist reducing the specificity significantly. These false positive cases 
were one dermoid, two fibromas and six cystadenomas. The fibromas were presumed to 
be rare malignant tumours by the image experts and the cystadenomas and the dermoid 
were presumed to be borderline ovarian tumours. In only one of these nine cases, two of 
three image experts were very confident about their diagnosis of malignancy, and in 
three cases one image expert was certain. In the remaining five false positive cases the 
image experts were either completely unsure or not really confident (probably benign or 
probably malignant). The real-time expert stated that he was very confident of his 
henign diagnosis in four of the nine cases and stated that the diagnosis was probably 
benign in the remaining five. The four cases that were misclassified by both the 
consensus opinion and the real-time expert were three cystadenofibromas (one with 
Brenner tumour component), all of which were misclassified as borderline tumours, and 
one thecoma that was misclassified as a rare malignant tumour by all the experts.
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T able 11. H istopathological diagnoses o f  the adnexal m asses included  in  the study.
Histopathological diagnosis Number (%)
Benign 96 (57.8)
Dermoid cyst 35 (21 .1)
Cystadenoma/-fibroma 35 (21 .1)
Endometrioma 16 (9.6)
Fibroma 6 (3.6)
Simple cyst/functional cyst 2 ( 1.2)
Abscess 1 (0 .6)
Rare benign tumour 1 (0 .6)
Malignant 70 (42.2)
Mucinous borderline tumour 16 (9.6)
Serous borderline tumour 18 (10.9)
Primary invasive carcinoma 25 (15.1)
Rare malignant tumour 11 (6 .6)
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Chapter 11
Study 4 
The use of ultrasound pattern recognition by expert ultrasound operators to 
identify borderline ovarian tumours: a study of diagnostic performance and 
interobserver agreement of ultrasound diagnoses
11.1 Background
An accurate pre-operative diagnosis of the nature of adnexal tumours facilitates the 
choice between conservative and surgical management. In women who are booked for 
surgery, information obtained by ultrasonography helps to decide on the most 
appropriate surgical approach and assists in deciding whether referral for specialised 
gynaecological oncological care is required.
Traditionally, adnexal tumours were classified on ultrasound scan as being either 
benign or malignant. Recent reports have suggested that, using pattern recognition, it is 
possible to establish a correct pre-operative diagnosis of borderline ovaiian tumours 
with a sensitivity of 69%. The low sensitivity may be explained by variations in the 
morphological appearance of borderline ovarian tumours. Nevertheless, the ability to 
identify borderline ovaiian tumours pre-operatively is of great importance. Borderline 
ovarian tumours tend to occur in younger women (Gotlieb et al., 2005) and they aie 
usually associated with good long term prognosis (Ahmed and Lawton, 2005; Boran et 
al., 2005, Silverberg et al., 2004). Therefore, pre-operative identification of this type of 
ovarian tumours should allow more conservative, fertility-sparing, surgery to be carried 
out on women who are in the reproductive age group and who have still not completed 
their families. The agreement between experienced ultrasound operators with regard to 
identifying borderline ovarian tumours as a separate entity from benign and invasive 
malignant ovarian tumours has not been formally tested.
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The aim of this study was to evaluate the reproducibility of ultrasound ‘pattern 
recognition’ for the diagnosis of borderline ovarian tumours by asking experienced 
ultrasound operators to systematically examine a lai'ge data set containing representative 
images of different types of adnexal tumours.
11.2 Methods
The database of the Early Pregnancy and Gynaecology Assessment Unit at King’s 
College Hospital, UK was searched to identify all women who were diagnosed with 
adnexal tumours in the period between January 2004 and June 2006. Only women who 
underwent surgery and in whom a final histological diagnosis was available were 
included. The cases were selected arbitrarily to ensure that the dataset included a mix of 
representative examples of benign, borderline and invasive malignant ovarian tumours. 
The study was a part of the multicentre IOTA (International Ovarian Tumor Analysis) 
group collaboration, which was approved by the King’s College Hospital Ethics 
Committee.
All original real-time examinations were performed by expert ultrasound 
examiners using an Aloka SSD-5000 machine (Aloka Co, Tokyo, Japan). In each case, 
the indication for the scan as well as the clinical history was recorded in a database 
(FIA- Fetal Database, Viewpoint Bildverabeitung GmbH, Wessling, Germany). Static 
two-dimensional B-mode images of standard views of the uterus, ovaries, and pouch of 
Douglas were obtained in all cases and they were digitally stored in the database. All 
detectable adnexal abnormalities were measured in three orthogonal planes. In each 
case, an effort was made to record ultrasound features, which were considered 
characteristic of a particular type of adnexal tumour.
The stored static two-dimensional B-mode images were independently assessed 
by three expert operators (EFSUMB Newsletter, 2005) (ACT, DT and LV). Each
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operator was given information about the indication for the scan and relevant clinical 
history, but they were unaware of the pre-operative real-time ultrasound diagnosis and 
of the histopathological findings. The operators were first asked to determine whether 
the images were of sufficient quality. If the quality of the images was found to be 
suboptimal by any of the three operators then the case was excluded from the final data- 
analysis. If the images were considered satisfactory, the operators were asked to 
examine them in detail and to classify the tumours as benign, borderline or invasive 
malignant.
The outcome measures included: accuracy of each operator in diagnosing 
benign, borderline or invasive malignant ovarian tumours, and the interobserver 
agreement in classifying the tumours as benign, borderline or invasive malignant.
11.3 Statistical Analysis
The statistical analyses were carried out using the SAS system 9.1.3, SAS Institute Inc., 
Cary, NC, USA.
The %2 test, Fisher’s exact test and McNemar’s test were used to test the 
statistical significance of differences in discrete data, Mann-Whitney’s test was used to 
compare the continuous vaiiable (patient’s age). All reported p values were two-tailed 
and we considered as significant a nominal p<0.05 although multiple tests were done, 
considering that all the analyses that were carried out had an exploratory purpose.
Percentage agreement was calculated and the agreement beyond chance was 
estimated using weighted Cohen’s kappa. Kappa values of 0.81-1.0 were assumed to 
indicate very good agreement, kappa values of 0.61-0.80 good agreement, kappa values 
of 0.41-0.60 moderate agreement. Kappa values of 0.21-0.40 fair agreement and Kappa 
values < 0.20 poor agreement (Brennan and Silman, 1992).
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11.4 Results
The static two-dimensional B-mode and Doppler images of 171 women diagnosed with 
adnexal tumours were collected. Five of 171 (3%) cases were excluded by the expert 
sonologists because of suboptimal image quality.
The 166 cases included in the analysis were assessed by the three expert 
operators (A, B and C). The data set included 96 (58%) benign ovarian tumours, 34 
(20%) borderline ovarian tumours and 36 (22%) primary invasive ovarian tumours. 
Median age (range) was 57 years (13-88) in patients with a primary invasive ovarian 
tumour compared to 36 years (21-65) and 39 years (14-83) in women with borderline 
and benign masses, respectively (p<0 .01).
Table 13 shows the experts’ diagnosis stratified by final histological diagnosis. 
The rates of correctly diagnosed masses for operators A, B and C were 74% (25/34), 
71% (24/34) and 59% (20/34) in borderline tumours, 91% (87/96), 79% (76/96) and 
85% (82/96) in benign tumours and 86% (31/36), 92% (33/36) and 89% (32/36) in 
primary invasive malignant tumours, respectively (borderline vs. benign A: p=0.02, B: 
p=0.35, C: p<0.01; borderline vs. invasive A: p=0.24, B: p=0.03, C: p<0.01). All thiee 
operators showed tendency to misclassify borderline tumours as benign rather than 
primary invasive: ratio of 8:1 in operator A, 6:1 in C and 4:1 in B. As a result of this, 
the diagnostic performance of the operators in making the discrimination between 
invasive and non-invasive (benign and borderline) tumours was better compared to the 
traditional discrimination of malignant (borderline and invasive) versus benign tumours: 
all three operators had higher sensitivity, specificity, LR+ and LR- in identifying 
invasive masses compared to malignant masses (borderline and invasive) (Tables 14 
and 15).
The proportion of agreement between any two observers with regards to making 
an ultrasound diagnosis of benign, borderline and primaiy invasive malignant ovarian
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tumour varied from 81% to 86% (Table 16). Cohen’s kappa ranged from 0.76 to 0.82 
indicating a good to very good agreement between each pair o f operators. The 
interobserver agreement between any two experts was very good when they were tested 
for their ability to discriminate between invasive and non-invasive ovaiian tumours 
(Kappa 0.85 to 0.88), but poorer for the discrimination between malignant versus 
benign (Kappa 0.70 to 0.78). All three operators were concordant in classifying the 
tumours as invasive or non-invasive in 154/166 (93%) compared to 134/166 (81%) in 
classifying the tumours as benign or malignant (p<0 .01).
The proportion of operators who correctly classified the adnexal masses is 
shown in Table 17. A correct classification was made by all three experts in 83% of the 
primary invasive cancers, 76% of the benign masses, compared to only 43% of the 
borderline malignant tumours (p<0 .01 ).
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T able  13. T he diagnosis o f  ind iv idual experts in  benign, borderline  and prim ary
invasive ovai'ian tum ours.
Histology
Expert Benign
'Expert’s diagnosis 
Borderline Primary invasive
Benign
(N = 96) A 87 91% 6 6% 3 3%
B 76 79% 16 17% 4 4%
C 82 85% 8 8% 6 6%
Borderline
(N = 34) A 8 24% 25 74% 1 3%
B 8 24% 24 71% 2 6%
C 12 35% 20 59% 2 6%
Primary invasive
(N = 36) A 2 6% 3 8% 31 86%
B 2 6% 1 3% 33 92%
C 2 6% 2 6% 32 89%
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T able 14. D iagnostic  perform ance o f  pattern  recognition w ith  regard  to d iscrim inating
betw een  invasive and non-invasive (benign and borderline) tum ours.
Operator Sensitivity 
(%, 95% Cl)
Specificity
(%,95%CI)
LR+ 
(95% Cl)
LR- 
(95% Cl)
A 31/36
(86,71-95)
126/130 
(97,92-99)
27.99
(10.57-74.10)
0.14
(0.06-0.32)
B 33/36 
(92, 78-98)
124/130 
(95, 90-98)
19.86
(9.04-43,66)
0.09
(0.03-0.26)
C 32/36 
(89,74-97)
122/130 
(94, 88-97)
14.44
(7.31-28.54)
0.12
(0.05-0.30)
LR+, positive likelihood ratio; LR-, negative likelihood ratio;
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T able  15. D iagnostic  perfo rm ance o f  pattern  recognition  w ith  regard  to  d iscrim ination
betw een  m alignan t (borderline and invasive m alignancies) and  benign  tum ours.
Operator Sensitivity 
(%, 95% Cl)
Specificity 
(%, 95% Cl)
LR4- 
(95% Cl)
LR- 
(95% Cl)
A 60/70 
(86,75-93)
87/96
(91,83-96)
9.14
(4.87-47.15)
0.16
(0.09-0.28)
B 60/70
(86,75-93)
76/96 
(79, 70-87)
4.11
(2.75-6.15)
0.18
(0.10-0.32)
C 56/70 
(80, 69-89)
82/96 
(85, 77-92)
5.49
(3.33-9.03)
0.23
(0.15-0.38)
LR+, positive likelihood ration; LR-, negative likelihood ratio
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T able 17. P roportion  o f  experts w ho correc tly  classified  the ovarian  m asses.
Histology
Proportion of 
Experts
Benign 
N = 96
Borderline 
N = 34
Primary invasive 
N = 36
N % N % N %
0/3 6 6 2 6 2 6
1/3 8 8 10 29 2 6
2/3 9 9 7 21 2 6
3/3 73 76 15 44 30 83
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Chapter 12
Study 5
Confidence of the ultrasound operator in making a differential diagnosis of an 
adnexal tumour: Effect on diagnostic accuracy and interobserver agreement
12.1 Background
Pattern recognition method is a subjective technique used for the ultrasound diagnosis 
of adnexal tumours (Valentin, 2004). Adnexal tumours often exhibit specific 
morphological features on gray-scale ultrasonography (Valentin, 2004, Valentin et al., 
2006a), which could be used to foretell their histological type and nature. In typical 
cases, the ultrasound operator may be able to make the diagnosis with a high level of 
confidence. However, a number of adnexal tumours exhibit complex or unusual 
moiphological features (Valentin et al., 2006b). As a result, these tumours are more 
difficult to classify. This may decrease both the diagnostic accuracy and the confidence 
with which the diagnosis is made. Operators do not usually report the level of 
confidence in reaching the diagnosis. In uncertain cases, however, many operators 
provide a morphological description of the adnexal tumour without committing 
themselves to a specific histological diagnosis.
The degree of the ultrasound operators’ confidence in making a diagnosis of an 
ovarian tumour is likely to be determined by the level of their skill and experience. 
However, confidence may also, to some extent, reflect the personality of the operator 
and it may vary even in operators with similar knowledge and experience.
Ultrasound pattern recognition technique enables accurate differentiation 
between benign and malignant adnexal tumours when used by expert ultrasound 
operators (Valentin 1999; Timmerman et al., 1999b). However, we do not know how 
much the level of confidence, when making diagnosis of adnexal tumour, varies
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between the operators and whether the diagnostic accuracy depends on the level of 
confidence.
The aim of this study was to assess the degree of confidence with which expert 
ultrasound operators differentiate between benign, borderline and invasive malignant 
ovarian tumours and to assess the effect of their diagnostic confidence on diagnostic 
accuracy and interobserver agreement.
12.2 Methods
The same methods of section 11.2 have been used in this study. In addition, the 
operators were also asked to provide the degree of confidence with which they made the 
diagnosis, confidence being classified into certain, probable and uncertain diagnosis. 
The operators were certain when they were nearly 100% sure of their diagnosis, 
probable when they were more than 50% sure and uncertain when they made a complete 
guess.
The main outcome measure was the degree of confidence of the three operators 
in making the diagnosis of benign, borderline or invasive malignant ovarian tumour. 
Secondary outcomes included:
- Diagnostic accuracy of each operator in diagnosing benign, malignant borderline and 
invasive malignant tumours depending on the level of confidence when suggesting the 
diagnosis (certain, probable and uncertain).
- Interobserver agreement in classifying tumours as benign, borderline or invasive 
malignant depending on the degree of diagnostic confidence.
The expert operators’ findings were compared to the histology, which was 
classified according to the World Health Organisation (WHO) guidelines (Serov et al., 
1973). Ovarian malignancies were staged according to the classification of the 
International Federation of Gynaecology and Obstetrics (FIGO) (Shepherd, 1989).
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12.3 Statistical Analysis
Please refer to section 11.3.
12.4 Results
The static two-dimensional B-mode images of 171 women diagnosed with adnexal 
tumours were collected. Five of 171 (3%) cases were excluded by the expert sonologists 
because of suboptimal image quality.
The 166 cases included in the analysis were assessed by the three expert 
operators (A, B and C). The data set included 96 (58%) benign ovarian tumours, 34 
(20%) borderline ovarian tumours and 36 (22%) primary invasive ovarian tumours. 
Median age (range) was 57 years (13-88) in patients with a primary invasive ovarian 
tumour compared to 36 years (21-65) and 39 yeai's (14-83) in women with borderline 
and benign masses, respectively (p<0 .01).
The diagnostic confidence differed significantly between the operators, mainly 
due to a lower number of probable diagnoses and higher number of certain diagnoses 
made by operator A than by operators B and C (Table 18). Confidence was also related 
to the suggested diagnosis in two of the investigators: the rates of “certain” diagnosed 
masses for operators A, B and C were 44% (15/34), 34% (14/41) and 43% (13/30) in 
suggested borderline tumours, 60% (58/97), 56% (48/86) and 59% (57/96) in suggested 
benign tumours and 71% (25/35), 33% (13/39) and 48% (19/40) in suggested primary 
invasive tumours, respectively (borderline vs. benign A: p=0.11, B: p=0.02, C: p=0.12; 
borderline vs. invasive A: p=0.02, B: p=0.94 C: p=0.73). The diagnostic performance 
decreased with decreasing diagnostic confidence (Table 19), e.g. operator A had an 
error rate of only 6% (6/98) in the ‘certain’ diagnoses, 17% (8/47) in the ‘probable’ 
diagnoses and 43% (9/21) in the ‘uncertain’ diagnoses (p<0.01). Similar conclusions 
hold for operators B and C (p=0.01 and p<0.01). Stratified by histology, the figures
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suggest similar trends, but statistical significance was only reached in cases of benign 
tumours (A: p=0.05, B: p=0.01, C: p<0.01) and in primary invasive tumours for 
operator A (p=0.02). All three investigators misdiagnosed borderline tumours more 
frequently as benign tumours rather than invasive tumours: A, 89% (8/9); B, 80% (8/10) 
and C, 86% (12/14).
Table 20 shows that the level of agreement in confidence is proportional to the 
level of agreement in diagnosis, e.g. operators A and B agreed in confidence in 64% 
(86/135) of the cases in which they agreed on the diagnosis compared to only 26% 
(8/31) of the cases in which they disagreed on the diagnosis (p<0 .01 ).
Table 21 shows that the interobserver agreement with regard to the diagnoses 
suggested between any two operators was very good when both suggested a diagnosis 
with a high level of certainty (agreement rate 98%-100%, Cohen’s Kappa 0.95-1.00), 
but was significantly lower in case both operators made a probable diagnosis 
(agreement rate 71%-78%, Cohen’s Kappa 0.64-0.80) (p<0.01 for any two operators). 
The agreement in both diagnosis and confidence was the lowest in the cases of 
borderline ovarian tumours compared to benign and primary invasive lesions (Table 
22).
Table 23 presents the cases which were misdiagnosed by all three investigators. 
In one case, all three operators were certain that the lesion was benign. The histology 
report showed evidence of mature cystic teratoma with a focus of squamous cell 
carcinoma.
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T able  18. D iagnostic confidence o f  the th ree  operators.
Operator Certain
n (%0
Probable
n(% )
Uncertain
N (% )
A 98(59) 47 (28) 21 (13)
B 75 (45) 81 (49) 10 (6)
C 89(54) 70 (42) 7 (4 )
Certain: A vs B, p<0.01 ; A vs C, p=0.19; B vs C, p=0.07 
Probable: A vs B, p<0.01; A vs C, p<0.01; B vs C, p=0.18 
Uncertain: A vs B, p=0.04; A vs C, p<0.01; B vs C, p=0.47
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Chapter 13
Study 6
Effect of the quality of gynaecological ultrasonography on management of patients 
with suspected ovarian cancer: a randomised controlled trial
13.1 Background
A clinical diagnosis of adnexal tumours is often made in patients who complain of 
abdominal swelling and pelvic pain. These tumours can also be noted incidentally 
during bimanual pelvic examination or on ultrasonography, when an examination is 
done for eaiiy pregnancy complications or other gynaecological symptoms (Beischer et 
al., 1971; Nelson et al., 1986; Yazbek et al., 2007; Bordgeldt and Andolf, 1999).
The differential diagnosis of adnexal masses includes ovarian cancer and 
patients are often offered additional investigations, such as tumour marker tests, to 
clarify the nature of the tumour (Jacobs et al., 1990). It is not unusual for the nature of 
the adnexal tumour to remain uncertain despite numerous tests and as a result many 
patients undergo major surgery because of the fear of missing an ovarian cancer (Miller 
et al., 1991).
Ultrasonography is a sensitive method for the detection of adnexal abnormalities 
and is routinely used for the assessment of patients with various gynaecological 
complaints. As previously discussed, the ability of ultrasonography to establish the 
nature of an adnexal tumour is variable and depends mainly on the experience and skill 
of the operator (Valentin, 1999; Timmerman et al., 1999b). Studies have shown that, 
when carried out by experts (known as level III ultrasonography) gynaecological 
ultrasonography can distinguish between benign and malignant adnexal tumours with an 
accuracy of 164/173 (94%) tumours (Valentin, 1999). The accuracy of routine 
ultrasonography (also known as level II ultrasonongraphy), which is usually done by
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less experienced operators, is likely to be lower (Timmerman et al., 1999b). The best 
survival rates for patients with ovaiian cancer are achieved when treatment is organised 
and carried out by gynaecological oncologists who work in cancer centres (Junor et al., 
1999). However, patients with asymptomatic benign tumours can be managed 
expectantly (Yazbek et al., 2007; Platek et al., 1995, Lee et al., 2004) or by minimally 
invasive surgery if symptomatic (Hilger et al., 2006; Mais et al., 1995). These 
operations can be safely undertaken by general gynaecologists in local hospitals.
In the UK, most patients with suspected or confirmed adnexal masses are 
referred to rapid-access gynaecological oncology clinics for detailed investigations and 
treatment. Most gynaecological ultrasonography examinations, both in local hospitals 
and tertiary cancer centres aie done by sonographers who are usually trained to do level 
II (EFSUMB Newsletter, 2005) ultrasonography. Before this study, patients who 
attended our regional gynaecological cancer centre (Guy’s and ST Thomas’ NHS 
Foundation Trust, London, UK) with an adnexal mass and had non-diagnostic level II 
ultrasonography, were subsequently referred for Level III scans (EFSUMB Newsletter, 
2005) in our unit (King’s College Hospital NHS Foundation Trust, London, UK). 
Although level III scans were not incorporated in the protocol of the regional 
gynaecological cancer centre, a retrospective audit showed an improved accuracy of 
Level III scanning for the diagnosis of ovarian cancers in comparison to level II scans.
The aim of this study was to examine whether the improved accuracy of level III 
ultrasonography has a measurable effect on the management of patients with adnexal 
masses when compared with routine level II ultrasonography.
13.2 Methods
We did a prospective randomised controlled study, which took place at Guy’s and St 
Thomas’ NHS Foundation Trust and at King’s College Hospital NHS Foundation Tmst
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(London, UK). The study was approved by the ethics committee and the research and 
development committee at both hospitals.
Patients were recruited from the rapid access clinic at the Southeast 
Gynaecological Cancer Centre (Guy’s and St Thomas’ NHS Foundation Trust), The 
inclusion criteria were: clinical diagnosis of adnexal mass in primary or secondary care 
or diagnosis of an adnexal mass by ultrasonography, MRI or CT; no indication for 
immediate surgical treatment and patients aged 14 and above who were able and willing 
to give written consent to take part in the study.
Randomisation was performed as detailed in section 7.4.
The paiticipants were not blinded to the group assignment. However, the 
ultrasonography operators were not aware that patients were taking part in the study. 
Patients who declined taking part in the study were managed in accordance with the 
cancer centre protocols, which included level II ultrasonography.
Ultrasonography was performed as described in section 7.5. Level II and II 
operators have also been defined in section 7.5. Level III ultrasonography was done 
using an Aloka SSD-5000 machine (Aloka Co, Tokyo, Japan) and level II 
ultrasonography was done using a Siemens Antares^'^ machine (Siemens Medical 
Solutions, Bracknell, UK).
The operators were asked to classify tumours as either benign or malignant. 
When such estimates could not be made, the ultiasonography findings were classified as 
non-diagnostic and only a moiphological description of the tumour was provided to the 
clinicians. Throughout the study period, level III ultrasonography was done at King’s 
College Hospital NHS Foundation Trust and level II ultrasonography was done at Guy’s 
and St Thomas’ NHS Foundation Trust.
After ultrasonography, patients in both groups of the study were reviewed within 
two weeks by a gynaecological oncologist at the rapid-access clinic at the Southeast
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Gynaecological Cancer Centre (Guy’s and St Thomas’ NHS Foundation Trust), who 
reviewed the patient and made decisions about further management. For most patients, 
the decision on management was made by the lead consultant gynaecological 
oncologist. In her absence, the decision on management was made by the other two 
consultant gynaecological oncologists. The gynaecological oncologists were allocated a 
random mix of the patients as they were recruited into the study. Non-surgical 
management included expectant management or neoadjuvant chemotherapy when the 
diagnosis of malignancy was confirmed by cytological or histological examination. If 
expectant management was chosen, patients attended for follow up ultrasonography 
within six months of the initial assessment. Patients were reviewed after the follow up 
scan and surgical management was considered if the patient became symptomatic, the 
tumour had increased in size or the tumour had changed in appearance (suggesting 
possible malignancy). Patients with persistent adnexal tumours, which had not changed 
substantially on follow up visits, were contacted by telephone at least one yeai* after 
recruitment into the study, and were asked whether they developed any symptoms, 
whether they needed additional medical help, or whether they had undergone surgery to 
remove the tumour.
Patients who did not attend follow-up visits were contacted by telephone and 
asked whether they had undergone ultrasonography in another centre, whether they 
developed any symptoms, or whether they had undergone a surgical procedure 
elsewhere.
Surgical management was divided into procedures undertaken for suspected 
adnexal malignancy or procedures done for presumed benign adnexal tumours. 
Procedures undertaken for suspected adnexal malignancy involved a major staging 
surgical procedure (including a laparotomy and at least an oophorectomy and omental 
biopsy) for a suspected adnexal malignancy at the regional gynaecological cancer
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centre. Procedures carried out for benign adnexal tumours included laparotomy by a 
general gynaecologist or a minimally invasive procedure (eg, operative laparoscopy or 
ultrasonography-guided cyst aspiration). Patients with suspected non-gynaecological 
tumours were referred to the appropriate specialty for management.
Findings on ultrasonography were compared with the final histological 
diagnosis, which was classified according to the World Health Organisation (WHO) 
guidelines (Serov et al., 1973). Ovarian malignancies were staged according to the 
classification of the International Federation of Gynecology and Obstetrics (FIGO) 
(International Federation of Gynecology and Obstetrics, 1971; Shepherd, 1989). Any 
additional tests used to aid diagnosis were documented. The length of post-operative 
hospital stay was also recorded in all patients.
The study objective was to examine whether differences in the expertise of 
ultrasonography operators have a measurable effect on the management of patients with 
adnexal tumours. The primary endpoint was the number of major staging surgical 
procedures done in each group. Secondary endpoints include: total number of surgical 
procedures; number of minimally invasive procedures; number of additional diagnostic 
tests (eg, CT or laparoscopy); number of follow-up scans; diagnostic accuracy of level 
II and level III ultrasonography; and duration of hospital stay. The cost-benefit analysis 
is not part of this paper and will be reported in the future.
A clinical audit performed in the Southeast Gynaecological Cancer Centre
between September 2003, and May 2004 showed that 25/55 (45%) patients diagnosed
with adnexal pathology underwent a staging laparotomy. Of these, 6/25 (24%) had the
diagnosis of ovarian cancer confirmed on histological examination, whereas the
remaining 19/25 (76%) patients had benign ovarian disease. Our hypothesis was that
level III ultrasonography would halve the number of patients undergoing staging
laparotomy. This study was designed to have an 80% power to detect a decrease in the
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proportion of staging laparotomies from 45% in the control group to 23% in the study 
group with a two-sided a  of 0.05. The study needed a minimum of 144 patients, but we 
randomised 150 patients to allow for loss of power due to cancellations or changes in 
the management plan.
This study is registered on the Current Controlled Trials website 
http://www.controlled-trials.eom/mrct/trial/230201/ISRCTN02631195.
This study was funded by King’s College Hospital NHS Foundation Trust. The 
funding source had no role in the design, data collection, data analysis, or interpretation 
of the findings. JY had full access to all the data in the study and had the final 
responsibility to submit for publication. JY, SR, JBN, TKH, KH and DJ had access to 
the raw data.
13.3 Statistical Analysis
All statistical analyses were carried out using Medcalc® version 9.2.0.2 (Medcalc 
Software, Mariakerke, Belgium). Continuous variables were expressed as mean and SD 
or median and interquartile range. Dichotomous variables were described using 
proportions. The relative risk (RR) ratio with 95% confidence intervals was used to 
compare the primary endpoint (number of major staging surgical procedures), the total 
number of surgical procedures, the number of minimally invasive procedures, the 
number of follow-up scans, and the number of additional diagnostic tests between the 
two study groups. Duration of hospital stay after surgery was compared between the 
two randomised groups using the Mann-Whitney U test. Proportions were compared 
using Yates corrected test. Two-tailed p value of less than 0.05 was considered 
statistically significant. The diagnostic accuracy of ultrasonography for the diagnosis of 
ovarian malignancy was assessed by calculating sensitivity, specificity, positive and 
negative predictive values. The likelihood ratio of a positive test (sensitivity/[l-
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specificity]) and the likelihood ratio of a negative test ( [ 1 -sensitivityj/specificity) were 
also calculated in order to eliminate the effect of the prevalence of ovarian malignancy 
on the interpretation of the value of the diagnostic test (Chien and Khan, 2001).
13.4 Results
The study was done between May 31, 2004 and February 15, 2007. 165 patients met the 
inclusion criteria, but ten patients declined participation and five were excluded because 
they needed urgent surgical treatment (Figure 7). The remaining 150 patients were 
randomised into the study, with 77 randomly assigned to a level III ultrasonography and 
73 randomly assigned to a level II ultrasonography. The demographic data of the 
patients in both groups of the study are presented in Table 24. The two groups were 
balanced in terms of age, menopausal status, source of referral, and presenting 
symptoms.
The number of major staging surgical procedures for suspected ovarian 
malignancy in patients who were randomly assigned to the level II group was 
significantly higher than the number of major staging surgical procedures in patients 
randomly assigned to the level III group (27/73 [37%, 95% Cl 27 -  48] vs. 17/77 [22%, 
95% Cl 14 -  33], respectively; RR 1.68 [95% Cl 1.00 -  2.81], p=0.049; table 25). The 
number of planned major staging surgical procedures by gynaecological oncologists in 
the level II arm was 30/73 (41%, 95% Cl 31 - 53) compared with 17/77 (22%, 95% Cl 
14 - 33) in the level III arm (RR 1.86 [95% Cl 1.13 -  3.07], p=0.015). However, three 
(4%) patients in the level II group declined surgery. One of these three patients 
eventually had a salpingo-oophorectomy in her local hospital 7 months after 
randomisation, and the histology showed a stage la serous borderline ovarian tumour. 
Another patient had a follow-up scan after two years, which showed no change in the 
size or consistency of the tumour, and the third patient was lost to follow-up.
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The total number of surgical procedures was 35 (48%, 95% Cl 37 -  59) in the 
level II group, which was not significantly different from 33 (43%, 95% Cl 32 -  54) in 
the level III group (RR 1.12 [95% Cl 0.79 -  1.59], p=0.53). 2/73 (3%, 95% Cl 1 -  9) 
patients had minimally invasive procedures in the level II group compared with 9/77 
(12%, 95% Cl 6 - 21) patients in the level III group (RR 0.23 [95% Cl 0.05 -  1.05], 
p=0.058).
In the subgroup of patients who underwent surgery, a greater number of major 
staging surgical procedures was done in the level II group compared with the level III 
group (27/35 [77%, 95% Cl 61-88] vs. 17/33 [52%, 95% Cl 35-68], respectively; RR 
1.50 [95% Cl 1.03-2.18]. p=0.036). Minimally invasive procedures were used 
significantly less in the level II group compared with the level III group (2/35 [6%, 95% 
Cl 2 -  19] vs. 9/33 [27%, 95% Cl 15 -  44], respectively; RR 0.21 [95% Cl 0.05-0.90], 
p=0.035).
The median duration of hospital stay for patients who were operated on was 6 
days (range 3 -  13) in the level II group and 5 days (range 1 -  9) in the level III group
(p=0 .01).
The proportion of benign and malignant tumours was not significantly different 
between the two groups (table 25). In the Level II group, a patient who underwent 
gynaecological surgery had a right borderline ovai'ian tumour and a left benign 
cystadenoma, and was, therefore, classified as having malignant disease. In the level III 
group, a patient who did not have surgery to remove the adnexal tumour had a biopsy 
taken during a diagnostic laparoscopy, which showed the presence of a benign uterine 
leiomyoma. Two patients in the level III group had a CT-guided biopsy, the histology of 
which showed primary peritoneal cancer, and a patient with intestinal leiomyosarcoma 
had a laparotomy by a general surgeon. The histological type and stage of the adnexal 
malignancies aie shown in table 26.
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10/27 (37%) patients who had a staging laparotomy in the level II arm of the 
study had malignant disease on histological examination compared with 8/17 (47%) 
patients in the level III arm (RR 0.78 [95% Cl 0.39-1.59], p=0.51). In both groups, no 
malignant pathology was detected on the histological assessment of patients who were 
originally planned to have procedures for benign adnexal tumours. However, as 
previously stated, one patient who declined staging laparotomy was later noted to have 
a borderline tumour on histological examination.
Initially, 36/73 (49%) patients in the level II group and 41/77 (53%) patients in 
the level III group were managed expectantly. However, two (3%) of these patients in 
the level II group and five (6%) of these patients in the level III group were not 
followed up (RR 0.42 [95% Cl 0.09-2.11], p=0.29). Of these, 3/41 (7%) patients in the 
level III arm of the study died of non-gynaecological causes before attending for the 
follow-up scan. The remaining four patients (two in each group) were not contactable 
by telephone and, were thus excluded from the final data analysis. Therefore, outcome 
data for expectant management were available for 35/73 (48%) patients in the level II 
group and 36/77 (47%) patients in the level III group (RR 1.03 [95% Cl 0.73-1.44], 
p=0.88; table 27).
The median number of follow-up scans was two (range 0 -  5) in the level II 
group and one (range 0 -  4) in the level III group (p=0.0004). The mean follow-up 
period was 427 days (range 1 -  853). Many ovarian cysts resolved spontaneously and 
only 2/37 (5%) patients managed expectantly in the level II group and 3/41 (7%) 
patients managed expectantly in the level III group required an intervention (RR 0.44 
[95% Cl 0.09-2.15], p=0.31). Indications for surgery were: pelvic pain (n=l) and 
increased size of pelvic tumour on follow-up scan (n=l) in the level II group, and pelvic 
pain (n=l), persistently high serum CA-125 concentrations (n=l), and suspected
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metastatic ovarian tumour (n= l) in the level III group. None of the patients showed 
malignancy on histology.
A conclusive ultrasonographic diagnosis of the nature of an adnexal tumour was 
made in 38/73 (52%, 95% Cl 41 -  63) patients in the level II group and in 76/77 (99%, 
95% Cl 93 -  100) in the level III group (RR 0.53, [95% Cl 0.42-0.66], p<0.0001). There 
were two level III and 16 level II ultrasonography operators. The number of conclusive 
ultrasonography findings among the three level II operators who examined five or more 
patients were 14/33 scans, 5/10 scans, and 2/5 scans, respectively (p=0.90). The overall 
number of conclusive scans among the remaining 13 level II operators who examined 1- 
4 patients was 17/25 scans. The rate of conclusive ultrasonography scans between these 
two groups of level II operators was not significantly different (p=0.09). The number of 
non-diagnostic scans did not change significantly over the course of the study. In the 
first half of the study 22/41 scans were non-diagnostic compared with 13/32 in the 
second half (p=0.38). The data analysis showed that there were no omission errors in 
the study, which could have increased the number of non-diagnostic scans.
The accuracy of conclusive diagnosis from ultrasonography was assessed in the 
subgroup of patients in whom histological findings were also available (table 28). 
Histological diagnosis was available in 35 (48%) patients in the level II group and in 36 
(47%) patients in the level III group. There were three false negative diagnoses of 
ovarian cancer in the level II group and one false negative diagnosis in the level III 
group. However, all patients with false negative diagnosis had optimal treatment with a 
staging laparotomy. The three false negative diagnoses in the level II group were: 
granulosa cell tumour (stage I), ovarian serous carcinoma (stage III) and a serous 
borderline ovarian tumour. The false negative diagnosis in the level III group was a 
mature cystic teratoma containing a focus of stage I squamous cell carcinoma. No false 
positive diagnoses were noted in the level II group and one false positive diagnosis was
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noted in the level III group. This false positive diagnosis was a suspected serous 
borderline ovarian tumour, which turned out to be a benign cystadenoma.
Serum CA-125 levels were routinely measured in all patients pre-operatively. 
The median concentrations were not significantly different between the two study 
groups (19 [range 9-1801] vs. 23 [range 5-2900], p=0.13).
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(n=165)
Assigned level III US
(n=77)
Assigned level II US
(n=73)
Randomised
(n=150)
Excluded (n=15)
Refused to participate (n=10) 
Needed urgent surgery (n=5)
Additional 
investigations 
CT
Diagnostic 
laparoscopy (n=l)
(n=3)
Additional
investigations
(n=2)
Diagnostic 
laparoscopy (n=l)
CT
US Diagnosis 
Benign (n=36) 
Malignant (n=2) 
Non-gynae cancer 
(n=0)
Non-diagnostic (n=35)
US Diagnosis
Benign (n=64) 
Malignant (n=9) 
Non-gynae cancer 
(n=3)
Non-diagnostic (n=l)
Planned management
Staging laparotomy 
Surgery for benign tumours 
Non-gynaecological surgery 
Chemotherapy 
Expectant
(n=17)
(n=16)
(n=l)
(n=2)
(n=41)
Planned management
Staging laparotomy 
Surgery for benign tumours 
Non-gynaecological surgery 
Chemotlierapy 
Expectant
(n=30)
(n=7)
(n=0)
(n=0)
(n=36)
Actual management
Staging laparotomy
Surgery for benign tumours
Non-gynaecological surgery
Chemotherapy
Expectant
Other
(n=17)
(n=16)
(n=l)
(n=2)
(n=36)
(n=5)
Actual management
Staging laparotomy
Surgery for benign tumours
Non-gynaecological surgery
Chemotherapy
Expectant
Other
(n=27)
(n=8)
(n=0)
(n=0)
(n=35)
(n=3)
Figure 7 Flow diagram of study participants. US, ultrasound; CT, computed 
tomography.
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Table 24. Demographic data, source of referral and presenting symptoms.
Level II 
n= 73
Level III 
n=77
Age (years, mean (SD)) 48 (17) 49(18)
Premenopausal, n 46 43
Source of referral, n
Primary care 22 24
Hospital gynaecologist 40 35
Other specialty 11 18
Presenting symptoms, n
Abdominal pain 30 30
Abdominal swelling 8 7
Other symptoms (PMB, raised CA-125) 9 9
Asymptomatic (incidental finding) 26 31
SD, standard deviation; US, ultrasound; CT, computed tomography; PMB, 
postmenopasual bleeding.
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Table 25. Management of all patients and final histopathological findings from 71 
patients.
Level II Level III RR (95% Cl)
n=73 n=77
Management, n
Major staging surgical procedure 27 17 1.68(1.00-2.81)
Laparotomy by general gynaecologist 6 7 0.90 (0.32-2.56)
Minimally invasive procedures 2 9 0.23 (0.05-1.05)
Laparotomy by other surgeons 0 1 -
Adjuvant chemotherapy for PPC 0 2 —
Expectant 35 36 1.03 (0.73-1.44)
Declined surgery 3* 0 —
Lost to follow up (expectant) 2 5 0.42 (0.09-2.11)
Histology, n
Benign 25 25 1.05 (0.68-1.64)
Malignant 10 8 1.31 (0.55-3.16)
Non-gynaecological cancer 0 3 —
RR, relative risk; PPC, primary peritoneal cancer; US, ultrasound. * One had expectant 
management, one had surgery at her local hospital and one was lost to follow-up.
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Table 26. Histology and International Federation of Gynaecology and Obstetrics stage 
of malignant adnexal tumours.
Level II ultrasonography (n=10) Level III ultrasonography (n=8)
Stage Invasive Invasive Non- BOT Invasive invasive Non- BOT
epithelial epithelial (n=3) epithelial epithelial (n=4)
(n=4) (n=3) (n=3) (n=l)
I ,n 2 2 3 1 1 2
II, n 0 1 0 2 0 0
m,n 2 0 0 0 0 2
IV, 11 0 0 0 0 0 0
BOT, borderline ovarian tumour.
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Table 27. Outcome of the patients managed expectantly.
Level II 
(n=37)
Level III 
(n=41)
Spontaneous resolution, n 18 15
Persistent cyst not needing intervention, n 15 18
Persistent cyst needing intervention, n 2 3
Death from non-gynaecological cause, n 0 3
Lost to follow up, n 2 2
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Chapter 14
Study 7
Value of preoperative ultrasound in the selection of women with adnexal masses 
for laparoscopic surgery
14.1 Background
Laparoscopic surgery is the method of choice for treating women with benign adnexal 
masses. The minimally invasive approach offers many advantages over laparotomy, 
including decreased postoperative pain, faster recovery and reduction in postoperative 
intra-abdominal adhesions (Lin et ah, 1995; Howard, 1995; Mais et al., 1995). As a 
result, many operations can be performed as day-surgery procedures, with patients 
being discharged home a few hours after operation. In order to ensure optimal use of 
day surgery facilities it is important to ensure that the risk of converting a laparoscopic 
procedure to a laparotomy is minimal. The factors that may increase the risk of 
laparotomy have not been defined scientifically, but there is a general consensus that 
severe pelvic adhesions and pelvic endometriosis can cause difficulties during pelvic 
surgery and increase the risk of complications. It is also known that spillage of material 
from dermoid cysts can occasionally cause severe peritonitis and is best avoided (Huus 
et al., 1996; Coccia el al., 1996; Remorgida et al., 1998). Therefore some authors 
advocate open surgery for large dermoid cysts >10  cm in mean diameter as they are 
difficult to remove form the abdominal cavity without rupture (Mettler et al., 2001). 
Finally, laparoscopic surgery should not be performed on women with invasive ovarian 
cancer (Parker, 1992; Kindermann et al., 1995). There is a consensus in the UK that 
optimal care for these women involves a lapai'otomy by a gynaecological oncologist in a 
regional cancer centre (Junor et al., 1999).
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Ultrasound examination is the main tool used to diagnose adnexal tumours and 
to differentiate between benign and malignant lesions. The value of ultrasound and 
Doppler in correctly identifying the risk of malignancy of adnexal tumours and 
selecting those with low risk of malignancy for laparoscopic surgery has been assessed 
previously (Beiianda et al., 2002; Guerriero et al., 2005). However, the value of 
ultrasound for the preoperative selection of women with benign adnexal masses for 
removal by either laparoscopic surgery or by laparotomy has not been examined.
The aim of this study was to prospectively develop and assess a set of ultrasound 
criteria that were designed to select women for laparoscopic removal of ovarian cyst 
with a minimum risk of converting the operation to a laparotomy.
14.2 Methods
This prospective observational study was carried out at the Gynaecological Assessment 
Unit at King’s College Hospital. Symptomatic women (abdominal pain, increased 
abdominal girth or abdominal mass) with a clinical or ultrasound diagnosis of an 
adnexal mass were offered a detailed transvaginal scan in order to assess the feasibility 
of laparoscopic surgery. All women were assessed by gynaecologists trained in 
transvaginal ultrasound. The clinical history was recorded and a brief clinical 
examination was performed. All women then underwent a gynaecological ultrasound 
examination using transvaginal and transabdominal transducers with B-mode and colour 
Doppler facilities (Aloka SSD-2000 or Aloka SSD-5000, Aloka Co, Tokyo, Japan).
Ultrasonography was carried out as detailed in section 7.2.
Severe endometriosis was suspected in women with evidence of ovarian 
endometriomas in whom the ovaries were firmly adherent to the posterolateral aspect of 
the uterus or in whom the pouch of Douglas was obliterated with adhesions (Ghezzi et 
al., 2005; Bhatt et al., 2006). The criteria we used to diagnose obliterated pouch of
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Douglas with adhesions were; the absence of free movement between the posterior 
uterine surface and the large bowel.
Pelvic adhesions were suspected when the adnexal tumour could not be 
mobilised by using gentle palpation using the transvaginal or transabdominal probe or 
in women with evidence of peritoneal pseudocysts.
All postmenopausal women and those older than 45 were booked for 
oophorectomies, whereas the remaining women were offered cystectomies.
Women with presumed benign lesions who did not meet the selection criteria for 
laparoscopic surgery were booked for a laparotomy. In addition, patients with adnexal 
cysts underwent a laparotomy, if they also required myomectomy or hysterectomy. All 
women with suspected cancers were referred for further management to the Regional 
Cancer Centre. These women were not included in our study.
Operation details were recorded in all patients. All the operations were carried 
out by a single team of surgeons, all of whom had considerable experience in 
intermediate-level laparoscopic surgery (RCOG in collaboration with BSGE, 2005). An 
intermediate-level laparoscopic surgeon would be able to independently perform 
laparoscopic procedures such as the treatment of ectopic pregnancy, ovarian 
cystectomy, oophorectomy, and excision or ablation of peritoneal endometriosis and 
endometriomas.
Laparoscopic surgery was classified as successful if the adnexal mass was 
removed completely without resorting to laparotomy. Laparoscopic ovarian cystectomy 
was classified as successful when the operation was completed with the conservation of 
the ipsilateral ovary.
The ultrasound findings were compared to the histology, which was classified 
according to the World Health Organisation (WHO) guidelines (Serov et al., 1973).
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14.3 Statistical Analysis
All statistical analyses were carried out using Medcalc® version 9.2.0.2 (Medcalc 
Software, Mariakerke, Belgium). The statistical significance of differences in 
continuous variables was determined using Mann-Whitney U-test, Kruskall-Wallis test 
or Student t-test depending on data distribution. Proportions were compared using 
Yates’-corrected Chi-square test. Two-tailed p <0.05 was considered statistically 
significant. The diagnostic accuracy of the tests was assessed using sensitivity, 
specificity, positive predictive value (PPV) and positive (LR+) and negative (LR-) 
likelihood ratio measures.
14.4 Results
A total 143 women with 162 benign adnexal masses on ultrasound scan were scheduled 
for surgery (Figure 8). Based on ultrasound assessment, 119 women were considered 
suitable for laparoscopic surgery. Two (1.7%) women also required myomectomy and 
one (0 .8%) woman needed a hysterectomy and they were booked for a laparotomy 
instead. Laparotomy was also performed in three women (2.5%) who refused 
laparoscopy. These six (5%) women were excluded from final data analysis.
The final dataset consisted of 137 women, 113 (82.5%) of whom were booked 
for a laparoscopy and 24 (17.5%) for a laparotomy. The indications for laparotomy 
were: dermoid cysts >10 cm in mean diameter in 10 (41.7%) women, suspected severe 
pelvic adhesions in six (25%), solid ovarian tumours > 5 cm in mean diameter in five 
(20.8%) and severe pelvic endometriosis in three (12.5%).
There were no statistically significant differences between women selected for 
laparoscopy and those selected for laparotomy in regard to their age, menopausal status, 
parity, history of previous laparoscopic surgery, history of previous laparotomy and 
history of previous ovarian surgery (Table 29). However, there was a statistically
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significant difference in the median tumour volume between the two groups (Table 29). 
A higher proportion of unilocular cysts were operated on laparoscopically, and a higher 
proportion of multilocular solid cysts were operated on by laparotomy (p<0.05).
The indication for laparotomy was confirmed at operation in 22/24 (91.7%; 95% 
Cl, 74-98) women who were booked for open surgery. In the remaining two (8.3%; 
95% Cl, 2-26) cases the ultrasound diagnosis of severe adhesions was not confirmed at 
surgery.
Some 113/137 (82.5%; 95% Cl, 75-88) women were considered suitable for 
laparoscopic surgery. Of these, 88 (77.9%; 95% Cl, 69-85) were booked for 
laparoscopic ovarian cystectomy and 25 (22.1%; 95% Cl, 15-31) were booked for 
laparoscopic oophorectomy.
In all, 107/113 (94.7%; 95% Cl, 89-98) women had their operation completed 
laparoscopically, and in the remaining six (5.3%; 95% Cl, 2-11) women, the operation 
was converted into a laparotomy. The reasons for failed laparoscopy were: extensive 
pelvic adhesions in three (50%; 95% Cl, 19-81) cases, morbid obesity in two (33.3%; 
95% Cl, 10-70) cases and injury to the inferior epigastric artery in one (16.7%; 95% Cl, 
3-56) case. There was no significant difference in the median volume of ovarian cysts of 
women who had a successful or failed laparoscopy. There was also no association 
between failed laparoscopy and the presence of bilateral ovarian cysts (p>0.05).
Laparoscopic ovarian cystectomy was successful in 81/88 (92%; 95% Cl, 84-96) 
cases and the operation was converted to laparoscopic oophorectomy in the remaining 
seven (8%; 95% Cl, 4-15) women. The reasons for conversion to laparoscopic 
oophorectomy were: heavy bleeding from the cyst site in four (57.1%; 95% Cl, 25-84) 
cases, severe periovarian adhesions in two (28.6%; 95% Cl, 8-64) cases and in one 
(14.3%; 95% Cl, 3-51) case the adnexa appeared necrotic owing to previous torsion. 
The median tumour volume in cases of successful laparoscopic ovarian cystectomy was
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67 (range 4-1972) mL, which was significantly less in comparison to 229 (range 29- 
1231) mL in failed laparoscopic ovarian cystectomy (Z=1.97, p<0.05).
The preoperative ultrasound assessment predicted the outcome of lapai'oscopic 
surgery with a sensitivity of 98% (95% Cl, 0.94-0.99), specificity of 79% (95% Cl, 
0.60-0.90), PPV of 95% (95% Cl, 0.89-0.98), LR+ of 4.58 (95% Cl, 2.25-9.32) and 
LR- of 0.02 (95% Cl, 0,01-0.09). Preoperative ultrasound assessment also predicted the 
success of laparoscopic ovarian cystectomy with specificity of 78% (95% Cl, 0 .61- 
0.89), PPV of 92% (95% Cl, 0.85-0.96) and LR+ of 4.6 (95% Cl, 2.38-8.80).
On histological examination, the diagnosis of benign adnexal cyst was 
confirmed in 152/153 (99.3%) cysts. All bilateral tumours in this study were of same 
histological type. One woman who had a laparoscopy for a presumed benign ovarian 
cyst was diagnosed with a gastrointestinal type borderline ovarian tumour. There were 
no cases of invasive ovarian cancer in either group of patients.
There was a statistically significant difference between histological subtypes in 
women who had laparoscopic surgery and those who had laparotomy (%^  = 35.61, 
P<0.001) (Table 30). Histological tumour type was correctly predicted in 141/153 
(92.2%) cysts. The false positive cases were: four (33.4%) endometriomas (one 
misdiagnosed as dermoid cyst and three as cystadenomas), two (16.7%) dermoid 
(misdiagnosed as cystadenomas), one (8.3%) cystadenoma (misdiagnosed as 
endometrioma), one (8.3%) thecoma (misdiagnosed as endometrioma), one (8.3%) 
mucinous gastrointestinal type borderline ovarian tumour (misdiagnosed as 
cystadenoma), one (8.3%) pseudocyst (misdiagnosed as fimbrial cyst), one (8.3%) 
simple ovarian cyst (misdiagnosed as fimbrial cyst) and one (8.3%) hydrosalpinx 
(misdiagnosed as cystadenoma). These cysts shared a common morphological 
appeai’ance, which was a unilocular cyst with echogenic fluid content.
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There were no dermoid cysts >10cm found at laparoscopy. Nor were there any 
cases of severe endometriosis encountered in the laparoscopy group. In three cases 
where severe endometriosis was suspected, laparotomy was performed and the 
ultrasound findings were confirmed at operation.
Five cases of severe adhesions were missed on ultrasound in the laparoscopy 
group and there were two false positive diagnoses of adhesions in the laparotomy group. 
The preoperative diagnosis of severe pelvic adhesions was made with a sensitivity of 
44% (95% Cl, 17-69), specificity of 98% (95% Cl, 94-99), PPV of 67% (95% Cl, 30 - 
90), LR+ of 28.4 (95% Cl, 6.00 -  134.96) and LR- of 0.56 (95% Cl, 0.31-1.01).
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Laparotomy
19 successful81 successful
25 women booked for 
oophorectomy
18 women booked for 
ovarian cystectomy
24 women not suitable for 
laparoscopic surgery
119 women suitable for 
laparoscopic surgery
143 women scheduled for surgery
6 converted to laparotomy:
- 3 adhesions
- 2 obesity
- 1 vascular injury
7 converted to
laparoscopic
oophorectomy:
- 4 heavy bleeding
- 2 adhesions
- 1 previous torsion
6 women 
excluded:
- 2 required 
myomectomy 
-1  required 
hysterectomy
- 3 declined 
laparoscopic 
surgery
Figure 8 Flow chart of the patients in the study.
165
Table 29. Demographic features of women and adnexal tumour characteristics of 
women booked for laparotomy or laparoscopy.
Characteristic
Intention
Laparoscopy
to treat
Laparotomy P
Age (years, median (range) 35 (14-72) 32 (20-62) NS
Premenopausal (n (%)) 99 (88) 22 (92) NS
Parity (median (range)) 1 (0-4) 0 (0 -4 ) NS
Previous laparoscopy (n (%)) 13(12) 3(13) NS
Previous laparotomy (n (%)) 23 (20) 9(38) NS
Ultrasound tumour
appearance* (n (%))
Unilocular 61 (54) 4(17) 0.002
Unilocular solid 8(7) 4(17) NS
Multilocular 27 (24) 5(21) NS
Multilocular solid 7(6) 6(25) 0.01
Solid 1 (1) 2(8) NS
Not defined 9(8) 3(12) NS
Previous ovarian surgery (n 6(5) 3(13) NS
(%))
Mass volume (mL, median 70(1-1972) 242 (0.3-2907) < 0.001
(range))
significant.
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Table 30. Histological subtypes of adnexal tumours operated on by laparoscopy and 
laparotomy.
Operated by
Histological
subtype
Laparoscopy
(n(%))
Laparotomy
(n(%))
Total
(n)
Dermoid 55 (44.4) 18 (62) 73
Cystadenoma 33 (26.6) 1 (3.5) 34
Endometrioma 5 (4.0) 3 (10.3) 8
Fibroma 0 (0.0) 5 (17.2) 5
Thecoma 1 (0.8) 0 (0.0) 1
Borderline 1 (0.8) 0 (0.0) 1
Simple cyst 19(15.3) 0 (0.0) 19
Hydrosalpinx 7 (5.7) 1 (3.5) 8
Pseudocyst 3 (2.4) 1(3.5) 4
Total 124(100) 29 (100) 153
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PART THREE;
Discussions
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Chapter 15
Study 1
A comparative study of the risk of malignancy index and the ovarian crescent sign 
for the diagnosis of invasive ovarian cancer
Our study confirms previous reports (Jacobs et al., 1990; Hillaby et al., 2004), which 
showed that RMI and CCS are fairly good methods for preoperative differentiation 
between invasive and non-invasive adnexal tumours. Both tests have proven to be very 
sensitive for the detection of invasive ovarian cancer. However, their false positive rates 
were well above 5%. False positive rates are particularly important when the tests are 
applied to low risk population diagnosed with ovarian tumours during opportunistic 
screening for ovarian abnormalities.
The RMI was particularly sensitive to elevations of serum CA-125 which was 
the main reason for high readings in benign pathology, 87.5% of which had ovarian 
endometriomas. The OCS was typically absent in larger tumours such as cystadenomas 
and borderline ovarian tumours, but it was always easily detectable in endometriotic 
cysts. Neither the RMI nor the OCS was accurate enough in the diagnosis of borderline 
ovarian tumours. The RMI failed to diagnose all five borderline ovarian tumours in our 
study population, whilst the sensitivity of the ovarian crescent sign was only 60%. This 
is an expected result as borderline ovarian tumours exhibit different morphological and 
biochemical characteristics to invasive cancers and therefore they are unlikely to be 
detectable using tests, which are primarily designed to detect invasive disease. There is 
some evidence that pattern recognition method may help to correctly diagnose some 
borderline tumours (Alfuhaid et al., 2003; Exacoustos et al., 2005; Fruscella et al., 
2005), but this approach has not been prospectively tested as yet.
The RMI has been used in clinical practice for many years, while the OCS is a
novel diagnostic test, which has been used by a limited number of units. One of the
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important advantages of RMI is its relative simplicity in the approach to ultrasound 
assessment of ovarian tumours. Rather than relying on complex ultrasound tests such as 
Doppler assessment of intraovarian blood flow or on the meticulous analysis of minute 
details of tumour architecture, The RMI simply divides ovarian cysts into unilocular and 
complex. This approach requires minimal ultrasound skills and it may be successfully 
applied in units without high level of expertise in gynaecological ultrasonography.
Many of the described ultrasound-based diagnostic models are too complex for 
the use in daily practice and they may not be easily transportable between different 
ultrasound units (Tailor et al., 1997; Timmerman et al., 1999a; Valentin et al., 2001; 
Aslam et al., 2000a). The OCS overcomes this problem, and similarly to the RMI, it 
only requires a modest level of expertise in gynaecological ultrasonography. It is 
therefore likely that the OCS may be successfully used in units with average ultrasound 
skills who aie currently relying on RMI.
Our study may be criticised for failing to obtain histological confirmation of the 
nature of ovarian tumours in all the cases. However, in modern clinical practice it is not 
acceptable to operate on all asymptomatic women with an incidental ultrasound 
diagnosis of a benign looking cyst. Nevertheless, all women in our study had follow up 
examinations and non-surgical treatment was offered only to women with cysts, which 
were not increasing in size.
Our results show that false positive results with the RMI and OCS occur in 
different types of ovarian tumours. Therefore, a combination of the two tests may be an 
effective way of reducing false positive findings.
This study could also be criticised for including a small number of invasive 
ovarian cancers especially stage I cancers as well as a small number of borderline 
ovarian tumours. However, women who were included in our study attended for an 
ultrasound scan not exclusively because of a known ovarian tumour and only a study
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performed at a regional cancer centre over a long period of time would pick up a higher 
rate of invasive ovarian malignancies or borderline ovarian tumours.
Future work carried out within a gynaecological cancer centre including a high 
number of women with borderline and invasive ovarian tumours will show whether the 
OCS may be a more effective way, compared to the RMI, of managing women with 
ultrasonographic diagnosis of ovaiian tumours.
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Chapter 16
Study 2
The accuracy of ultrasound subjective “pattern recognition” for the diagnosis of 
borderline ovarian tumours
Our study has confirmed that borderline ovarian tumours tend to occur in younger 
women and that they are detected incidentally during clinical or ultrasound examination 
in the majority of cases for indications other than a suspected ovarian tumour. The 
differences in age and clinical symptoms between borderline and invasive ovarian 
tumours were statistically significant and should be taken into consideration when 
assessing an adnexal tumour by ultrasound. These observations were in agreement with 
the results of previous studies, which also showed that women diagnosed with a BOT 
were more likely to be asymptomatic than those with benign or invasive ovarian 
tumours (Gotlieb et al., 2005; Boran et al., 2005; Webb et al., 2004; Gotlieb et al., 
1998).
We were able to establish a correct histological diagnosis in more than two- 
thirds of all BOTs. The specificity of ultrasound diagnosis was very high, but the 
sensitivity was only 69%. This was mostly due to the relatively high proportion of cysts, 
which did not exhibit typical ultrasonic features of BOTs. Amongst 11 false-negative 
cases encountered in our study, there were four (36%) cysts, which were unilocular with 
smooth inner walls and no papillary projections. In all these four cases, there was a 
complete agreement between the ultrasound morphological appearances and the 
histopathological macroscopic description in misdiagnosed ovarian tumours. There 
were no cases in which papillary projections were missed on ultrasound scan when the 
results were compared to histology. Nonetheless, our data do not support surgical 
intervention in all cases of unilocular cysts, although it would be fair to say that the
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diagnosis of BOT needs to be considered in women with large and growing unilocular 
cysts.
The proportion of unilocular cysts in our population of women with BOT was 
11.4%, which was much higher than the findings of a retrospective study by Fruscella 
and co-workers (2005), who found unilocular cysts in only 3.5% of their population of 
BOTs.
However, we were able to confirm their observation that different subtypes of 
BOTs display different morphological features, which is helpful in the differential 
diagnosis. We also agree with Fruscella and co-workers’s (2005) findings that serous / 
endocervical type BOTs are characterised by a higher rate of unilocular solid lesions, 
higher number of papillary projections and lower prevalence of multilocular lesions 
when compared with GI type BOTs. Both studies showed a statistically significant 
difference between the moiphological ultrasound appearances of serous /  endocervical 
type and GI type BOT. We were more accurate in diagnosing serous / endocervical type 
BOT compared to GI type BOT. This is important in view of the relatively worse 
prognosis of serous /  endocervical type BOT and the higher recurrence rate (Ahmed and 
Lawton, 2005).
The presence of a honeycomb nodule was highly specific for GI type BOTs. 
Although, slightly more than half GI type BOT had a honeycomb nodule, this nodule 
was present in a case of benign mucinous cystadenoma. On the other hand, all GI type 
BOTs had thick fluid noted within the cyst, which makes this finding a highly sensitive 
marker for this subtype of mucinous BOTs. Thick fluid content was also a chaiacteristic 
of the majority of ovarian endometriomas, a few serous /  endocervical type BOTs and 
some epithelial malignant ovarian tumours.
Our description of GI type BOTs is not substantially different from the one 
provided by Fruscella and co-workers (2005) who described the typical pattern of
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mucinous gastrointestinal type BOX as being a multilocular cyst with a high number of 
locules. Using International Ovarian Tumor Analysis (IOTA) (Timmerman et al., 2000) 
group classification these tumours should indeed be described as multilocular cysts. The 
honeycomb nodule, however, is a specific feature of GI type BOX, which represents a 
subgroup of multilocular cysts. This distinction is important, as there are many benign 
and invasive tumours, which aie classified as multilocular cysts. Nearly two-thirds of 
benign cystadenomas in this study were described as multilocular cysts and, without 
performing a more detailed analysis, they could have all been wrongly classified as GI 
type BOTs.
The ovarian crescent sign was present in 75% of serous /  endocervical type 
BOTs, but only in 20% of GI type BOTs. This was mainly due to the large size of GI 
type BOX, which makes the visualisation of healthy ovarian tissue more difficult. 
However, in the presence of a positive ovaiian crescent sign, the diagnosis of an 
invasive tumour is very unlikely. There was only one case of an invasive tumour with a 
positive crescent sign in this series, which was a mature cystic teratoma with a focus of 
squamous cell carcinoma (Stage I). In practical terms the ovarian crescent sign can be 
used to exclude an invasive ovarian cancer, but its absence is not diagnostic of invasive 
ovarian disease.
In this study, the overall sensitivity of pattern recognition in differentiating 
between benign and malignant tumours (including both borderline and invasive lesions) 
was 91% (95% Cl, 83 -  95), which was similar to the findings by Valentin et al. (2000) 
who reported a sensitivity of 83% (95% Cl, 67 -  94). However, the specificity in our 
study was less (85% (95% Cl, 75 -  92) vs. 91% (95% Cl, 84 -  96)), which may be 
explained by a higher proportion of BOTs in our study population.
Our data show that the preoperative ultrasound diagnosis of BOX using the 
pattern recognition method is highly specific. Thus, women who are in the reproductive
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age group could benefit from fertility sparing surgery in a regional gynaecological 
cancer centre. On the other hand, when reproductive potential is not an issue, accuracy 
in preoperative diagnosis would allow better preoperative counselling and a more 
conservative surgical approach.
All the correctly diagnosed BOTs and one false negative case (thought to be an 
invasive cancer) underwent surgical staging. Staging remains important in cases of 
serous / endocervical type BOTs, due to the possibility of advanced stage disease at 
diagnosis (Silverberg et al., 2004), especially in the case of micropapillary subtype 
serous BOT. The importance of staging may be less in GI type BOT and the impact of a 
complete staging on prognosis of BOTs is far from cleai* (Gotlieb et al., 1998; Fauvet et 
al., 2004).
A relatively high number of women in this study had early stage borderline and 
invasive ovarian tumours. However, this finding is not representative of all the women 
who were operated on at the regional gynaecological cancer centre as our study only 
included the proportion of women in whom the nature of the lesion was indeterminate 
during the level II scan. Women with conclusive features of ovarian cancer or benign 
tumours were managed according to the centre’s protocols as stated in the methods and 
these were not included in our study.
It is also unclear whether spillage of the cyst content adversely affects the 
prognosis of women with BOTs. This is particularly an important issue in the context of 
laparoscopic surgery for ovarian tumours. Laparoscopic surgery offers many 
advantages to women with benign cysts because of the shorter hospital stay, reduced 
postoperative pain, faster recovery and return to normal daily activities (Lin et al., 1995; 
Howai'd, 1995; Mais et al., 1995). However, the risk of cyst spillage during laparoscopy 
may be much greater in comparison to open surgery. This opinion is not shared by 
Fauvet el al. (2005) who think that the reason for ovarian cyst rupture was not related to
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the surgical route but to the frequency of cystectomy. No wound metastasis occurred in 
their series (Fauvet et al., 2005). Our data show, that even in the optimal circumstances 
a number of BOTs will be misclassified as benign on ultrasound scan and therefore 
considered to be suitable for minimally invasive surgery. Thus, there is a great need to 
continue improving non-invasive diagnosis of borderline tumours and, at the same time, 
to assess the effects, if any, of BOT spillage on the survival and recurrence rates 
(Maneo et al., 2004; Fauvet et al., 2005). Until such data are available, every effort 
should be made to minimise the risk of spillage of cyst content during surgery for all 
types of ovarian cysts.
This study only assessed the value of pattern recognition in diagnosing BOTs 
and differentiating them from benign and invasive ovarian tumours. Doppler studies 
were not used in the differentiation between different types of ovarian tumours in this 
study. To our knowledge, no studies have investigated the role of this modality in the 
diagnosis of BOTs and, perhaps, the value of Doppler studies in aiding the diagnosis of 
BOTs should be evaluated in a prospective randomised study.
Our dataset included a significant number of functional and dermoid cysts, 
which are usually simple to diagnose on a routine ultrasound examination. They were 
often referred to the regional cancer centre because of raised serum CA-125 levels in 
association with the cyst. In such situations it is not unusual for gynaecological 
oncologists to refer these patients for an expert scan even if non-specialist ultrasound 
findings were reassuring.
In conclusion, our study has shown that the correct ultrasound diagnosis of BOT 
can be achieved in two-thirds of cases. Further work is required to identify 
moiphological and biochemical features that may help to increase the accuracy of pre­
operative detection of such tumours.
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Chapter 17
Study 3
Real-time ultrasound versus evaluation of static images in the preoperative 
assessment of adnexal masses
Our results indicate that predicting the character of an adnexal mass by evaluating static 
ultrasound images is less accurate than by evaluating ultrasound findings during a real­
time scan. The difference in accuracy is explained by a difference in specificity, and it 
seems that ultrasound examiners tend to be more confident in excluding malignancy 
during a real-time scan than when looking at saved static ultrasound images of an 
adnexal mass. Because a second opinion is more frequently requested in difficult cases 
than in obviously benign or malignant cases, it was deliberate that our study population 
comprised mainly ‘difficult* and complex masses, i.e., an unrealistically high number of 
borderline tumours, which are known to be difficult to classify as benign or malignant 
using pattern recognition (Valentin et al., 2006). Masses that can be obviously identified 
as being benign and malignant on real-time ultrasound examination can probably also 
be more easily and accurately classified (in comparison to difficult cases) by the 
assessment of static ultrasound images, and in such cases the difference in accuracy 
between real-time and static image assessment that was found in this study may not 
exist.
It is likely that the performance of the image experts in this study would have 
been poorer if the real-time examination had been performed, and the static ultrasound 
images saved, by a less experienced sonologist. An expert sonologist is more likely to 
be able to create representative ultrasound images of an adnexal mass demonstrating 
relevant ultrasound features. On the other hand, it is possible that the performance of the 
image experts would have been better if they had had the possibility to evaluate a
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volume of static images collected by three-dimensional ultrasound instead of only a few 
selected two-dimensional ultrasound images. However, when looking at static images, 
the dynamic aspect of the real-time ultrasound examination is lost. On static images a 
liquefying blood clot in a haemorrhagic cyst or a recent bleeding in an endometrioma 
may be misinterpreted as an irregular papillary projection of solid tissue, but during a 
real-time ultrasound examination, clots may be seen sliding against the cyst wall when 
the cyst is pushed on with the ultrasound probe. Blood clots mimicking a multilocular 
cyst on a static image may demonstrate the typical “jelly” movement when pushed on 
during a real-time scan. On a static image, adhesions may give the impression of thick 
septa in a cystic tumour, while gently pushing on them with the probe will show the 
“flapping sail sign” (Savelli et al., 2004). Thus, the performance of the image experts 
might have been better if they had been presented with representative video clips or 
with the use of four-dimensional cine loops of volume instead of with static images. 
Failure to use video clips in our study was a missed opportunity and this should be 
investigated in a future work.
In conclusion, a preoperative diagnosis of an adnexal mass made on the basis of 
a real-time ultrasound examination is more accurate than a diagnosis made on the basis 
of saved static ultrasound images. Evaluation of static images is associated with lower 
specificity. The dynamic aspect of the real-time scan gives the examiner supplementary 
information and makes it possible to scrutinise every part of the mass.
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Chapter 18
Study 4
The use of ultrasound pattern recognition by expert ultrasound operators to 
identify borderline ovarian tumours: a study of diagnostic performance and 
interobserver agreement of ultrasound diagnoses
This study has confirmed previous findings that ultrasound pattern recognition method 
is a reproducible and accurate test for differential diagnosis of adnexal tumours 
(Valentin, 1999; Timmerman et al., 1999b). The level of interobserver agreement 
ranged from substantial to very good, when the operators were asked to assess the 
nature of adnexal lesions by ultrasound. This study has also shown that borderline 
ovarian tumours are more difficult to diagnose correctly than benign and invasive 
malignant ovarian tumours. The decline in diagnostic performance in cases of 
borderline ovarian tumour was observed in all three expert operators.
The diagnostic performance of the expert sonologists was higher when 
discriminating invasive from non-invasive (benign and borderline) ovarian tumours than 
in discriminating malignant (borderline and invasive) from benign masses, mainly due 
to tendency to misclassify borderline ovarian tumours as benign lesions. As the 
interobserver agreement in the former was also better, these findings suggest that the 
outcomes could be dichotomised into non-invasive and invasive malignant lesions, as 
opposed to traditional diagnosis of benign and malignant lesions.
These findings were in agreement with our second study, which showed a low 
sensitivity of ultrasound pattern recognition method for the diagnosis of borderline 
ovarian tumours with 11% (4/35) of them presenting as simple cysts, which could not 
be differentiated from benign cysts. This problem was mostly encountered in cases of 
mucinous endocervical and serous types borderline ovarian tumours, whilst the
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diagnostic accuracy was better in cases of mucinous gastro-intestinal type borderline 
ovarian tumours.
Provided the results of our study are confirmed by others, ultrasound operators 
using pattern recognition method may be advised in the future to describe adnexal 
lesions as invasive or non-invasive, rather than as benign or malignant. The drawback of 
this approach is that a proportion of women with borderline lesions may be offered 
minimally invasive surgery, which increases the risk of the spillage of tumour content 
into the abdominal cavity. There is some evidence in the literature that spillage of 
invasive epithelial ovarian tumours at surgery may adversely affect patient’s long term 
outcomes (Vergote et al., 2001). The prognosis of borderline tumours, particularly those 
of gastro-intestinal type is very good and there is no strong data to suggest that the 
spillage of cyst fluid in these cases could cause harm (Fauvet et al., 2005). Nevertheless, 
it is pmdent to take measures to minimise the risk of spillage until more evidence is 
available about its effect on women’s health.
Our previous work also showed that the specificity of ultrasound diagnosis of 
borderline tumours is high. Therefore the risk of spillage may be minimised if 
ultrasound operators are encouraged to report the diagnosis of a borderline ovaiian 
tumour whenever typical moiphological features are present on ultrasound scan 
(Exacoustos et al., 2005; Fruscella et al., 2005).
Our study may be criticised for being performed on images stored on our 
database, rather than being based on real-time examination. However, the expert 
operators were given the option of removing cases from the study if they felt that there 
was insufficient data to form an opinion about the nature of an adnexal mass. In more 
than 97% (166/171) of the cases they felt that the information provided was satisfactory, 
which is probably not different from live scanning. It is also important to remember that
180
evaluation of static ultrasound images by radiologists is standar d practice in many units 
around the world.
The relative proportion of borderline ovarian tumours in our dataset was higher 
than one would expect to see in routine clinical practice, which could have had a 
negative effect on the diagnostic accuracy and reproducibility. The operators were 
aware, however, that the main objective of the study was to assess their accuracy in 
detecting borderline ovarian tumours, which could have improved their ability to 
diagnose these tumours.
In conclusion, our study has confirmed that ultrasound pattern recognition is an 
accurate and highly reproducible method for characterisation of adnexal tumours. The 
test, however, performs less well in cases of borderline ovarian tumours, which are 
sometimes difficult to distinguish from benign tumours. If this finding is reproduced by 
others, the structure of reporting ultrasound findings may need to change in order to 
classify ovarian tumours as being non-invasive or invasive, rather than making a 
diagnosis of benign or malignant tumour.
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Chapter 19
Study 5
Confidence of the ultrasound operator in making a differential diagnosis of an 
adnexal tumour: Effect on diagnostic accuracy and interobserver agreement
This study showed a clear association between the level of confidence and the 
diagnostic performance as the diagnostic accuracy of all three operators decreased in 
proportion to decreasing diagnostic confidence. Nonetheless, the three ultrasound 
operators, despite their similar high expertise, had variable degrees of confidence when 
they suggested a diagnosis of benign, borderline or invasive malignant ovarian tumours. 
Pattern recognition was a very useful test for discriminating between benign, borderline 
and invasive malignant ovarian tumours if the operators made their diagnoses with 
certainty, but if the operators were uncertain about their diagnoses, it was a virtually 
useless test.
Diagnostic certainty is usually associated with knowledge in medical decision 
making. ‘Assessing confidence and its individual components may prove extremely 
difficult as this may be influenced by complex factors, which interact and influence the 
level of confidence. These include the amount of training or expertise, time allocated to 
decision making, the degree of self-confidence, cultural differences and the operator’s 
internal mental process influenced by memory and emotions, which interact with the 
external environment and problem context’ (Rohrbaugh and Shanteau, 1999; Baranski 
and Petrusic, 1998).
The agreement in both diagnosis and confidence, in our study, was the lowest in 
the case of borderline ovarian tumours. Borderline ovarian masses were most often 
misclassified as benign tumours. This could be because certain types of benign and 
borderline ovaiian tumours share similai* morphological features, which make the
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differentiation between these two types of tumours difficult (Exacoustos et al., 2005; 
Fruscella et al., 2005).
The inter-observer agreement was almost perfect when the operators were 
certain about their final diagnoses (Cohen’s Kappa 0.95-1.00). This high level of 
agreement was not influenced by the way in which the tumours were classified: benign, 
borderline and invasive malignant ovarian tumours; non-invasive (benign, borderline) 
and invasive; or benign and malignant (borderline and invasive malignant). However, 
the inter-observer agreement was reduced to good (Cohen’s Kappa 0.64-0.80) when the 
operators made probable diagnoses. In this subgroup of cases, agreement between the 
operators was best when ovarian tumours were dichotomised into non-invasive (benign 
and borderline) and invasive malignant lesions, as opposed to traditional diagnosis of 
benign and malignant (borderline and invasive cancers) lesions. This result indicates a 
tendency of the ultrasound operators to confuse benign tumours with borderline ovaiian 
tumours.
In conclusion, our study has shown that the diagnostic performance with regard 
to discrimination between benign, borderline and malignant tumours when using pattern 
recognition depends on the confidence with which the diagnosis is suggested. 
Borderline ovarian tumours are the main source of diagnostic uncertainty. Our findings 
suggest that the level of confidence with which the diagnosis is made should be 
included into the ultrasound report. In cases of certain diagnosis, it would be safe to 
plan further management on the basis of the ultrasound diagnosis. In the case of a 
probable diagnosis, the moiphological description of the tumour should be accompanied 
by a list of possible histological diagnoses and it might be wise to consider additional 
diagnostic methods to improve the diagnostic accuracy. In cases with uncertain 
diagnosis the ultrasound report should include a clear statement that ultrasound 
examination was not informative enough to establish the likely histological diagnosis.
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Chapter 20
Study 6
Effect of the quality of gynaecological ultrasonography on management of patients 
with suspected ovarian cancer: a randomised controlled trial
This study shows that the quality of gynaecological ultrasonography diagnosis has a 
significant effect on the choices made by gynaecological oncologists in the management 
of patients with suspected ovarian cancer. The number of major staging surgical 
procedures for presumed ovaiian malignancy was significantly lower after a level III 
(expert) ultrasonography compared with after a (routine) scan done by a non-specialist. 
This finding is likely to be the consequence of the greatly increased proportion of 
patients in whom a conclusive diagnosis of the nature of the adnexal tumour was 
possible from level III ultrasonography compared with level II ultrasonography. It could 
be argued that level II operators used a different ultrasound machine, which may be 
regarded by some ultrasound operators as being inferior to the one used by the level III 
operators in our study. Furthermore, level II operators could also have been at a 
different time pressure compared to level III operators. However, all the level II 
operators in our study were happy with the quality of the ultrasound machine they used 
and they always took all the time they needed to complete the examination.
The total number of surgical procedures done in the two groups was similar. 
However, the number of minimally invasive procedures in the Level III group was 
higher than in the Level II group, which contributed to the significant decrease in the 
length of hospital stay in the level III group.
A common problem in the management of patients with adnexal masses in 
routine clinical practice is the inability of the ultrasonography operator to reach a 
confident preoperative differentiation between benign and malignant masses. As a
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result, benign cysts in many patients are treated as potentially malignant and these 
patients are routinely referred to regional cancer centres for further management. This 
problem is clearly highlighted in this study, where only 18 (12%) of the 150 of patients 
recruited were eventually diagnosed with ovarian cancer.
The main difference between the two groups of this study was the significantly 
higher proportion of non-diagnostic scans in the level II group. A likely histological 
diagnosis was provided to the clinicians in 76 (99%) of 77 patients in the level III group 
compared with 38 (52%) of 73 patients in the level II group. This finding can be largely 
explained by the differing approaches to obtaining a diagnosis from ultrasonography 
between non-specialist ultrasonographers and experts. Ultrasonographers tend to 
provide a summary of morphological characteristics of adnexal tumours on 
ultrasonography, but infrequently attempt to differentiate between benign and malignant 
ovarian tumours or attempt to predict a histological diagnosis. The interpretation of the 
ultrasonography findings is, thus, left to the clinicians with little or no experience in 
ultrasonography diagnosis, and who feel compelled to undertake surgery to ensure that 
patients with ovarian cancer are not managed incorrectly. The ultrasonography 
equipment used for each group was of a similar high quality and there is no reason to 
believe that the performance of ultrasonography machines contributed to the difference 
in group. This difference is more likely to be a result of discrepancies in the assessment 
of adnexal tumours and the reporting of ultrasonography findings between level II and 
level III operators.
Our findings suggest that another advantage of a level III scan is a better overall 
ability to diagnose benign adnexal pathology. This ability decreases the number of 
patients who are treated as potentially having ovarian cancer and aids the use of more 
conservative management options. Even in the context of care within the regional 
cancer centre, where the prevalence of malignancy is likely to be much higher compared
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with low-risk units, the increased number of patients with a conclusive ultrasound 
diagnosis of benign adnexal pathology was accompanied by a significant decrease in the 
number of open staging surgical procedures.
The effect of expert scanning may be even higher if used in the primary 
assessment of ovarian pathology. Increased confidence in the diagnosis of benign 
ovarian lesions is likely to decrease the need for additional diagnostic tests, such as MRI 
or serum CA-125 concentration, and also decrease the number of referrals to regional 
cancer centres. A large proportion of benign ovarian cysts are detected incidentally 
during opportunistic ultrasonography screening. Many of these patients are offered 
surgical treatment because of uncertainty about the nature of the ovarian lesion, which 
could be avoided by an improved ultrasonography diagnosis.
The accuracy of level III ultrasonography in this study was similar to the 
findings reported from other expert centres (Valentin, 1999; Timmerman et al., 1999b). 
One patient had a false negative diagnosis of squamous cell carcinoma, within a mature 
cystic teratoma. This carcinoma is a rare tumour, which is difficult to diagnose. Expert 
ultrasonography operators who use the “pattern recognition” method, do not normally 
miss epithelial ovarian cancers. However, the diagnosis of borderline ovarian tumours is 
more difficult and false negative findings are more common. This problem, however, is 
offset by the high specificity achieved by expert ultrasonography operators, which helps 
to avoid unnecessary interventions in patients with benign adnexal pathology.
The use of other imaging modalities to clarify the nature of the ovarian tumour 
was no different between the two groups of our study, despite a large difference in the 
number of conclusive ultrasonography diagnoses. This finding suggests clinicians 
believe that other non-invasive tests contribute little to diagnostic accuracy, and they 
tend to use surgery both as a diagnostic and a therapeutic procedure in ovarian tumours. 
Such an approach is clearly not cost-effective and a powerful argument exists in favour
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of improving the quality of ultrasonography assessment in routine gynaecological 
practice. However, the cost-benefit ratio might be affected by the greater cost of using 
expert ultrasonography operators compared with routine ultrasonographers.
In the UK, most ultrasonography assessments are done by ultrasonographers 
who are trained in the use of ultrasonography equipment for the assessment of patients 
with various medical conditions. The number of examiners who specialise in 
gynaecological ultrasonography is low. By contrast with other areas of clinical practice, 
such as obstetrics, the ultrasonography findings in gynaecology are often non-specific. 
To achieve a high diagnostic accuracy, ultrasonography imaging needs to be combined 
with clinical history and physical examination. This method has been recognised by the 
Royal College of Obstetricians and Gynaecologists who have integrated gynaecological 
ultrasonography training into core and advanced speciality training in gynaecology 
(Special Skills Training in Obstetrics and Gynaecology, 2002). This policy is likely to 
have a long term positive effect on the quality of diagnosis from gynaecological 
ultrasonography diagnosis in secondary and tertiary caie centres. Until the number of 
highly trained gynaecological ultrasonographers is increased, effort should be made to 
provide expert ultrasonography scanning at least in tertiary referral units.
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Chapter 21 i
IStudy 7 I
Value of preoperative ultrasound in the selection of women with adnexal masses 
for laparoscopic surgery
The results of our study have shown that preoperative ultrasound examination may be 
used to identify women with low risk of converting minimally invasive surgery for an 
ovarian tumour into a laparotomy. The most important prerequisite for performing safe i
laparoscopic surgery is an accurate diagnosis of a benign cyst (Parker, 1992). It is ,
therefore reassuring that there were no cases of invasive ovaiian cancer in the study 
population.
One mucinous gastro-intestinal type borderline ovarian cyst was misdiagnosed 
as a benign tumour. The cyst appeared unilocular on the scan with a smooth internal 
wall and it did not contain solid foci or septations. At laparoscopy the cyst also 
appeared benign and the patient underwent a laparoscopic oophorectomy. She has been 
followed up with ultrasound scans, for the past two years, which showed no signs of 
tumour recurrence so far. A small number of gastro-intestinal type borderline ovarian 
tumours cannot be differentiated from benign cysts on ultrasound scan (Fruscella et al.,
2005). Therefore it is likely that this type of borderline tumour will be occasionally 
operated on laparoscopically. However, the prognosis of gastro-intestinal type 
borderline ovarian tumours is very good, and there is no evidence that spillage of 
tumour content at laparoscopy has an adverse effect on long-term prognosis and 
survival rates (Ahmed and Lawton, 2005; Silverberg et al., 2004; Maneo et al., 2004).
Therefore, the inability to rule out with absolute confidence a borderline gastro­
intestinal tumour should not stop surgeons performing laparoscopies on women with 
presumed benign cysts. However, a careful audit of the outcome of these cases is
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necessary in order to monitor for possible adverse outcomes that may be associated with 
spillage of borderline ovarian tumours.
Our study was in agreement with other reports (Valentin et al., 2001; Valentin, 
2004), which examined the value of ultrasound pattern recognition for the diagnosis of 
ovarian cancer. As demonstrated in this study, pattern recognition was highly accurate 
in identifying benign lesions suitable for conseiwative surgery.
Berlanda et al. (2002) evaluated the accuracy and impact of a multiparameter, 
ultrasound-based triage on surgical management of adnexal masses. They divided 
tumours into low-risk, moderate-risk and high-risk of being malignant. However, three 
tumours that were diagnosed as low/moderate-risk turned out to be malignant on 
histological examination and they were classified as mismanaged, because they 
underwent laparoscopic surgery.
Another study by Guerriero and co-workers (2005) assessed whether 
ultrasonography with colour Doppler can identify and triage the patients with adnexal 
masses to the most appropriate surgical approach. Again, masses were classified based 
on the risk of malignancy. Adnexal masses with low risk of malignancy were operated 
on by conventional laparoscopy. No malignant tumour in this study was operated on by 
laparoscopic surgery.
However, our study did not attempt to differentiate adnexal tumours as being 
high or low risk of malignancy. All tumours suspected to be malignant were operated on 
by a gynaecological oncologist. Our study, aimed to predict the success of laparoscopic 
surgery by performing a preoperative ultrasound assessment, taking into account that 
these tumours must be benign in nature.
Approximately 80% of all presumed benign ovarian cysts were selected for a 
laparoscopy, which was successfully completed in nearly 95% of cases. This indicates 
that our criteria for performing laparoscopy may be used to identify those women in
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whom the risk of conversion is low. It is equally important to emphasise that the 
proposed criteria are not too strict as almost four-fifths of women with benign cysts 
were offered minimally invasive surgery.
Our results also show that the sensitivity of ultrasound examination for the 
diagnosis of pelvic adhesions is not as high as we hoped. The PPV of ultrasound was 
not very good as in 2/6 (33%) of women with suspected severe adhesions the ultrasound 
diagnosis was not confirmed at laparotomy. Although only 3/113 (2.7%) women had 
severe adhesions that were not detected on the scan, adhesions were the main reason for 
failed laparoscopy and accounted for 50% of all failures. The presence of adhesions was 
particularly difficult to predict in obese patients and in those with large tumours. It is 
difficult to speculate why the accuracy of ultrasound was low in diagnosing pelvic 
adhesions in our study. The need for easier ultrasound signs that describe adhesions 
may be a solution. Nonetheless, the ultrasound examiner should maintain a high level of 
clinical suspicion and the assessment of pelvic anatomy’ mobility should be done 
systematically by a combination of gentle pressure with the vaginal probe and 
abdominal pressure with the examiners free hand as in a bimanual examination in order 
to assess movement of organs and tissues and their relation to each other.
Guerriero et al. (1997) in a previous study found that the adhesion of the ovary 
to the uterus (fixation), as evaluated by transvaginal ultrasonography, had a good PPV 
(81%) in diagnosing adhesions and this was more accurate than was blurring of the 
margins of the ovary (PPV 65%) and augmentation of the usual distance of the ovary 
from the probe which persisted with abdominal palpation (PPV 74%). In a recent study, 
Okaro and co-workers (2006) assessed ovarian mobility by applying pressure with the 
ultrasound probe. They reported a good correlation between ovarian mobility on 
transvaginal ultrasound and at laparoscopy (kappa 0.81). However, most of their
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patients had normal ovaries, which are much easier to assess for mobility than are large 
pelvic tumours.
All the other unsuccessful laparoscopies failed purely because of technical 
difficulties, which may be encountered during laparoscopic surgery. Morbid obesity is 
not an absolute contraindication for laparoscopic surgery, but it is well known that it is 
often complicated by difficulties in gaining entry into the abdominal cavity. The other 
technical reason for failed laparoscopy in our study was an injury to the inferior 
epigastric artery. This is an unfortunate complication, which occasionally requires 
converting a laparoscopy into a laparotomy due to inability to contain bleeding from the 
injured vessel. Our conversion rate was not significantly different from the publication 
by Berlanda et al. (2002) and it was much lower than the 25% reported by Havrilesky 
(2003), who evaluated the clinical outcomes of laparoscopic management of adnexal 
masses that were thought to be benign before surgery. These differences are dependent 
on many factors including patient population, indication for surgery and experience of 
surgeon. It is difficult to compare our study with previous reports because we performed 
surgery only on women with conclusive diagnosis of benign ovarian tumours, whereas 
all other studies included women with significant proportion of malignant adnexal 
tumours.
It is also important to say that ultrasound was accurate in excluding severe 
pelvic endometriosis; hence there were no cases of severe endometriosis among those 
women who underwent intermediate-level laparoscopic surgery.
Laparoscopic ovarian cystectomy was successfully completed in just over 90% 
of the planned cases. Undiagnosed pelvic adhesions were the reason for conversion of 
laparoscopic cystectomy into laparoscopic oophorectomy in nearly a third of the cases. 
The remaining reasons for conversion were heavy bleeding from the cyst bed and the 
presence of a chronic adnexal torsion. However, ovarian tumour volume appeared to
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have played an important role in dictating the success of laparoscopic ovarian 
cystectomy as demonstrated in our results. Although it is difficult to establish a cut-off 
tumour volume for laparoscopic ovarian cystectomy, we should bear in mind that the 
risk of oophorectomy increases with the increasing size of the cyst. This is in agreement 
with a previous study by Havrilesky et al. (2003), which also showed that the risk of 
failed laparoscopic surgery increases with increasing tumour size.
There is no doubt that the success of laparoscopic surgery is mainly dependent 
on the skill and expertise of the operating surgeon. In expert hands most operations can 
be completed successfully using a laparoscopic approach. Most consultant 
gynaecologists in the UK and worldwide perform intermediate-level laparoscopic 
surgery. The results of this study may aid them when selecting women with benign 
cysts for minimally invasive surgery.
In conclusion, our study has shown that a detailed preoperative transvaginal 
ultrasound is helpful for assessing the feasibility of intermediate-level laparoscopic 
surgery in women with benign adnexal lesions. A correct diagnosis of benign tumour is 
of critical importance when deciding on the type of operation to remove an adnexal 
cyst. However, the assessment of tumour consistency and mobility helps to identify 
women in whom the risk of conversion to laparotomy is minimal and surgery may be 
performed as a day case.
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PART FOUR:
Conclusions and Further Research
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Chapter 23: Conclusions and Further Research
This thesis has shown that RMI and OCS are fairly good methods for preoperative 
differentiation between invasive and non-invasive adnexal tumours. Both tests have 
proven to be very sensitive for the detection of invasive ovarian cancer. The use of the 
OCS is easy and has the potential benefit of reducing the number of unnecessary 
referrals to regional gynaecological cancer centres for planning further management, 
and it would eventually lead to reduction in both cost and anxiety. However, future 
work including a higher number of ovarian malignancies, will show whether the use of 
the OCS as an alternative to RMI, either during the initial scan or within tertiary referral 
centres, may be a more effective way of managing women with ultrasonographic 
diagnosis of ovarian tumours.
This work had demonstrated that the correct ultrasound diagnosis of BOT using 
pattern recognition can be achieved in two-thirds of cases with a very good specificity. 
Further work is required to identify morphological and biochemical features that may 
help to increase the accuracy of pre-operative detection of such tumours.
The thesis has confirmed that preoperative diagnosis of an adnexal mass made 
on the basis of a real-time ultrasound examination is more accurate than a diagnosis 
made on the basis of saved static ultrasound images. Evaluation of static images is 
associated with lower specificity. The dynamic aspect of the real-time scan gives the 
examiner supplementary information and makes it possible to scrutinise every pait of 
the mass. The ‘rarity’ of experts in gynaecological ultrasonography would make the 
aspect of providing a second opinion by email, in the case of ‘difficult’ adnexal 
tumours, very appealing. It would be interesting in the future to assess whether the 
performance of these experts would be better if they were presented with representative
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video clips or with the use of four-dimensional cine loops of volume instead of with 
static images.
Our dataset showed that ultrasound pattern recognition is an accurate and highly 
reproducible method for characterisation of adnexal tumours, and its accuracy is 
dependent on the confidence with which the diagnosis is suggested. The test, however, 
performs less well in cases of BOT, which are sometimes difficult to distinguish from 
benign tumours and are the main source of diagnostic uncertainty. We suggest that the 
structure of reporting ultrasound findings may need to change in order to classify 
ovarian tumours as being non-invasive or invasive, rather than making a diagnosis of 
benign or malignant tumour. It is also important that the level of confidence with which 
the diagnosis is made is also included into the ultrasound report. In cases of certain 
diagnosis, it would be safe to plan further management on the basis of the ultrasound 
diagnosis. In the case of a probable diagnosis, the morphological description of the 
tumour should be accompanied by a list of possible histological diagnoses and it might 
be wise to consider additional diagnostic methods to improve the diagnostic accuracy. 
In cases with uncertain diagnosis the ultrasound report should include a clear statement 
that ultrasound examination was not informative enough to establish the likely 
histological diagnosis.
The randomised controlled trial included in this thesis has confirmed the 
importance of expertise in gynaecological ultrasonography in view of the improved 
accuracy in differential diagnosis of ovarian tumours and the positive effect on their 
optimal management. Our findings suggest that a greater number of minimally invasive 
procedures and shorter hospital stays can be achieved in women with adnexal lesions 
suspicious of ovarian malignancy if they are scanned by experienced gynaecologists 
rather than ultrasonographers. There is an urgent need for a detailed cost-benefit 
analysis and quality of life assessment of this management strategy and for its
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assessment in the primary-care setting. Independent validation should lead to the 
provision of expert ultrasonography, at least in tertiary cancer centres. Additionally, in 
countries like the UK, where few gynaecologists specialise in ultrasonography and most 
scans are done by ultrasonographers, there are important implications for training and 
workforce planning.
Finally, this thesis did show that detailed preoperative transvaginal ultrasound is 
helpful for assessing the feasibility of intermediate-level laparoscopic surgery in women 
with benign adnexal lesions. A correct diagnosis of benign tumour is of critical 
importance when deciding on the type of operation to remove an adnexal cyst. 
However, the assessment of tumour consistency and mobility helps to identify women 
in whom the risk of conversion to laparotomy is minimal and surgery may be performed 
as a day case. Future work should concentrate on assessing the role of gynaecological 
ultrasonography in the estimation of the severity of pelvic endometriosis. The 
identification of patients with severe endometriosis will provide these women with an 
opportunity to be managed by experts in laparoscopic surgery in tertiary endometriosis 
centres.
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